- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID B10R
AC CVCL_0155
DR MCCL; MCC:0000047
RX PubMed=1856597;
RX PubMed=9490047;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/10A.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID B10S
AC CVCL_0156
DR MCCL; MCC:0000048
RX PubMed=1856597;
RX PubMed=9490047;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/10A.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID B11
AC CVCL_B038
DR CLO; CLO_0001785
DR ATCC; HB-8372
RX Patent=US4637984;
CC Monoclonal antibody target: UniProtKB; P00860; Mouse Odc.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID B117H
AC CVCL_Y506
DR EFO; EFO_0002040
RX PubMed=16647569;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y505 ! B117p
CA Cancer cell line
//
ID B117p
AC CVCL_Y505
SY B117P
DR EFO; EFO_0002041
RX PubMed=16647569;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID B140H
AC CVCL_Y508
DR EFO; EFO_0002042
RX PubMed=16647569;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y507 ! B140p
CA Cancer cell line
//
ID B140p
AC CVCL_Y507
SY B140P
DR EFO; EFO_0002043
RX PubMed=16647569;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID B119-iPSC
AC CVCL_DE33
RX PubMed=25843045;
RX PubMed=27191603;
CC Characteristics: Heterozygous for the PARK2 p.Arg275Trp mutation.
ST Source(s): PubMed=27191603
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 12,13
ST D21S11: 29,30
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,12
ST vWA: 16
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DD48 ! ND29369
SX Female
CA Induced pluripotent stem cell
//
ID B11F7
AC CVCL_B039
DR ATCC; CRL-2944
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID B12
AC CVCL_4111
SY B-12
DR BTO; BTO:0005450
DR CLO; CLO_0001786
DR CLDB; cl331
DR ECACC; 85042303
RX PubMed=4151463;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: BDIX.
DI NCIt; C121567; Rat neuroblastoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Cancer cell line
//
ID B12-11
AC CVCL_C623
DR ISCR; 282
RX PubMed=18849973;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID B12-2
AC CVCL_C620
DR ISCR; 285
RX PubMed=18849973;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID B12-3
AC CVCL_C621
DR ISCR; 284
RX PubMed=18849973;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID B12-6
AC CVCL_C622
DR ISCR; 283
RX PubMed=18849973;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID B12.F8
AC CVCL_2301
DR ECACC; 11060102
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 9,11
ST vWA: 14,16
DI NCIt; C3098; Hepatitis C infection
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2404 ! CM3.B6
CA Transformed cell line
//
ID B1203L
AC CVCL_8658
DR CLO; CLO_0050057
DR BioSample; SAMN03471929
DR RCB; RCB2818
RX PubMed=11267941;
RX PubMed=12114371;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 9,10
ST vWA: 18
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID B124-1
AC CVCL_C624
DR ISCR; 281
RX PubMed=18849973;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID B124-10
AC CVCL_C626
DR ISCR; 279
RX PubMed=18849973;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID B124-13
AC CVCL_C627
DR ISCR; 278
RX PubMed=18849973;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID B124-2
AC CVCL_C625
DR ISCR; 280
RX PubMed=18849973;
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID B13
AC CVCL_4W12
SY B-13
DR BCRJ; 0043
RX PubMed=2469765;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=B13
CC Characteristics: IL5 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID B13-24
AC CVCL_4583
DR CLO; CLO_0001787
DR ATCC; CRL-11397
RX Patent=US5854070;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_1977 ! CHO-DXB11
SX Female
CA Transformed cell line
//
ID B13.29
AC CVCL_B953
SY Clone 9.9
RX PubMed=3491732;
RX PubMed=3500054;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B13B
AC CVCL_CY49
DR ATCC; CRL-2636
RX PubMed=11401970;
CC Monoclonal antibody target: UniProtKB; Q48245; Helicobacter pylori vacA.
CC Discontinued: ATCC; CRL-2636; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B14-150
AC CVCL_L858
SY B14150; UCW 104
DR CLO; CLO_0001788
DR CLDB; cl332
DR ATCC; CCL-14.1
RX PubMed=5833550;
RX PubMed=6965094;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/ab14-150.htm
CC Misspelling: Occasionally 'B14I50'.
CC Discontinued: ATCC; CCL-14.1; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4584 ! B14FAF28-G3
SX Female
CA Transformed cell line
//
ID B14.2
AC CVCL_J941
RX PubMed=6789331;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B14FAF28-G3
AC CVCL_4584
SY B14FAF28 clone G3; B14 FAF 28-G3; B14 FAF-28 clone G3
DR CLO; CLO_0001789
DR CLDB; cl333
DR ATCC; CCL-14
DR ECACC; 91010302
RX PubMed=13787312;
CC Discontinued: ECACC; 91010302; probable.
OX NCBI_TaxID=10029; ! Cricetulus griseus
SX Female
CA Transformed cell line
//
ID B151K12
AC CVCL_U121
DR CLO; CLO_0050246
DR RCB; RCB0793
RX PubMed=6159416;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_U120 ! BW 5147-AZG(R),OU(R)
CA Hybridoma
//
ID B157
AC CVCL_6276
DR Lonza; 1017
RX PubMed=16136460;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID B16
AC CVCL_F936
SY B-16; B16 melanoma; B16 subline B78; B78
DR CLO; CLO_0050752
DR CCRID; 3111C0001CCC000215
DR CCRID; 3111C0001CCC000324
DR CCRID; 3131C0001000800002
DR CCRID; 3153C0001000000029
DR ChEMBL-Cells; CHEMBL3308454
DR ChEMBL-Targets; CHEMBL381
DR JCRB; JCRB0202
DR KCB; KCB 93030YJ
DR RCB; RCB1283
DR TKG; TKG 0144
DR TOKU-E; 3564
DR Wikidata; Q25112368
RX PubMed=4981070;
RX PubMed=5513504;
RX PubMed=6498800;
WW https://en.wikipedia.org/wiki/B16_Melanoma
CC Miscellaneous: This line seems to be the B78 line described in PubMed=4981070 which itself seems to be derived from the HFH-18 line that itself originate from a B16 melanoma.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_GS32 ! HFH-18
SX Male
CA Cancer cell line
//
ID B16 melanoma 4A5
AC CVCL_4612
SY B164A5
DR CLO; CLO_0001790
DR CLO; CLO_0050758
DR CLDB; cl335
DR ECACC; 94042254
DR IZSLER; BS TCL 184
DR RCB; RCB0557
RX PubMed=23890195;
CC Doubling time: 24 hours (PubMed=23890195).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B16 melanoma/lacZ
AC CVCL_L291
DR CLO; CLO_0050753
DR RCB; RCB1284
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B16-A
AC CVCL_8298
DR CLO; CLO_0001791
DR CLDB; cl336
RX PubMed=6644070;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B16-B
AC CVCL_8299
RX PubMed=6644070;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B16-BL6
AC CVCL_0157
SY B16/BL6; B16 BL6; B16BL6; BL6; BL-6; B16-F10-BL6
DR BTO; BTO:0002808
DR CLO; CLO_0050759
DR MCCL; MCC:0000049
DR KCLB; 80006
DR RCB; RCB2638
DR TKG; TKG 0598
RX PubMed=7370995;
RX PubMed=11833741;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B16-Blue IFN-alpha/beta
AC CVCL_X605
WW http://www.invivogen.com/b16-blue-ifnab
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-alpha/beta-inducible ISG54 promoter enhanced by a multimeric ISRE.
CC Transfected with: HGNC; 439; ALPP.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0158 ! B16-F1
SX Male
CA Cancer cell line
//
ID B16-Blue IFN-gamma
AC CVCL_X604
WW http://www.invivogen.com/b16-blue-ifng
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter fused to 4 IFNG-activated sites (GAS).
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: HGNC; 11362; STAT1.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0158 ! B16-F1
SX Male
CA Cancer cell line
//
ID B16-Blue ISG
AC CVCL_X602
WW http://www.invivogen.com/b16-blue-isg
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE.
CC Transfected with: HGNC; 439; ALPP.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0158 ! B16-F1
SX Male
CA Cancer cell line
//
ID B16-Blue ISG-KO-STING
AC CVCL_X603
WW http://www.invivogen.com/b16-blue-isg-ko-sting
CC Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE.
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1919762; Tmem173.
CC Transfected with: HGNC; 439; ALPP.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_X602 ! B16-Blue ISG
SX Male
CA Cancer cell line
//
ID B16-C2M
AC CVCL_H720
SY B16 C2M; B16C2M; C2M
DR TKG; TKG 0346
RX PubMed=4209534;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B16-C2W
AC CVCL_H721
SY B16 C2W; B16C2W; C2W
DR TKG; TKG 0666
RX PubMed=4209534;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B16-F0
AC CVCL_0604
SY B16/F0; B16F0
DR CLO; CLO_0001792
DR CLDB; cl340
DR ATCC; CRL-6322
DR BCRC; 60029
DR BCRJ; 0044
DR CCRID; 3142C0001000000038
DR ECACC; 92101204
DR Lonza; 873
RX PubMed=1109790;
RX PubMed=11833741;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B16-F0-Luc
AC CVCL_4W99
DR JCRB; JCRB1474
DR JCRB; NIHS0698
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0604 ! B16-F0
SX Male
CA Cancer cell line
//
ID B16-F1
AC CVCL_0158
SY B16/F1; B16 F1; B16F1
DR BTO; BTO:0003853
DR CLO; CLO_0001793
DR CLO; CLO_0050764
DR MCCL; MCC:0000050
DR CLDB; cl337
DR CLDB; cl338
DR ATCC; CRL-6323
DR BCRC; 60030
DR BCRJ; 0045
DR CCRID; 3111C0001CCC000365
DR CCRID; 3142C0001000000039
DR CLS; 400122/p793_B16-F1
DR ECACC; 92101203
DR KCLB; 80007
DR Lonza; 1278
DR RCB; RCB2649
DR TKG; TKG 0347
DR TOKU-E; 581
RX PubMed=1109790;
RX PubMed=6498800;
RX PubMed=6539703;
RX PubMed=11833741;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0604 ! B16-F0
SX Male
CA Cancer cell line
//
ID B16-F10
AC CVCL_0159
SY B16/F10; B16 F10; B16F10; B16 melanoma F10
DR BTO; BTO:0002014
DR CLO; CLO_0001794
DR CLO; CLO_0050763
DR MCCL; MCC:0000051
DR CLDB; cl339
DR CLDB; cl4967
DR ATCC; CRL-6475
DR BCRC; 60031
DR BCRJ; 0046
DR ChEMBL-Cells; CHEMBL3307762
DR ChEMBL-Targets; CHEMBL612656
DR ICLC; ATL99010
DR KCB; KCB 2014047YJ
DR KCLB; 80008
DR Lonza; 998
DR NCBI_Iran; C540
DR RCB; RCB2630
DR TKG; TKG 0348
RX PubMed=1109790;
RX PubMed=6539703;
RX PubMed=11833741;
RX PubMed=23890195;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-1.html
CC Doubling time: 17.2 hours (PubMed=23890195).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0158 ! B16-F1
SX Male
CA Cancer cell line
//
ID B16-F10-Lr6
AC CVCL_U240
SY B16-F10-LR6; B16-F10Lr6; B16F10Lr6; F10 Lr6; Lr6
DR ATCC; CRL-6324
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6324; true.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B16-F10-Luc 1-#3
AC CVCL_4Y00
SY B16F10-Luc 1-#3
DR JCRB; JCRB1465
DR JCRB; NIHS0699
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B16-F10-luc-G5
AC CVCL_5J39
SY B16F10-luc-G5; B16F10-lucG5
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119269.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B16-F10-luc2
AC CVCL_5J17
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124734.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B16-F10-Nex2
AC CVCL_F942
SY B16F10-Nex2; B16F10-NEX2; B16F10Nex2
DR BTO; BTO:0003424
DR BCRJ; 0342
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B16-F10-Red-FLuc
AC CVCL_5I87
SY B16F10-Red-FLuc; B16F10 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124734
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B16-FLT3L
AC CVCL_IJ12
SY B16-Flt3l; B16FLT3
RX PubMed=10866317;
RX PubMed=23890195;
CC Doubling time: 18.4 hours (PubMed=23890195).
CC Transfected with: MGI; MGI:95560; Flt3l.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B1647
AC CVCL_3357
DR CLDB; cl7141
DR ICLC; HTL03004
RX PubMed=9332307;
ST Source(s): ICLC
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,9
ST D16S539: 11,12
ST D21S11: 30,31
ST D5S818: 8,10
ST D7S820: 12
ST TH01: 6
ST TPOX: 8
ST vWA: 18,20
DI NCIt; C9160; Childhood acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID B16F10/mGM
AC CVCL_L292
SY B16-GMCSF; B16GMCSF; B16-GM
DR CLO; CLO_0050762
DR RCB; RCB1158
RX PubMed=9886252;
RX PubMed=23890195;
CC Doubling time: 17.9 hours (PubMed=23890195).
CC Transfected with: MGI; MGI:1339752; Csf2.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0159 ! B16-F10
SX Male
CA Cancer cell line
//
ID B16V
AC CVCL_1950
SY B-16V
DR CLO; CLO_0001795
DR CLDB; cl341
DR DSMZ; ACC-370
RX PubMed=3730255;
CC Doubling time: 15 + 1.64 hours (PubMed=3730255); ~20 hours (DSMZ).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B16VDXR
AC CVCL_F937
SY B16VDxR
DR CLO; CLO_0001796
DR CLDB; cl342
RX PubMed=3730255;
RX PubMed=3741758;
CC Doubling time: 25 + 1.75 hours (PubMed=3730255).
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1950 ! B16V
SX Male
CA Cancer cell line
//
ID B18
AC CVCL_V065
DR CLO; CLO_0001797
DR CLDB; cl343
DR IHW; IHW8122
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID B19
AC CVCL_V066
DR CLO; CLO_0001798
DR CLDB; cl344
DR IHW; IHW8124
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_V055 ! DAP.3
SX Male
CA Spontaneously immortalized cell line
//
ID B1A2A
AC CVCL_L928
RX PubMed=5062896;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_L927 ! BHK 21/13 subline B1
SX Male
CA Spontaneously immortalized cell line
//
ID B1A2A5
AC CVCL_L929
SY Line A-5; A5 subline; GM00511
DR CLO; CLO_0025932
DR Coriell; GM00511
RX PubMed=5062896;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_L928 ! B1A2A
SX Male
CA Spontaneously immortalized cell line
//
ID B1B3
AC CVCL_G635
SY 464 B1B3; 464B1B3
DR CLO; CLO_0001800
DR ATCC; CRL-2249
RX PubMed=3973009;
CC Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B1B6
AC CVCL_G636
SY 464 B1B6; 464B1B6
DR CLO; CLO_0001801
DR ATCC; CRL-2248
RX PubMed=3973009;
CC Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B1D6
AC CVCL_L832
DR ECACC; 98042014
CC Monoclonal antibody target: UniProtKB; P07355; Human ANXA2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID B1OXI
AC CVCL_6C17
SY B1oxi
RX CelloPub=CLPUB00293;
RX PubMed=20444515;
RX PubMed=22193509;
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of chicken origin but found to be a porcine cell (PubMed=22193509).
CC Misspelling: 'B10XI' in PubMed=22193509.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Undefined cell line type
//
ID B2-1
AC CVCL_4503
SY cl. B2-1
DR CLO; CLO_0001805
DR CLDB; cl346
DR ATCC; CRL-8085
DR IZSLER; BS CL 122
RX Patent=US4465769;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Y303 ! 10E2
CA Spontaneously immortalized cell line
//
ID B2-17
AC CVCL_2864
DR BioSample; SAMN03151975
DR Cosmic; 911904
DR Cosmic; 2367508
DR IFO; IFO50361
RX CelloPub=CLPUB00152;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a U-251MG derivative.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0021 ! U-251MG
SX Male
CA Cancer cell line
//
ID B2.Bm
AC CVCL_R940
DR ATCC; CRL-6021
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6021; true.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_3647 ! B2.Ln
OI CVCL_3648 ! B2.Sp
OI CVCL_3649 ! B2.Sp/Thy
OI CVCL_S316 ! B2.Thy
SX Male
CA Finite cell line
//
ID B2.Ln
AC CVCL_3647
DR CLO; CLO_0001802
DR ATCC; CRL-6022
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6022; true.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_R940 ! B2.Bm
OI CVCL_3648 ! B2.Sp
OI CVCL_3649 ! B2.Sp/Thy
OI CVCL_S316 ! B2.Thy
SX Male
CA Finite cell line
//
ID B2.Sp
AC CVCL_3648
DR CLO; CLO_0001803
DR CLDB; cl347
DR ATCC; CRL-6023
DR ECACC; 90030906
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6023; true.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_R940 ! B2.Bm
OI CVCL_3647 ! B2.Ln
OI CVCL_3649 ! B2.Sp/Thy
OI CVCL_S316 ! B2.Thy
SX Male
CA Finite cell line
//
ID B2.Sp/Thy
AC CVCL_3649
DR CLO; CLO_0001804
DR ATCC; CRL-6024
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6024; true.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_R940 ! B2.Bm
OI CVCL_3647 ! B2.Ln
OI CVCL_3648 ! B2.Sp
OI CVCL_S316 ! B2.Thy
SX Male
CA Finite cell line
//
ID B2.Thy
AC CVCL_S316
DR ATCC; CRL-6025
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6025; true.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_R940 ! B2.Bm
OI CVCL_3647 ! B2.Ln
OI CVCL_3648 ! B2.Sp
OI CVCL_3649 ! B2.Sp/Thy
SX Male
CA Finite cell line
//
ID B203L
AC CVCL_U097
RX PubMed=11267941;
RX PubMed=12114371;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID B21-2
AC CVCL_9164
DR CLO; CLO_0001806
DR ATCC; TIB-229
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID B239
AC CVCL_L055
RX PubMed=1664237;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L056 ! B240
OI CVCL_1835 ! NALM-19
SX Male
CA Transformed cell line
//
ID B240
AC CVCL_L056
RX PubMed=1664237;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L055 ! B239
OI CVCL_1835 ! NALM-19
SX Male
CA Transformed cell line
//
ID B25.2
AC CVCL_J942
DR CLO; CLO_0001808
DR ATCC; HB-8107
RX Patent=US4522918;
RX PubMed=6789331;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B250
AC CVCL_L054
RX PubMed=1817649;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1836 ! NALM-20
OI CVCL_1837 ! NALM-21
OI CVCL_5662 ! NALM-22
OI CVCL_5663 ! NALM-23
SX Male
CA Transformed cell line
//
ID B27M1
AC CVCL_J172
DR CLO; CLO_0001809
DR ATCC; HB-157
RX PubMed=6166821;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J171 ! Sp2/08A2
CA Hybridoma
//
ID B27M2
AC CVCL_J173
DR CLO; CLO_0001810
DR ATCC; HB-165
RX PubMed=6981637;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J171 ! Sp2/08A2
CA Hybridoma
//
ID B29
AC CVCL_G637
DR CLO; CLO_0001811
DR ATCC; HB-9746
DR IZSLER; BS Hy 49
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B2LT1
AC CVCL_HE71
RX Patent=US6825394;
CC Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 97032720.
CC Breed/subspecies: Sprague-Dawley SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Conditionally immortalized cell line
//
ID B3 NIH
AC CVCL_J978
SY B3
DR ATCC; HB-10573
RX Patent=US5612032;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID B3/25
AC CVCL_G096
DR CLO; CLO_0001813
DR ATCC; CRL-8034
DR ECACC; 94050507
RX Patent=US4626507;
RX PubMed=6265934;
RX PubMed=7412870;
CC Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4696 ! S194/5.XXO.BU.1
CA Hybridoma
//
ID B3/AN
AC CVCL_3358
DR CLO; CLO_0001814
DR CLDB; cl349
DR CLDB; cl350
DR ECACC; 94031009
DR ICLC; ATL97004
CC Discontinued: ECACC; 94031009; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID B3.2
AC CVCL_T690
SY B 3.2
RX PubMed=3419920;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID B3.2(tTA)1
AC CVCL_6E63
RX PubMed=9542626;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
HI CVCL_T690 ! B3.2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID B301
AC CVCL_M579
RX PubMed=10925292;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0106 ! VG-1
SX Male
CA Transformed cell line
//
ID B3180
AC CVCL_AW12
RX PubMed=16136460;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID B35
AC CVCL_1951
DR BTO; BTO:0002649
DR CLO; CLO_0001815
DR ATCC; CRL-2754
DR Lonza; 1397
DR TOKU-E; 596
RX PubMed=4151463;
WW http://cellbiology.med.unsw.edu.au/units/lab/cells/cell_B35.htm
WW http://php.med.unsw.edu.au/cellbiology/index.php?title=Cells_-_B35
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-211.html
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: BDIX.
DI NCIt; C121567; Rat neuroblastoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Cancer cell line
//
ID B35M
AC CVCL_D319
SY B35 M; B-35M; 35M
DR CGH-DB; 9190-4
RX PubMed=4166872;
CC Doubling time: ~21 hours (PubMed=4166872).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID B38.1
AC CVCL_J943
DR CLO; CLO_0001816
DR ATCC; HB-8110
RX Patent=US4522918;
RX PubMed=6789331;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B39.1
AC CVCL_J944
RX PubMed=6789331;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B3D
AC CVCL_G638
DR CLO; CLO_0001817
DR ATCC; CRL-2634
RX PubMed=11401970;
CC Monoclonal antibody target: UniProtKB; Q48245; Helicobacter pylori vacA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B3Z
AC CVCL_6277
DR Lonza; 1535
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID B4
AC CVCL_C795
SY BJMUe003-A
DR hPSCreg; BJMUe003-A
DR ISCR; 1561
RX PubMed=16143641;
CC From: Peking University Third Hospital; Beijing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID B407
AC CVCL_L601
RX PubMed=10848782;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5842 ! MOLP-5
SX Male
CA Transformed cell line
//
ID B422
AC CVCL_L076
RX PubMed=15863212;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L077 ! B423
OI CVCL_7922 ! MOLM-17
OI CVCL_7923 ! MOLM-18
SX Male
CA Transformed cell line
//
ID B423
AC CVCL_L077
RX PubMed=15863212;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L076 ! B422
OI CVCL_7922 ! MOLM-17
OI CVCL_7923 ! MOLM-18
SX Male
CA Transformed cell line
//
ID B46M
AC CVCL_D320
DR CGH-DB; 9191-4
RX DOI=10.1266/jjg.47.211;
RX PubMed=5566367;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID B4B8
AC CVCL_0B35
SY B4B8-3
RX PubMed=10399955;
RX PubMed=15868906;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID B4D6
AC CVCL_V005
SY KH88 B4D6
DR Cosmic; 949097
RX PubMed=8289484;
RX PubMed=9644295;
RX PubMed=14603991;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_G364 ! KH88
SX Male
CA Cancer cell line
//
ID B5 NIH
AC CVCL_J979
SY B5
DR CLO; CLO_0001819
DR ATCC; HB-10569
RX Patent=US5612032;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID B50
AC CVCL_4112
SY B-50
DR BTO; BTO:0002665
DR CLO; CLO_0001820
DR CLDB; cl351
DR CLDB; cl5139
DR ECACC; 85042302
DR IZSLER; BS TCL 115
RX PubMed=4151463;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: BDIX.
DI NCIt; C121567; Rat neuroblastoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Cancer cell line
//
ID B50.1
AC CVCL_J945
RX PubMed=6789331;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B50.4
AC CVCL_J946
DR ATCC; HB-8111
RX Patent=US4522918;
RX PubMed=6789331;
CC Discontinued: ATCC; HB-8111; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B503
AC CVCL_IQ96
DR ATCC; HB-11999
RX Patent=US7034124;
CC Monoclonal antibody target: UniProtKB; P01229; Human LHB.
CC Discontinued: ATCC; HB-11999; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID B504
AC CVCL_IQ97
DR ATCC; HB-12001
RX Patent=US7034124;
CC Monoclonal antibody target: UniProtKB; P01229; Human LHB.
CC Discontinued: ATCC; HB-12001; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID B505
AC CVCL_J976
DR CLO; CLO_0001821
DR ATCC; HB-12000
RX Patent=US7034124;
CC Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID B509
AC CVCL_IQ98
DR ATCC; HB-12002
RX Patent=US7034124;
CC Monoclonal antibody target: UniProtKB; P01229; Human LHB.
CC Discontinued: ATCC; HB-12002; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID B5KTu
AC CVCL_IQ00
RX DOI=10.1007/978-1-4612-0411-4_26;
RX PubMed=1638679;
CC Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4688 ! 184B5
SX Female
CA Transformed cell line
//
ID B6
AC CVCL_L814
RX PubMed=8671449;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID B6 [Contaminated chicken cell line]
AC CVCL_6C18
RX PubMed=20444515;
RX PubMed=22193509;
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of chicken origin but found to be a porcine cell (PubMed=22193509).
OX NCBI_TaxID=9823; ! Sus scrofa
CA Undefined cell line type
//
ID B6-6
AC CVCL_K094
DR RCB; AES0172
DR RCB; AES0187
CC Breed/subspecies: C57BL/6NCrSlc.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6-RPE07
AC CVCL_DF62
RX PubMed=18421091;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID B6-White
AC CVCL_E267
DR Millipore; SCR011
CC Breed/subspecies: C57BL/6 tyrc-2J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6.1.1
AC CVCL_F732
DR Ximbio; 151488
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID B6.2
AC CVCL_J947
DR CLO; CLO_0001822
DR ATCC; HB-8106
RX Patent=US4522918;
RX PubMed=6789331;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B6/BLU
AC CVCL_C258
DR ATCC; SCRC-1019
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6/FA
AC CVCL_8834
DR CLO; CLO_0001823
DR CLDB; cl353
DR ECACC; 94031008
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Discontinued: ECACC; 94031008; probable.
CC Breed/subspecies: AKR/J.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6565 ! AKR1.G.1.OUAR.1.26
CA Cancer cell line
//
ID B65
AC CVCL_4113
DR CLO; CLO_0001825
DR CLDB; cl352
DR ECACC; 85042305
DR Lonza; 299
DR NCBI_Iran; C134
RX PubMed=4151463;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-525.html
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: BDIX.
DI NCIt; C121567; Rat neuroblastoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Cancer cell line
//
ID B69
AC CVCL_4504
DR CLO; CLO_0001826
DR CLDB; cl5140
DR ATCC; HB-9437
DR IZSLER; BS Hy 44
RX Patent=US4956452;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B6B11
AC CVCL_9V32
DR ATCC; HB-12481
RX Patent=US6197582;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
HI CVCL_0014 ! RPMI-8226
CA Hybrid cell line
//
ID B6fc-1
AC CVCL_F038
DR RCB; AES0037
DR RCB; RCB2186
RX PubMed=15601921;
CC Discontinued: RCB; RCB2186; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID B6fc-2
AC CVCL_F039
DR RCB; AES0038
DR RCB; RCB2187
RX PubMed=15601921;
CC Discontinued: RCB; RCB2187; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID B6ft-1
AC CVCL_F036
DR RCB; AES0035
DR RCB; RCB2184
RX PubMed=15601921;
CC Discontinued: RCB; RCB2184; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID B6ft-2
AC CVCL_F037
DR RCB; AES0036
DR RCB; RCB2185
RX PubMed=15601921;
CC Discontinued: RCB; RCB2185; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID B6G-2
AC CVCL_D275
DR RCB; AES0003
DR RCB; RCB2002
RX PubMed=15830376;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Discontinued: RCB; RCB2002; true.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6H12.2
AC CVCL_J980
SY B6H12
DR CLO; CLO_0001827
DR ATCC; HB-9771
RX Patent=US6111080;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID B6J-23^(UTR)
AC CVCL_0J02
SY B6J-23 (UTR)
DR RCB; AES0143
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6J-S1^(UTR)
AC CVCL_0J03
SY B6J-S1 (UTR)
DR RCB; AES0140
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6mt-1
AC CVCL_F034
DR RCB; AES0033
DR RCB; RCB2182
RX PubMed=15601921;
CC Discontinued: RCB; RCB2182; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6mt-2
AC CVCL_F035
DR RCB; AES0034
DR RCB; RCB2183
RX DOI=10.4051/ibc.2010.2.4.0014;
RX PubMed=15601921;
CC Discontinued: RCB; RCB2183; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6MYC-CaP
AC CVCL_DF38
RX PubMed=27225803;
CC Breed/subspecies: B6MYC (FVB Hi-Myc x C57BL/6N).
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID B6N-22^(UTR)
AC CVCL_0J04
SY B6N-22 (UTR)
DR RCB; AES0144
CC Breed/subspecies: C57BL/6NCrlCrlj.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6NJ-22^(UTR)
AC CVCL_0J05
SY B6NJ-22 (UTR)
DR RCB; AES0141
CC Breed/subspecies: C57BL/6NCrlCrlj x C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID B6SUtA
AC CVCL_5981
SY B6SUt-A; B6SUtA cl 27
RX PubMed=6574462;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=B6SUt-A
CC Characteristics: IL3 dependent.
CC Breed/subspecies: B6.S.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID B6SUtA1
AC CVCL_D635
DR BTO; BTO:0005321
RX PubMed=2649169;
CC Characteristics: CSF2 and IL3 dependent.
CC Breed/subspecies: B6.S.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5981 ! B6SUtA
CA Factor-dependent cell line
//
ID B6Tert-1
AC CVCL_6880
DR BTO; BTO:0005021
RX PubMed=16772430;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L814 ! B6
SX Male
CA Telomerase immortalized cell line
//
ID B6YD10
AC CVCL_DB47
DR ATCC; HB-18
CC Discontinued: ATCC; HB-18; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B6YH4
AC CVCL_DB48
DR ATCC; HB-17
CC Discontinued: ATCC; HB-17; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B7
AC CVCL_C796
SY BJMUe004-A
DR hPSCreg; BJMUe004-A
DR ISCR; 1562
RX PubMed=16143641;
CC From: Peking University Third Hospital; Beijing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID B7-24-E1G4
AC CVCL_J981
SY B7-24
DR CLO; CLO_0001829
DR ATCC; HB-11341
RX Patent=US5677165;
CC Registration: Chiron Master Culture Collection; CMCC 11060 (CMCC #11060).
CC Monoclonal antibody target: UniProtKB; P33681; Human CD80.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B72.3
AC CVCL_G097
DR CLO; CLO_0001828
DR ATCC; HB-8108
RX Patent=US4522918;
RX PubMed=6789331;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B76/Huh7
AC CVCL_U442
SY B76
RX PubMed=12097587;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0336 ! Huh-7
SX Male
CA Cancer cell line
//
ID B76.1/Huh7
AC CVCL_U443
SY B76.1/Huh-7; B76.1
RX PubMed=12097587;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U442 ! B76/Huh7
SX Male
CA Cancer cell line
//
ID B78/TNF
AC CVCL_0160
DR MCCL; MCC:0000052
RX PubMed=11228537;
CC Transfected with: HGNC; 11892; TNF.
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_8341 ! B78H1
SX Male
CA Cancer cell line
//
ID B78H1
AC CVCL_8341
SY B-78-H1
DR CLO; CLO_0001830
DR CLDB; cl355
RX PubMed=6324393;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F936 ! B16
SX Male
CA Cancer cell line
//
ID B7E11
AC CVCL_0B36
SY B7E11-4
RX PubMed=10399955;
RX PubMed=15868906;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID B7E3
AC CVCL_0B37
SY B7E3-4
DR BTO; BTO:0005554
RX PubMed=10399955;
RX PubMed=15868906;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID B8-24-3
AC CVCL_G639
DR CLO; CLO_0001832
DR ATCC; TIB-139
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID B80-PT3
AC CVCL_DP15
RX PubMed=11281650;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A283 ! Bre-80
SX Female
CA Transformed cell line
//
ID B80-TERT1
AC CVCL_DP16
RX PubMed=11791183;
RX PubMed=18451136;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A283 ! Bre-80
SX Female
CA Telomerase immortalized cell line
//
ID B80-TERT2
AC CVCL_DP17
RX PubMed=11791183;
RX PubMed=18451136;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A283 ! Bre-80
SX Female
CA Telomerase immortalized cell line
//
ID B80-TERT3a
AC CVCL_DP18
RX PubMed=11791183;
RX PubMed=18451136;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A283 ! Bre-80
SX Female
CA Telomerase immortalized cell line
//
ID B80-TERT3b
AC CVCL_DP19
RX PubMed=11791183;
RX PubMed=18451136;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A283 ! Bre-80
SX Female
CA Telomerase immortalized cell line
//
ID B82
AC CVCL_4114
SY B82 (Hamprecht); B-82; GM00347
DR CLO; CLO_0001831
DR CLO; CLO_0025567
DR CLDB; cl356
DR CCRID; 3142C0001000000021
DR ECACC; 08062522
DR ECACC; 85011408
DR Coriell; GM00347
DR JCRB; JCRB0212
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-219.html
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Miscellaneous: ECACC has two catalogue entries for B82 which differ in that they were deposited by different groups: B82 (ECACC 85011408) and B82 (Hamprecht) (ECACC 08062522).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0462 ! NCTC clone 929
SX Male
CA Spontaneously immortalized cell line
//
ID B84-15
AC CVCL_6A88
RX PubMed=4333982;
RX PubMed=4357683;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9521; ! Saimiri sciureus
CA Transformed cell line
//
ID B84.1
AC CVCL_J948
RX PubMed=6789331;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID B9
AC CVCL_1952
DR CLO; CLO_0001836
DR CLDB; cl360
DR CLDB; cl4929
DR CLDB; cl5051
DR ATCC; CRL-2344
DR DSMZ; ACC-211
DR ECACC; 12121201
DR ECACC; 96080128
DR ICLC; HYL98004
DR IZSLER; BS Hy 55
RX PubMed=3500054;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=B9
CC Characteristics: IL6 dependent.
CC Doubling time: ~30-50 hours (DSMZ).
CC Discontinued: ATCC; CRL-2344; true.
CC Discontinued: ECACC; 96080128; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B953 ! B13.29
CA Hybridoma
//
ID B9-1-3
AC CVCL_C557
WW http://www.cells-talk.com/index.php/page/copelibrary?key=B9-1-3
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1952 ! B9
CA Hybridoma
//
ID B9-11
AC CVCL_C558
WW http://www.cells-talk.com/index.php/page/copelibrary?key=B9-11
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1952 ! B9
CA Hybridoma
//
ID B9-TY1
AC CVCL_C559
WW http://www.cells-talk.com/index.php/page/copelibrary?key=B9-TY1
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1952 ! B9
CA Hybridoma
//
ID B901L
AC CVCL_U098
DR Cosmic; 1513406
DR RCB; RCB3530
RX PubMed=11267941;
RX PubMed=12114371;
RX PubMed=21498706;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID B92
AC CVCL_4115
DR CLO; CLO_0001837
DR CLDB; cl361
DR ECACC; 85042304
DR NCBI_Iran; C132
RX PubMed=4151463;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: BDIX.
DI NCIt; C121567; Rat neuroblastoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Cancer cell line
//
ID B95-8
AC CVCL_1953
SY B95.8; B 95.8; B 95-8; B-95-8; B958; GM07404; GM07404D
DR BTO; BTO:0000107
DR CLO; CLO_0001776
DR CLO; CLO_0001838
DR CLDB; cl364
DR CLDB; cl365
DR CLDB; cl366
DR CLDB; cl367
DR CLDB; cl368
DR CLDB; cl369
DR ATCC; CRL-1612
DR BCRJ; 0042
DR CCRID; 3131C0001000400003
DR CCRID; 3142C0001000000015
DR CCRID; 3153C0001000000039
DR CCRID; 3153C0001000000090
DR ChEMBL-Cells; CHEMBL3307906
DR ChEMBL-Targets; CHEMBL614276
DR Coriell; GM07404
DR DSMZ; ACC-100
DR ECACC; 85011419
DR ICLC; ATL95004
DR IZSLER; BS CL 110
DR JCRB; JCRB9123
DR KCB; KCB 91004YJ
DR KCB; KCB 93008YJ
DR KCLB; 21612
DR NCBI_Iran; C110
DR TKG; TKG 0186
DR TOKU-E; 3559
RX PubMed=2153236;
RX PubMed=2824833;
RX PubMed=3145248;
RX PubMed=4333982;
RX PubMed=4346033;
RX PubMed=4357683;
RX PubMed=6265077;
RX PubMed=6294325;
WW http://www.atcc.org/Global/FAQs/0/A/Obtaining%20B958%20ATCC%20CRL1612%20cells-318.aspx
WW http://en.vircell.com/products/b95-8-cell-line/
CC Group: Non-human primate cell line.
CC Characteristics: This cell line sheds the Epstein-Barr virus (EBV) strain B95-8 and is often used to transform human or other primates B lymphocytes.
CC Doubling time: ~41 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-1612; true.
CC Discontinued: Coriell; GM07404; probable.
CC Discontinued: KCLB; 21612; probable.
OX NCBI_TaxID=9490; ! Saguinus oedipus
CA Transformed cell line
//
ID B95a
AC CVCL_4116
DR CLO; CLO_0001839
DR CLDB; cl5156
DR ECACC; 01092505
DR IZSLER; BS CL 140
RX PubMed=1900885;
RX PubMed=2153236;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9490; ! Saguinus oedipus
HI CVCL_1953 ! B95-8
CA Transformed cell line
//
ID B9V
AC CVCL_AZ85
RX PubMed=8041783;
CC Transformant: Polyoma middle T antigen.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BA
AC CVCL_U803
DR Cosmic; 928723
RX PubMed=9354451;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ba Del
AC CVCL_0F48
DR ATCC; CRL-1141
RX PubMed=865488;
CC Discontinued: ATCC; CRL-1141; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Ba Pot
AC CVCL_1477
DR CLO; CLO_0001841
DR ATCC; CRL-1280
DR BioSample; SAMN03473640
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 9,12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID BA-D5
AC CVCL_1954
DR CLO; CLO_0001847
DR CLDB; cl371
DR ATCC; HB-287
DR DSMZ; ACC-75
CC Doubling time: ~25 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID BA-F8
AC CVCL_1955
DR CLO; CLO_0001852
DR CLDB; cl372
DR DSMZ; ACC-154
CC Doubling time: ~30 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID BA-G5
AC CVCL_G695
DR CLO; CLO_0001854
DR ATCC; HB-276
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID BA-HAN-1
AC CVCL_0Q47
RX PubMed=2900572;
CC Breed/subspecies: Lewis.
DI NCIt; C60504; Rat rhabdomyosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID BA-HAN-1A
AC CVCL_0Q48
SY BA-HAN-1 subpopulation A
RX PubMed=2900572;
RX PubMed=8422707;
CC Breed/subspecies: Lewis.
DI NCIt; C60504; Rat rhabdomyosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0Q47 ! BA-HAN-1
CA Cancer cell line
//
ID BA-HAN-1B
AC CVCL_0Q49
SY BA-Han-1B; BA-HAN-1 subpopulation B
RX PubMed=2900572;
RX PubMed=8422707;
CC Breed/subspecies: Lewis.
DI NCIt; C60504; Rat rhabdomyosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0Q47 ! BA-HAN-1
CA Cancer cell line
//
ID BA-HAN-1C
AC CVCL_0Q50
SY BA-Han-1C; BA-HAN-1 subpopulation C
RX PubMed=2272313;
RX PubMed=2900572;
RX PubMed=8422707;
CC Breed/subspecies: Lewis.
DI NCIt; C60504; Rat rhabdomyosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0Q47 ! BA-HAN-1
CA Cancer cell line
//
ID Ba/ER
AC CVCL_6C87
DR RCB; RCB4623
RX PubMed=10915858;
CC Characteristics: EPO or IL3 dependent.
CC Transfected with: MGI; MGI:95408; EpoR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID Ba/F3
AC CVCL_0161
SY BA/F3; BaF3; BAF3; Baf3
DR BTO; BTO:0001516
DR CLO; CLO_0001842
DR CLO; CLO_0051421
DR MCCL; MCC:0000053
DR CCRID; 3111C0001CCC000095
DR ChEMBL-Cells; CHEMBL3307634
DR ChEMBL-Targets; CHEMBL614524
DR DSMZ; ACC-300
DR Lonza; 693
DR PRIDE; PXD000461
DR RCB; RCB0805
DR RCB; RCB4476
DR TOKU-E; 3694
DR TOKU-E; 4128
RX PubMed=17133113;
WW http://www.brc.riken.jp/lab/cell/english/rcb0805_announce.shtml
WW http://www.cells-talk.com/index.php/page/copelibrary?key=BaF3
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-429.html
CC Characteristics: IL3 dependent.
CC Doubling time: ~20 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID Ba/F3-CL1
AC CVCL_T765
DR RCB; RCB4474
CC Characteristics: IL3 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID Ba/F3-hGHR
AC CVCL_K247
RX PubMed=9440818;
CC Characteristics: IL3 dependent.
CC Transfected with: HGNC; 4263; GHR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID Ba/F3-Mpl
AC CVCL_0183
SY BaF3/Mpl; BaF3/mpl; BaF3-mpl; BAF3MpI
DR MCCL; MCC:0000074
RX PubMed=9122198;
CC Characteristics: IL3 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID Ba/F3GR
AC CVCL_8789
RX PubMed=7531988;
CC Characteristics: CSF3 dependent.
CC Transfected with: MGI; MGI:1339755; Csf3r.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID Ba/F3IL-5R
AC CVCL_8790
RX PubMed=11480567;
CC Characteristics: IL5 dependent.
CC Transfected with: MGI; MGI:96558; Il5ra.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID Ba/F3MR
AC CVCL_8791
RX PubMed=7531988;
CC Characteristics: CSF1 dependent.
CC Transfected with: MGI; MGI:1339758; Csf1r.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID BA3
AC CVCL_HF39
RX PubMed=26586283;
CC Group: Bird cell line.
CC Group: Vaccine production cell line.
CC Doubling time: 21 hours (PubMed=26586283).
CC Breed/subspecies: Black Australorp.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Induced pluripotent stem cell
//
ID BA7.3C.9
AC CVCL_K124
DR CLO; CLO_0001844
DR ATCC; HB-10716
RX Patent=US5919911;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BAAn1F
AC CVCL_6E13
SY ABAn1F; Branchial Arches Acipenser naccarii 1F
RX DOI=10.1111/j.1439-0426.2010.01408.x;
RX DOI=10.1111/j.1439-0426.2010.01411.x;
CC Group: Fish cell line.
CC Misspelling: 'ABA1F' in DOI 10.1111/j.1439-0426.2010.01411.x.
OX NCBI_TaxID=42330; ! Acipenser naccarii
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BAB/BM
AC CVCL_Y452
DR ATCC; CRL-6298
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6298; true.
OX NCBI_TaxID=9557; ! Papio hamadryas
SX Male
CA Cancer cell line
//
ID BAC1
AC CVCL_6770
RX PubMed=6319490;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c x A.CA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BAC1.2F5
AC CVCL_6771
SY Bac1.2F5; Bac12F5; Bac 1.2F5; Bac1 2F5
RX PubMed=3031090;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=BAC1.2F5
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c x A.CA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6770 ! BAC1
CA Transformed cell line
//
ID BACA
AC CVCL_L311
RX PubMed=21801068;
DI NCIt; C129299; Canine lung adenocarcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Bad KO SV40 MEF
AC CVCL_U624
DR ATCC; CRL-2909
CC Knockout cell: Method=KO mouse; MGI; MGI:1096330; Bad.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BADA.20
AC CVCL_5G11
SY BADA20
RX PubMed=10906754;
RX PubMed=15541571;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9913; ! Bos taurus
CA Conditionally immortalized cell line
//
ID BAE-1
AC CVCL_3359
AS CVCL_4505
SY BAE; Bovine Aortic Endothelium-1
DR CLO; CLO_0001848
DR CLO; CLO_0001849
DR CLDB; cl377
DR CLDB; cl378
DR CLDB; cl380
DR CLDB; cl5157
DR CLDB; cl5253
DR ECACC; 88031149
DR ICLC; AL00004
DR IZSLER; BS PRC 42
DR NCBI_Iran; C188
RX PubMed=187876;
CC Breed/subspecies: Holstein Friesian.
OX NCBI_TaxID=9913; ! Bos taurus
CA Finite cell line
//
ID BAEC
AC CVCL_4690
DR BTO; BTO:0003247
DR CLO; CLO_0001850
DR CLDB; cl381
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-161.html
OX NCBI_TaxID=9913; ! Bos taurus
CA Finite cell line
//
ID BAEC-1
AC CVCL_0162
SY BAEC1; BAEC 1; Bovine Aortic Endothelial Cells-1
DR CLO; CLO_0001851
DR MCCL; MCC:0000054
DR CLDB; cl382
OX NCBI_TaxID=9913; ! Bos taurus
CA Finite cell line
//
ID BaF-B03
AC CVCL_0072
SY BAF-B03; BAF/B03
CC Characteristics: IL3 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID Baf3/WSX E63x7 sort
AC CVCL_K248
DR ATCC; CRL-12015
RX Patent=US7524937;
CC Characteristics: IL3 dependent.
CC Transfected with: HGNC; 6554; LEPR.
CC Discontinued: ATCC; CRL-12015; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0161 ! Ba/F3
CA Factor-dependent cell line
//
ID BAG-12G2
AC CVCL_1956
DR CLO; CLO_0001853
DR CLDB; cl7079
DR DSMZ; ACC-470
CC Doubling time: ~24 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID BAG-85D10
AC CVCL_1957
DR CLO; CLO_0001855
DR DSMZ; ACC-471
CC Doubling time: ~72 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P16284; Human PECAM1/CD31.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID BAI,FL
AC CVCL_E467
SY BAI, FL
DR dbMHC; 48484
DR ECACC; 94082266
DR IHW; IHW9166
DR IMGT/HLA; 11709
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl166.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94082266; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID BAI,JE
AC CVCL_E468
SY BAI, JE
DR dbMHC; 48485
DR ECACC; 94082267
DR IHW; IHW9167
DR IMGT/HLA; 11710
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl167.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID BAI,NJ
AC CVCL_E469
SY BAI, NJ
DR dbMHC; 48486
DR ECACC; 94082268
DR IHW; IHW9168
DR IMGT/HLA; 11711
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl168.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Bak KO SV40 MEF
AC CVCL_U625
DR ATCC; CRL-2912
CC Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BAL-KH
AC CVCL_C884
DR Cosmic; 996305
DR Cosmic; 998722
DR Cosmic; 1037705
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BALB SFME
AC CVCL_9102
SY BABL/c Serum Free Mouse Embryo
DR CLO; CLO_0001857
DR ATCC; CRL-9392
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID BALB-MC
AC CVCL_J361
SY BALB/c-MC
DR JCRB; JCRB0233.0
RX PubMed=3680103;
CC Breed/subspecies: BALB/cHe.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID BALB-MC.D3
AC CVCL_J362
DR JCRB; JCRB0233.1
CC Breed/subspecies: BALB/cHe.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J361 ! BALB-MC
SX Female
CA Cancer cell line
//
ID BALB-MC.E12
AC CVCL_J363
DR JCRB; JCRB0233.2
CC Breed/subspecies: BALB/cHe.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J361 ! BALB-MC
SX Female
CA Cancer cell line
//
ID BALB/3T12-3
AC CVCL_0637
SY Balb/3T12-3; BALB 3T12-3; BALB/3T12; Balb 3T12; 3T12
DR BTO; BTO:0000111
DR CLO; CLO_0001856
DR CLO; CLO_0001858
DR CLDB; cl383
DR CLDB; cl384
DR ATCC; CCL-164
DR ECACC; 90030803
DR IZSLER; BS CL 5
DR KCLB; 10164
RX PubMed=4301006;
CC Discontinued: ECACC; 90030803; probable.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID BALB/3T3 A31-1-1
AC CVCL_J646
SY Balb/c 3T3 A31-I-1; A31-1-1; 1-1
DR IFO; IFO50070
DR IFO; IFO50298
DR JCRB; JCRB0601
DR JCRB; JCRB1356
DR JCRB; NIHS0590
RX PubMed=27844419;
CC Problematic cell line: Contaminated/misidentified. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419). Therefore this cell line is not a clone of BALB/3T3 clone A31 (CVCL_0184) as originally reported.
CC Discontinued: JCRB; NIHS0590; true.
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID BALB/3T3 A31-1-13
AC CVCL_L996
SY Balb/c 3T3 A31-1-13; A31-1-13
DR IFO; IFO50299
RX PubMed=27844419;
CC Problematic cell line: Contaminated/misidentified. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419). Therefore this cell line is not a clone of BALB/3T3 clone A31 (CVCL_0184) as originally reported.
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID BALB/3T3-APR-MUC1 cl.16
AC CVCL_4E32
SY BALB/3T3-APR-MUC1 clone 16
DR RCB; RCB2632
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Problematic cell line: Contaminated/misidentified. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (DOI 10.4051/ibc.2010.2.4.0014). It is therefore not a BALB/3T3 derivative.
CC Transfected with: HGNC; 7508; MUC1.
CC Discontinued: RCB; RCB2632; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Undefined cell line type
//
ID BALB/3T3 clone A31
AC CVCL_0184
SY BALB/c 3T3 clone A31; Balb/c3T3; Balb/c 3T3; BALB/3T3; Balb/3T3-4-Cl31; 3T3 clone A31; BALB/3T3 cl. A31; BALB 3T3 clone A31; BALB/3T3 (clone A31); B/C3T3; 3T3-A31; 3T3(A31)
DR BTO; BTO:0000218
DR CLO; CLO_0001346
DR CLO; CLO_0001859
DR CLO; CLO_0050542
DR MCCL; MCC:0000075
DR CLDB; cl385
DR CLDB; cl386
DR CLDB; cl387
DR CLDB; cl388
DR CLDB; cl389
DR CLDB; cl7216
DR ATCC; CCL-163
DR ATCC; CRL-6587
DR ATCC; CRL-6588
DR BCRC; 60009
DR BCRJ; 0047
DR CCRID; 3131C0001000300003
DR ChEMBL-Cells; CHEMBL3308086
DR ChEMBL-Targets; CHEMBL613876
DR ECACC; 86110401
DR ICLC; AL09001
DR IZSLER; BS CL 4
DR JCRB; JCRB9005
DR KCB; KCB 200713YJ
DR KCLB; 10163
DR Lonza; 1351
DR MeSH; D041702
DR NCBI_Iran; C162
DR RCB; RCB0005
DR TOKU-E; 615
DR TOKU-E; 3612
DR Wikidata; Q28334278
RX PubMed=4301006;
RX PubMed=22576795;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-255.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Misspelling: 'BABL/3T3' in KCB 200713YJ.
CC Discontinued: ATCC; CRL-6587; true.
CC Discontinued: ATCC; CRL-6588; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID BALB/B 0.75BAE A.1R.1 HD A.8
AC CVCL_9096
DR CLO; CLO_0001860
DR ATCC; TIB-84
RX PubMed=723934;
CC Breed/subspecies: BALB.B.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K167 ! BALB/B CL.6
CA Transformed cell line
//
ID BALB/B CL.6
AC CVCL_K167
RX PubMed=723934;
CC Breed/subspecies: BALB.B.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID BALB/c 10CrMCA A.2R.1
AC CVCL_9097
DR CLO; CLO_0001861
DR ATCC; TIB-86
RX PubMed=723934;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9101 ! BALB/c CL.7
CA Transformed cell line
//
ID BALB/c 10ME HD A.5R.1
AC CVCL_9098
DR CLO; CLO_0001862
DR ATCC; TIB-85
RX PubMed=723934;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9101 ! BALB/c CL.7
CA Transformed cell line
//
ID BALB/c AMuLV A.3R.1
AC CVCL_9099
DR CLO; CLO_0001863
DR ATCC; TIB-87
RX PubMed=723934;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9101 ! BALB/c CL.7
CA Transformed cell line
//
ID BALB/c AMuLV A.6R.1
AC CVCL_9100
DR CLO; CLO_0001864
DR ATCC; TIB-90
RX PubMed=723934;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-337.html
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9101 ! BALB/c CL.7
CA Transformed cell line
//
ID BALB/c CL.7
AC CVCL_9101
DR CLO; CLO_0001865
DR ATCC; TIB-80
RX PubMed=723934;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID BALB/cJ-line I
AC CVCL_2H84
SY BALB/c-I
RX PubMed=8840532;
WW http://jaxmice.jax.org/strain/012482.html
CC Breed/subspecies: BALB/cJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BALB/MK
AC CVCL_1B29
SY Balb/Mk
DR ChEMBL-Cells; CHEMBL3307298
DR ChEMBL-Targets; CHEMBL614065
RX PubMed=6297803;
CC Characteristics: EGF dependent.
CC Caution: Erroneously indicated as originating from pig in ChEMBL CHEMBL614065/CHEMBL3307298.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID BALB/MK-1
AC CVCL_1B30
SY BALB/MK1
RX PubMed=6297803;
CC Characteristics: EGF dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1B29 ! BALB/MK
CA Factor-dependent cell line
//
ID BALB/MK-2
AC CVCL_U622
SY BALB/MK2; Balb/MK-2
RX PubMed=2506887;
RX PubMed=6297803;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-254.html
CC Characteristics: EGF dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1B29 ! BALB/MK
CA Factor-dependent cell line
//
ID BALENLM 17
AC CVCL_9474
SY BALENLM-17; Balenlm 17; BAL-17; Bal-17; Bal 17; Bal17; BAL17
RX PubMed=310843;
RX PubMed=3020122;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: BALB/cAnN.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BALL-1
AC CVCL_1075
SY Ball-1; BALL1
DR BTO; BTO:0001148
DR CLO; CLO_0051004
DR CLO; CLO_0051005
DR BioSample; SAMN03471059
DR BioSample; SAMN03472350
DR ChEMBL-Cells; CHEMBL3308839
DR ChEMBL-Targets; CHEMBL2366269
DR Cosmic; 910705
DR Cosmic; 919134
DR Cosmic; 999755
DR Cosmic; 999762
DR Cosmic; 1150902
DR Cosmic-CLP; 910705
DR DSMZ; ACC-742
DR GDSC; 910705
DR GEO; GSM827223
DR GEO; GSM1669606
DR JCRB; JCRB0071
DR KCB; KCB 94007YJ
DR RCB; RCB0256
DR RCB; RCB1882
DR TKG; TKG 0467
RX CelloPub=CLPUB00015;
RX PubMed=195075;
RX PubMed=197412;
RX PubMed=6582512;
RX PubMed=8156010;
RX PubMed=9290701;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~48-72 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): Cosmic-CLP; DSMZ; JCRB; RCB; TKG
ST Amelogenin: X,Y (Cosmic-CLP; DSMZ; RCB)
ST Amelogenin: X (JCRB; TKG)
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 9
ST D5S818: 10,13 (Cosmic-CLP; JCRB; TKG)
ST D5S818: 10,12,13 (RCB)
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BALL-2
AC CVCL_B388
RX PubMed=1650133;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BALM-1
AC CVCL_5687
SY BALM 1; BALM1
DR Cosmic; 919143
DR Cosmic; 998720
DR Cosmic; 999759
DR Cosmic; 1037695
RX PubMed=406986;
RX PubMed=3106068;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5696 ! BALM-2
SX Male
CA Cancer cell line
//
ID BALM-10
AC CVCL_5688
DR Cosmic; 999788
RX PubMed=10695022;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5707 ! BALM-9
OI CVCL_5689 ! BALM-11
OI CVCL_5690 ! BALM-12
SX Female
CA Cancer cell line
//
ID BALM-11
AC CVCL_5689
DR Cosmic; 999789
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5707 ! BALM-9
OI CVCL_5688 ! BALM-10
OI CVCL_5690 ! BALM-12
SX Female
CA Cancer cell line
//
ID BALM-12
AC CVCL_5690
DR Cosmic; 999790
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5707 ! BALM-9
OI CVCL_5688 ! BALM-10
OI CVCL_5689 ! BALM-11
SX Female
CA Cancer cell line
//
ID BALM-13
AC CVCL_5691
SY Balm13
DR Cosmic; 998713
DR Cosmic; 999785
DR Cosmic; 1037698
RX PubMed=9183631;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5692 ! BALM-14
SX Male
CA Cancer cell line
//
ID BALM-14
AC CVCL_5692
SY BALM14
DR Cosmic; 998714
DR Cosmic; 999786
DR Cosmic; 1037699
RX PubMed=9183631;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5691 ! BALM-13
SX Male
CA Cancer cell line
//
ID BALM-16
AC CVCL_5693
DR Cosmic; 999761
RX PubMed=9447837;
CC Characteristics: EBV-negative.
CC Doubling time: 32 hours (PubMed=9447837).
DI NCIt; C7954; Adult Burkitt leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BALM-18
AC CVCL_5694
RX PubMed=10374849;
CC Characteristics: EBV-negative.
CC Doubling time: 36 hours (PubMed=10374849).
DI NCIt; C7954; Adult Burkitt leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BALM-19
AC CVCL_5695
RX PubMed=12703546;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5697 ! BALM-20
OI CVCL_5698 ! BALM-21
OI CVCL_5699 ! BALM-22
OI CVCL_5700 ! BALM-23
OI CVCL_5702 ! BALM-26
SX Male
CA Cancer cell line
//
ID BALM-2
AC CVCL_5696
SY BALM 2; BALM2
RX PubMed=406986;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5687 ! BALM-1
SX Male
CA Cancer cell line
//
ID BALM-20
AC CVCL_5697
RX PubMed=12703546;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5695 ! BALM-19
OI CVCL_5698 ! BALM-21
OI CVCL_5699 ! BALM-22
OI CVCL_5700 ! BALM-23
OI CVCL_5702 ! BALM-26
SX Male
CA Cancer cell line
//
ID BALM-21
AC CVCL_5698
RX PubMed=12703546;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5695 ! BALM-19
OI CVCL_5697 ! BALM-20
OI CVCL_5699 ! BALM-22
OI CVCL_5700 ! BALM-23
OI CVCL_5702 ! BALM-26
SX Male
CA Cancer cell line
//
ID BALM-22
AC CVCL_5699
RX PubMed=12703546;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5695 ! BALM-19
OI CVCL_5697 ! BALM-20
OI CVCL_5698 ! BALM-21
OI CVCL_5700 ! BALM-23
OI CVCL_5702 ! BALM-26
SX Male
CA Cancer cell line
//
ID BALM-23
AC CVCL_5700
RX PubMed=12703546;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5695 ! BALM-19
OI CVCL_5697 ! BALM-20
OI CVCL_5698 ! BALM-21
OI CVCL_5699 ! BALM-22
OI CVCL_5702 ! BALM-26
SX Male
CA Cancer cell line
//
ID BALM-25
AC CVCL_5701
RX PubMed=15160921;
CC Characteristics: EBV-negative.
CC Doubling time: 30 hours (PubMed=15160921).
DI NCIt; C7954; Adult Burkitt leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BALM-26
AC CVCL_5702
RX PubMed=12703546;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5695 ! BALM-19
OI CVCL_5697 ! BALM-20
OI CVCL_5698 ! BALM-21
OI CVCL_5699 ! BALM-22
OI CVCL_5700 ! BALM-23
SX Male
CA Cancer cell line
//
ID BALM-27
AC CVCL_5703
RX PubMed=12389627;
CC Characteristics: EBV-negative.
CC Doubling time: 32 hours (PubMed=12389627).
DI NCIt; C7954; Adult Burkitt leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BALM-3
AC CVCL_5426
SY BALM 3; BALM3
DR Cosmic; 999782
RX PubMed=160894;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5427 ! BALM-4
OI CVCL_5205 ! BALM-5
SX Female
CA Cancer cell line
//
ID BALM-4
AC CVCL_5427
SY BALM 4; BALM4
DR Cosmic; 999783
RX PubMed=160894;
RX PubMed=3106068;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=BALM-4
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5426 ! BALM-3
OI CVCL_5205 ! BALM-5
SX Female
CA Cancer cell line
//
ID BALM-5
AC CVCL_5205
DR Cosmic; 999784
RX PubMed=160894;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5426 ! BALM-3
OI CVCL_5427 ! BALM-4
SX Female
CA Cancer cell line
//
ID BALM-6
AC CVCL_5704
DR Cosmic; 801723
DR Cosmic; 996303
DR Cosmic; 998721
DR Cosmic; 999760
DR Cosmic; 1037696
RX PubMed=1390421;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5705 ! BALM-7
OI CVCL_5706 ! BALM-8
CA Cancer cell line
//
ID BALM-7
AC CVCL_5705
RX PubMed=1390421;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5704 ! BALM-6
OI CVCL_5706 ! BALM-8
CA Cancer cell line
//
ID BALM-8
AC CVCL_5706
RX PubMed=1390421;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5704 ! BALM-6
OI CVCL_5705 ! BALM-7
CA Cancer cell line
//
ID BALM-9
AC CVCL_5707
SY BALM9; Balm9
DR Cosmic; 801724
DR Cosmic; 998712
DR Cosmic; 999787
DR Cosmic; 1037697
DR Cosmic; 2297028
DR GEO; GSM115808
RX PubMed=8618450;
RX PubMed=10695022;
RX PubMed=16960149;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5688 ! BALM-10
OI CVCL_5689 ! BALM-11
OI CVCL_5690 ! BALM-12
SX Female
CA Cancer cell line
//
ID BALM-9K
AC CVCL_5708
RX PubMed=8618450;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5707 ! BALM-9
SX Female
CA Cancer cell line
//
ID BALM-9KL
AC CVCL_5709
RX PubMed=8618450;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5707 ! BALM-9
SX Female
CA Cancer cell line
//
ID BALM-9N
AC CVCL_5710
RX PubMed=8618450;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5707 ! BALM-9
SX Female
CA Cancer cell line
//
ID BAM [Mouse chondrosarcoma]
AC CVCL_0J39
RX PubMed=1560787;
CC Breed/subspecies: ST/Eh.
DI NCIt; C24018; Mouse chondrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_3506 ! EHS
OI CVCL_0J38 ! EHSPEL
CA Cancer cell line
//
ID BAM [Mouse macrophage]
AC CVCL_6772
RX PubMed=6319490;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BAM1
AC CVCL_0J21
RX PubMed=6300147;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BAM3
AC CVCL_0J22
RX PubMed=6300147;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Bang/FeT-J
AC CVCL_V315
DR ATCC; CRL-11975
RX Patent=US5846825;
OX NCBI_TaxID=9685; ! Felis catus
HI CVCL_3687 ! FeT-J
CA Spontaneously immortalized cell line
//
ID BAOEC
AC CVCL_4117
SY Bovine AOrtal Endothelial Cells
DR CLO; CLO_0001867
DR CLDB; cl391
DR ECACC; 86123102
OX NCBI_TaxID=9913; ! Bos taurus
CA Finite cell line
//
ID BAR-T
AC CVCL_4M95
RX PubMed=17509124;
RX PubMed=19673046;
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C2891; Barrett esophagus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID BARF7
AC CVCL_0F74
SY BARF 7; GM14052
DR CLO; CLO_0033779
DR ATCC; CRL-2789
DR Coriell; GM14052
RX PubMed=2612208;
RX PubMed=8314575;
CC Group: Human/rodent somatic cell hybrid.
CC Discontinued: ATCC; CRL-2789; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
CA Hybrid cell line
//
ID Bartlett 96
AC CVCL_X852
SY BARTLETT 96
DR Wikidata; Q28198446
RX Patent=WO1994019478A1;
RX PubMed=7690960;
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3645 ! Anjou 65
SX Female
CA Transformed cell line
//
ID BAT,J
AC CVCL_E470
SY BAT, J
DR dbMHC; 48487
DR ECACC; 94082214
DR IHW; IHW9115
DR IMGT/HLA; 11660
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl115.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID BAU
AC CVCL_E471
DR IHW; IHW0501
DR IMGT/HLA; 10297
WW http://bioinformatics.hsanmartino.it/ecbr/cl369.html
CC Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Bax Bak DKO SV40 MEF
AC CVCL_U626
DR ATCC; CRL-2913
CC Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BAX KO SV40 MEF
AC CVCL_U627
DR ATCC; CRL-2910
CC Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Bay91
AC CVCL_M658
SY Bay9I; BAY-91
RX PubMed=8683996;
RX PubMed=16809887;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BB [Barramundi]
AC CVCL_HG34
SY Barramundi Brain
RX PubMed=16060261;
CC Group: Fish cell line.
OX NCBI_TaxID=8187; ! Lates calcarifer
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BB [Bullhead]
AC CVCL_4118
SY Brown Bullhead
DR CLO; CLO_0001869
DR CLDB; cl394
DR CLDB; cl395
DR ATCC; CCL-59
DR ECACC; 87101201
DR IZSLER; BS CL 6
CC Group: Fish cell line.
OX NCBI_TaxID=27778; ! Ameiurus nebulosus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Bb(ApMC1)
AC CVCL_9Y66
DR CLO; CLO_0001870
DR CLDB; cl396
CC Group: Insect cell line.
OX NCBI_TaxID=7119; ! Antheraea pernyi
SX Female
CA Spontaneously immortalized cell line
//
ID BB0111
AC CVCL_8B89
DR ECACC; 93090516
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BB132-EBV
AC CVCL_6F65
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M777 ! BB132-MEL
CA Transformed cell line
//
ID BB132-MEL
AC CVCL_M777
DR Cosmic; 753530
RX PubMed=14762065;
CC Omics: CNV analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6F65 ! BB132-EBV
CA Cancer cell line
//
ID BB30-HNC
AC CVCL_1076
SY BB30 HNC
DR ChEMBL-Cells; CHEMBL3308548
DR ChEMBL-Targets; CHEMBL2366271
DR Cosmic; 753531
DR Cosmic; 1995343
DR Cosmic-CLP; 753531
DR GDSC; 753531
DR GEO; GSM1669607
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9,14
ST D5S818: 11
ST D7S820: 8
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BB49-HNC
AC CVCL_1077
SY BB49 HNC; BB49-SCCHN
DR ChEMBL-Cells; CHEMBL3308282
DR ChEMBL-Targets; CHEMBL2366295
DR Cosmic; 753532
DR Cosmic; 2116768
DR Cosmic-CLP; 753532
DR GDSC; 753532
DR GEO; GSM1669608
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 12
ST D7S820: 9,12
ST TH01: 6
ST TPOX: 7,9
ST vWA: 15,19
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BB64-EBV
AC CVCL_S693
RX PubMed=10661410;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E907 ! BB64-RCC
CA Transformed cell line
//
ID BB64-RCC
AC CVCL_E907
SY BB64 RCC
RX PubMed=10661410;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S693 ! BB64-EBV
CA Cancer cell line
//
ID BB65-EBV
AC CVCL_6F66
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1078 ! BB65-RCC
SX Male
CA Transformed cell line
//
ID BB65-RCC
AC CVCL_1078
SY BB65 RCC
DR ChEMBL-Cells; CHEMBL3308283
DR ChEMBL-Targets; CHEMBL2366247
DR Cosmic; 753533
DR Cosmic-CLP; 753533
DR GDSC; 753533
DR GEO; GSM1669609
RX PubMed=14762065;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 12,13
ST D5S818: 11,14
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8
ST vWA: 18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6F66 ! BB65-EBV
SX Male
CA Cancer cell line
//
ID BB7.1
AC CVCL_7245
DR CLO; CLO_0001871
DR ATCC; HB-56
RX PubMed=95015;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BB7.2
AC CVCL_7246
DR CLO; CLO_0001872
DR ATCC; HB-82
DR CCRID; 3131C0001000600047
DR NCBI_Iran; H152
RX PubMed=95015;
RX PubMed=7035415;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BB7.3
AC CVCL_CW41
RX PubMed=95015;
CC Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BB7.4
AC CVCL_CW42
RX PubMed=95015;
CC Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BB7.5
AC CVCL_7247
DR CLO; CLO_0001873
DR ATCC; HB-120
RX PubMed=95015;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BB7.6
AC CVCL_7248
DR CLO; CLO_0001874
DR ATCC; HB-115
RX PubMed=95015;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BB7.7
AC CVCL_7249
DR CLO; CLO_0001875
DR ATCC; HB-94
RX PubMed=95015;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BB7.8
AC CVCL_CW43
RX PubMed=95015;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BB88
AC CVCL_3490
DR CLO; CLO_0001877
DR ATCC; TIB-55
RX PubMed=185295;
RX PubMed=564410;
CC Breed/subspecies: BALB.B.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID BBA4
AC CVCL_T978
DR ECACC; 00020912
RX PubMed=2606940;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID BBf
AC CVCL_4230
SY Black Bear fibroblast; KCB 85015
DR CLO; CLO_0007082
DR CLDB; cl3012
DR ECACC; 93052110
DR KCB; KCB 85015
CC Discontinued: ECACC; 93052110; probable.
OX NCBI_TaxID=9642; ! Ursus thibetanus
SX Female
CA Finite cell line
//
ID BBF
AC CVCL_8659
RX PubMed=15956410;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5711 ! BJAB
SX Female
CA Cancer cell line
//
ID BBG1
AC CVCL_8606
SY BBG-1
DR Cosmic; 1238080
RX PubMed=10706463;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BBm
AC CVCL_4399
SY Bovine Bone marrow
DR BTO; BTO:0003356
DR CLO; CLO_0001883
DR ATCC; CRL-6016
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Finite cell line
//
ID BBM
AC CVCL_4400
SY BEAS-2B/BBM
DR BTO; BTO:0003355
DR CLO; CLO_0001884
DR ATCC; CRL-9482
RX Patent=US4885238;
CC Transfected with: HGNC; 7553; MYC.
CC Transformant: Ad12-SV40.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 13
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 10,13
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0168 ! BEAS-2B
SX Male
CA Transformed cell line
//
ID BBM.1
AC CVCL_4506
SY BBM-1
DR CLO; CLO_0001885
DR ATCC; HB-28
RX PubMed=91522;
RX PubMed=95015;
CC Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID BBM.1 clone E9
AC CVCL_4507
DR CLO; CLO_0001886
DR CLDB; cl5158
DR IZSLER; BS Hy 4
CC Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4506 ! BBM.1
CA Hybridoma
//
ID BBWV-22K3-9B
AC CVCL_U122
DR CLO; CLO_0050327
DR RCB; RCB1914
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID BBWV-22K5-12A
AC CVCL_U123
DR CLO; CLO_0050329
DR RCB; RCB1915
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID BBWV-22K6-2A
AC CVCL_U124
DR CLO; CLO_0050328
DR RCB; RCB1916
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID BC 1217
AC CVCL_M380
SY Bc 1217
RX PubMed=3471855;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-009
AC CVCL_U286
DR CCRID; 3142C0001000000197
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0197.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-019
AC CVCL_U250
DR CCRID; 3142C0001000000198
RX PubMed=19121212;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0198.
CC Doubling time: 36 hours (PubMed=19121212).
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-020
AC CVCL_U251
DR CCRID; 3142C0001000000199
RX PubMed=19121212;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0199.
CC Doubling time: 35 hours (PubMed=19121212).
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-021
AC CVCL_U252
DR CCRID; 3142C0001000000200
RX PubMed=19121212;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0200.
CC Doubling time: 48 hours (PubMed=19121212).
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-022
AC CVCL_U253
DR CCRID; 3142C0001000000201
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0201.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-023
AC CVCL_U254
DR CCRID; 3142C0001000000202
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0202.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-024
AC CVCL_U255
DR CCRID; 3142C0001000000203
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0203.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-025
AC CVCL_U256
DR CCRID; 3142C0001000000204
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0204.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-027
AC CVCL_U257
DR CCRID; 3142C0001000000205
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0205.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-028
AC CVCL_U258
DR CCRID; 3142C0001000000206
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); GDC0206.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-1
AC CVCL_1079
SY BC1
DR BTO; BTO:0002720
DR CLO; CLO_0001887
DR EFO; EFO_0002044
DR ATCC; CRL-2230
DR BioSample; SAMN03471843
DR BioSample; SAMN03473432
DR BioSamples; SAMEA365796
DR BioSamples; SAMEA365808
DR ChEMBL-Cells; CHEMBL3307907
DR ChEMBL-Targets; CHEMBL614277
DR Cosmic; 687602
DR Cosmic; 910919
DR Cosmic; 1515186
DR Cosmic; 1588556
DR Cosmic-CLP; 910919
DR DSMZ; ACC-677
DR GDSC; 910919
DR GEO; GSM38792
DR GEO; GSM38793
DR GEO; GSM634731
DR GEO; GSM710417
DR GEO; GSM710433
DR GEO; GSM1669610
DR IGRhCellID; BC1
DR Lonza; 914
RX PubMed=7670109;
RX PubMed=15613351;
RX PubMed=21685375;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=BC-1
CC Doubling time: ~35-48 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 16,20
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BC-2
AC CVCL_1856
SY BC2
DR BTO; BTO:0002721
DR CLO; CLO_0001889
DR EFO; EFO_0002045
DR ATCC; CRL-2231
DR BioSample; SAMN03471845
DR BioSamples; SAMEA365820
DR BioSamples; SAMEA365831
DR Cosmic; 1238076
DR Cosmic; 1515187
DR Cosmic; 1588557
DR DSMZ; ACC-678
DR GDSC; 1295743
DR GEO; GSM38794
DR GEO; GSM38795
DR GEO; GSM634732
DR GEO; GSM710418
DR GEO; GSM710434
DR IGRhCellID; BC2
RX PubMed=7670109;
RX PubMed=15613351;
RX PubMed=21685375;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=BC-2
CC Doubling time: ~50-70 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 8,9
ST TH01: 7
ST TPOX: 10,11
ST vWA: 14,19
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BC-3
AC CVCL_1080
SY BC3
DR BTO; BTO:0002722
DR CLO; CLO_0001891
DR EFO; EFO_0002046
DR ATCC; CRL-2277
DR BioSample; SAMN03472835
DR BioSamples; SAMEA365848
DR BioSamples; SAMEA365859
DR ChEMBL-Cells; CHEMBL3308890
DR ChEMBL-Targets; CHEMBL2366371
DR Cosmic; 687836
DR Cosmic; 910918
DR Cosmic; 1238077
DR Cosmic; 1515188
DR Cosmic; 1588558
DR Cosmic-CLP; 910918
DR DSMZ; ACC-679
DR GDSC; 910918
DR GEO; GSM38796
DR GEO; GSM38797
DR GEO; GSM634733
DR GEO; GSM710419
DR GEO; GSM710435
DR GEO; GSM1669611
DR IGRhCellID; BC3
RX PubMed=8839859;
RX PubMed=15613351;
RX PubMed=21685375;
RX PubMed=27397505;
CC Doubling time: ~50-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BC-3C
AC CVCL_1958
SY BC3c
DR CLO; CLO_0001893
DR BioSample; SAMN03473550
DR CCLE; BC3C_URINARY_TRACT
DR Cosmic; 1046690
DR Cosmic; 1285112
DR Cosmic; 1286004
DR Cosmic; 2050437
DR Cosmic; 2057442
DR Cosmic; 2444240
DR DSMZ; ACC-450
DR GEO; GSM886873
DR GEO; GSM887938
RX PubMed=9794224;
RX PubMed=22460905;
RX PubMed=24367658;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~25-30 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-5
AC CVCL_B040
SY BC5
DR EFO; EFO_0002047
DR BioSamples; SAMEA365869
DR BioSamples; SAMEA365880
DR Cosmic; 1588559
DR GEO; GSM38798
DR GEO; GSM38799
DR GEO; GSM634734
DR GEO; GSM710420
DR GEO; GSM710436
RX PubMed=15613351;
RX PubMed=21685375;
CC Omics: Transcriptome analysis.
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BC-M1 [Human breast carcinoma Germany]
AC CVCL_AS91
RX PubMed=19714817;
CC Omics: Proteome analysis by 2D-DE.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC-M1 [Human breast carcinoma Taiwan]
AC CVCL_AS89
RX PubMed=8083436;
RX PubMed=15642166;
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC12
AC CVCL_U335
SY BC-12
DR TKG; TKG 0121
RX PubMed=381090;
RX PubMed=3918910;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: ACI/N.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID BC16.1
AC CVCL_M898
SY BC16_1
DR Cosmic; 1093985
RX PubMed=8041746;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Caution: Indicated (PubMed=8041746) to be established from normal human bladder epithelial tissue but used in many studies as a bladder cancer cell line.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BC16A
AC CVCL_3491
DR CLO; CLO_0001888
DR ATCC; TIB-59
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID BC215
AC CVCL_Y281
RX PubMed=543011;
RX PubMed=6085723;
RX PubMed=6480290;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5653 ! 3LL
CA Cancer cell line
//
ID BC3
AC CVCL_2099
DR CLO; CLO_0001890
DR ATCC; HB-10166
CC Monoclonal antibody target: UniProtKB; P07766; Human CD3E.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID BC3 H1
AC CVCL_0163
SY BC3H1; BC3H-1; BC-3H-1; BC-3-H-I
DR BTO; BTO:0000115
DR CLO; CLO_0001894
DR MCCL; MCC:0000055
DR CLDB; cl398
DR CLDB; cl399
DR CLDB; cl5161
DR ATCC; CRL-1443
DR CCRID; 3111C0001CCC000096
DR DSMZ; ACC-171
DR ECACC; 86093001
DR IZSLER; BS TCL 145
DR KCLB; 21443
RX PubMed=4363958;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-222.html
CC Doubling time: ~70 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID BC31
AC CVCL_9U95
DR TKG; TKG 0324
RX PubMed=381090;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: ACI/N.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID BC35
AC CVCL_U336
SY BC-35
DR TKG; TKG 0122
RX PubMed=381090;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: ACI/N.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID BC3A
AC CVCL_6567
SY BC-3A
DR CLO; CLO_0001892
DR ATCC; TIB-60
RX PubMed=185295;
RX PubMed=564410;
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID BC43
AC CVCL_9U96
DR TKG; TKG 0325
RX PubMed=381090;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: ACI/N.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID BC44
AC CVCL_D724
DR Cosmic; 1696918
RX PubMed=22669776;
DI NCIt; C39851; Bladder urothelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BC47
AC CVCL_U337
SY BC-47
DR TKG; TKG 0123
RX PubMed=381090;
RX PubMed=3918910;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: ACI/N.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID BC50
AC CVCL_U338
SY BC-50
DR TKG; TKG 0124
RX PubMed=381090;
RX PubMed=3918910;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: ACI/N.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID BC61
AC CVCL_D725
DR Cosmic; 1696919
DR GEO; GSM1574567
RX PubMed=22669776;
RX PubMed=25997541;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C39851; Bladder urothelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BC7
AC CVCL_1E03
DR NIH-ARP; 11434-279
RX PubMed=8929542;
DI NCIt; C7210; Childhood T lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1714 ! SUP-T1
SX Male
CA Cancer cell line
//
ID BC8
AC CVCL_DD26
DR ATCC; HB-10507
RX Patent=US5273738;
CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BC9
AC CVCL_G192
DR ECACC; 95030301
RX PubMed=1459585;
CC Monoclonal antibody target: UniProtKB; Q06599; Bovine TNF.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID BC9-E5
AC CVCL_G193
DR CLO; CLO_0001900
DR ATCC; CRL-1670
RX PubMed=6833281;
CC Monoclonal antibody target: ChEBI; CHEBI:61793; Sialyl Lewis A.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BCa-11
AC CVCL_M364
RX PubMed=17959394;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BCa-15
AC CVCL_M365
RX PubMed=17959394;
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BcaCD885
AC CVCL_D655
DR Cosmic; 851223
RX PubMed=10889927;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Bcap37
AC CVCL_0164
SY Bcap-37; BCAP37
DR MCCL; MCC:0000056
DR CCRID; 3131C0001000700009
DR ChEMBL-Cells; CHEMBL3308069
DR ChEMBL-Targets; CHEMBL613842
DR TOKU-E; 4153
RX PubMed=26116706;
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Was originally thought to originate from a breast carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): PubMed=26116706
ST Amelogenin: X
ST CSF1PO: 9,10
ST D12S391: 20,25
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 27,28
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 11,12
ST D6S1043: 18,19
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 21
ST Penta D: 8,15
ST Penta E: 7,17
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID BCBL-1
AC CVCL_0165
SY BCBL1; BCBL
DR BTO; BTO:0002727
DR EFO; EFO_0002048
DR MCCL; MCC:0000057
DR BioSample; SAMN03473436
DR BioSamples; SAMEA365914
DR BioSamples; SAMEA365927
DR Cosmic; 1238078
DR Cosmic; 1515185
DR Cosmic; 1588560
DR DSMZ; ACC-683
DR GEO; GSM38800
DR GEO; GSM38801
DR GEO; GSM634735
DR GEO; GSM710421
DR GEO; GSM710437
DR Lonza; 238
DR TOKU-E; 4070
RX PubMed=8612236;
RX PubMed=9375005;
RX PubMed=15613351;
RX PubMed=21685375;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=BCBL-1
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Characteristics: Has lost chromosome Y.
CC Doubling time: ~50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 8,9
ST TH01: 9,9.3
ST TPOX: 9
ST vWA: 17
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BCC-1/KMC
AC CVCL_A033
SY BCC1/KMC
DR BioSample; SAMN03151666
RX PubMed=8007045;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID BCC/P
AC CVCL_DQ00
SY BCC/Permanent
RX PubMed=27356577;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID bcd mab23
AC CVCL_B389
DR CLO; CLO_0001901
DR ATCC; CRL-2107
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BCE C/D-1b
AC CVCL_2865
DR CLO; CLO_0001902
DR CLDB; cl5162
DR ATCC; CRL-2048
DR BCRC; 60044
DR IZSLER; BS CL 142
DR JCRB; JCRB9129
CC Doubling time: 55 hours (at 70th passage), 30 hours (at 90th passage) (ATCC).
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Finite cell line
//
ID BCfc-2
AC CVCL_C322
DR RCB; AES0024
DR RCB; RCB2173
RX PubMed=15601921;
CC Discontinued: RCB; RCB2173; true.
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID BCft-1
AC CVCL_C323
DR RCB; AES0022
DR RCB; RCB2171
RX PubMed=15601921;
CC Discontinued: RCB; RCB2171; true.
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID BCi-NS1
AC CVCL_T028
RX PubMed=24298994;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID BCi-NS1.1
AC CVCL_T029
RX PubMed=24298994;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T028 ! BCi-NS1
SX Male
CA Telomerase immortalized cell line
//
ID BCIRL-AG-AM1
AC CVCL_Z395
SY BCIRL-AG-AM
RX DOI=10.1016/0022-2011(89)90145-6;
RX DOI=10.1016/0022-2011(91)90151-F;
RX PubMed=8799737;
RX PubMed=10777062;
CC Group: Insect cell line.
OX NCBI_TaxID=129554; ! Anticarsia gemmatalis
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-AtE-CLG11
AC CVCL_IV46
SY AtE-CLG11
RX PubMed=28205141;
CC Group: Insect cell line.
OX NCBI_TaxID=236421; ! Anasa tristis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL-AtE-CLG15
AC CVCL_IV47
SY AtE-CLG15
RX PubMed=28205141;
CC Group: Insect cell line.
OX NCBI_TaxID=236421; ! Anasa tristis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL-AtE-CLG15A
AC CVCL_IV48
SY AtE-CLG15A
RX PubMed=28205141;
CC Group: Insect cell line.
CC Doubling time: 190 hours (PubMed=28205141).
OX NCBI_TaxID=236421; ! Anasa tristis
HI CVCL_IV47 ! BCIRL-AtE-CLG15
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL-Cc-AM
AC CVCL_Z421
RX PubMed=22580906;
CC Group: Insect cell line.
CC Doubling time: 176.6 hours (with daily medium change), 204.3 hours (with weekly medium change) (PubMed=22580906).
OX NCBI_TaxID=59379; ! Cactoblastis cactorum
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-Cc-JG
AC CVCL_Z422
RX PubMed=22580906;
CC Group: Insect cell line.
CC Doubling time: 192.6 hours (with daily medium change), 112 hours (with weekly medium change) (PubMed=22580906).
OX NCBI_TaxID=59379; ! Cactoblastis cactorum
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-DP-AM/JG
AC CVCL_Z403
RX DOI=10.1303/aez.2009.331;
CC Group: Insect cell line.
CC Doubling time: 32 hours (DOI=10.1303/aez.2009.331).
OX NCBI_TaxID=13037; ! Danaus plexippus
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HA-AM1
AC CVCL_Z402
RX DOI=10.1007/BF02619571;
RX PubMed=8799737;
CC Group: Insect cell line.
OX NCBI_TaxID=29058; ! Helicoverpa armigera
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HS-AM1
AC CVCL_Z396
SY BCIRL-HsAM1
RX DOI=10.1016/0022-2011(89)90145-6;
RX DOI=10.1016/0022-2011(91)90151-F;
RX Patent=US5405770;
RX PubMed=8799737;
CC Group: Insect cell line.
OX NCBI_TaxID=38041; ! Heliothis subflexa
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HV-AM-CL1
AC CVCL_Z846
SY BCIRL-HV-AMCL1
RX PubMed=10777062;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
HI CVCL_Z397 ! BCIRL-HV-AM1
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HV-AM-CL2
AC CVCL_Z858
SY BCIRL-HV-AMCL2
RX PubMed=10777062;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
HI CVCL_Z397 ! BCIRL-HV-AM1
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HV-AM-CL3
AC CVCL_Z636
SY BCIRL-HV-AMCL3
RX PubMed=10777062;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
HI CVCL_Z397 ! BCIRL-HV-AM1
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HV-AM-CL5
AC CVCL_Z637
SY BCIRL-HV-AMCL5
RX PubMed=10777062;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
HI CVCL_Z397 ! BCIRL-HV-AM1
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HV-AM-CL7
AC CVCL_Z638
SY BCIRL-HV-AMCL7
RX PubMed=10777062;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
HI CVCL_Z397 ! BCIRL-HV-AM1
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HV-AM1
AC CVCL_Z397
SY BCIRL-Hv-AM1; BCIRL-HvAM1; HVAM1; HvAM1
RX DOI=10.1007/BF02628399;
RX DOI=10.1016/0022-2011(81)90084-7;
RX DOI=10.1016/0022-2011(89)90145-6;
RX DOI=10.1016/0022-2011(91)90151-F;
RX DOI=10.1303/aez.18.262;
RX DOI=10.3923/jas.2007.4040.4043;
RX PubMed=8799737;
RX PubMed=10777062;
RX PubMed=23891577;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HV-AM2
AC CVCL_Z398
SY BCIRL-HvAM2
RX DOI=10.1007/BF02628399;
RX DOI=10.1303/aez.18.262;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HZ-AM1
AC CVCL_Z399
SY BCIRL-Hz-AM1; BCIRL-HZAM1; BCIRL-HzAM1; Hz-AM1; HZBCIRLAM1; AM1
RX DOI=10.1016/0022-2011(81)90084-7;
RX DOI=10.1016/0022-2011(89)90145-6;
RX DOI=10.1016/0022-2011(91)90151-F;
RX DOI=10.1303/aez.18.262;
RX PubMed=1367489;
RX PubMed=8799737;
RX PubMed=10777062;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HZ-AM1-A11
AC CVCL_Z977
SY BCIRL-HZ-AM1-11; HzAM1-A11; HZ-A11
RX DOI=10.1303/aez.2001.349;
RX PubMed=10475263;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z399 ! BCIRL-HZ-AM1
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HZ-AM2
AC CVCL_Z400
SY BCIRL-Hz-AM2; BCIRL-HzAM2; AM2
RX DOI=10.1016/0022-2011(81)90084-7;
RX DOI=10.1303/aez.18.262;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-HZ-AM3
AC CVCL_Z401
SY BCIRL-Hz-AM3; BCIRL-HzAM3; AM3
RX DOI=10.1016/0022-2011(81)90084-7;
RX DOI=10.1016/0022-2011(89)90145-6;
RX DOI=10.1303/aez.18.262;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-Lepd-SL1
AC CVCL_Z247
RX DOI=10.1303/aez.2002.447;
CC Group: Insect cell line.
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-PX2-HNU3
AC CVCL_Z570
SY BCIRL-Px2-HNU3; BCIRL-PX-HNU3; BCIRL-Px-HNU3
RX CelloPub=CLPUB00165;
RX CelloPub=CLPUB00177;
RX DOI=10.1016/0022-2011(89)90145-6;
RX DOI=10.1016/0022-2011(91)90151-F;
RX DOI=10.3923/jas.2007.4040.4043;
RX PubMed=1367489;
RX PubMed=8799737;
CC Group: Insect cell line.
CC Doubling time: 30 +- 2.06 hours (CelloPub=CLPUB00165).
OX NCBI_TaxID=51655; ! Plutella xylostella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL-SO3-HNU1
AC CVCL_Z567
RX CelloPub=CLPUB00166;
CC Group: Insect cell line.
CC Doubling time: 47 +- 3.2 hours (CelloPub=CLPUB00166).
OX NCBI_TaxID=42029; ! Spodoptera ornithogalli
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-SO4-HNU4
AC CVCL_Z568
RX CelloPub=CLPUB00166;
CC Group: Insect cell line.
CC Doubling time: 54 +- 5.07 hours (CelloPub=CLPUB00166).
OX NCBI_TaxID=42029; ! Spodoptera ornithogalli
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL-TcA-CLG1
AC CVCL_Z276
SY TcA
RX PubMed=22752637;
RX PubMed=25354547;
CC Group: Insect cell line.
CC Doubling time: 155.2 hours (PubMed=22752637).
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7070; ! Tribolium castaneum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-AfOV-CLG
AC CVCL_Z656
SY AfOV
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=56368; ! Anagrapha falcifera
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-AfTS-CLG
AC CVCL_Z657
SY AfTS
RX PubMed=11515970;
CC Group: Insect cell line.
OX NCBI_TaxID=56368; ! Anagrapha falcifera
SX Male
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-AgE-CLG
AC CVCL_Z658
SY AgE
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=129554; ! Anticarsia gemmatalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-AgOV-CLG1
AC CVCL_Z659
SY AgOV1
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=129554; ! Anticarsia gemmatalis
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-AgOV-CLG2
AC CVCL_Z660
SY AgOV2
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=129554; ! Anticarsia gemmatalis
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-AgOV-CLG3
AC CVCL_Z661
SY AgOV3
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=129554; ! Anticarsia gemmatalis
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-AiOV-CLG
AC CVCL_Z662
SY AiOV
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=56364; ! Agrotis ipsilon
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-AiTS-CLG
AC CVCL_Z663
SY AiTS
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=56364; ! Agrotis ipsilon
SX Male
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HvE-CLG1
AC CVCL_Z664
SY HvE1
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HvE-CLG2
AC CVCL_Z665
SY HvE2
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HvE-CLG3
AC CVCL_Z666
SY HvE3
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HvOV-CLG
AC CVCL_Z667
SY HvOV
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Female
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HvTS-GES
AC CVCL_Z668
SY HvTS
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Male
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HzE-CLG1
AC CVCL_Z669
SY HzE1
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HzE-CLG2
AC CVCL_Z670
SY HzE2
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HzE-CLG3
AC CVCL_Z671
SY HzE3
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HzE-CLG5
AC CVCL_Z672
SY HzE5
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HzE-CLG6
AC CVCL_Z673
SY HzE6
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HzE-CLG7
AC CVCL_Z674
SY HzE7
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HzE-CLG8
AC CVCL_Z675
SY HzE8
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-HzE-CLG9
AC CVCL_Z676
SY HzE9
RX PubMed=11515970;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-OnFB-GES1
AC CVCL_Z677
SY OnFB1
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=29057; ! Ostrinia nubilalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-OnFB-GES3
AC CVCL_Z678
SY OnFB3
RX PubMed=11515970;
RX PubMed=11515971;
RX PubMed=26820856;
CC Group: Insect cell line.
CC Misspelling: 'BCIRL/AMCY-OnFB-GES2' in PubMed=26820856.
OX NCBI_TaxID=29057; ! Ostrinia nubilalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-PxE-CLG
AC CVCL_Z679
SY PxE
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=51655; ! Plutella xylostella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-PxLP-CLG
AC CVCL_Z680
SY PxLP
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=51655; ! Plutella xylostella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-SeE-CLG1
AC CVCL_Z681
SY BCIRL/AMCY-Se-E1; SeE1
RX PubMed=10777062;
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-SeE-CLG4
AC CVCL_Z682
SY SeE4
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-SeE-CLG5
AC CVCL_Z683
SY BCIRL/AMCY-Se-E5; SeE5
RX PubMed=10777062;
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-SfTS-GES
AC CVCL_Z684
SY SfTS
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
SX Male
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-TnE-CLG1
AC CVCL_Z685
SY TnE1
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-TnE-CLG1MK
AC CVCL_Z686
SY TnE1MK
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-TnE-CLG2
AC CVCL_Z687
SY TnE2
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-TnE-CLG2MK
AC CVCL_Z688
SY TnE2MK
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-TnE-CLG3
AC CVCL_Z689
SY TnE3
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-TnTS-GES1
AC CVCL_Z690
SY TnTS1
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Male
CA Spontaneously immortalized cell line
//
ID BCIRL/AMCY-TnTS-GES3
AC CVCL_Z691
SY TnTS3
RX PubMed=11515970;
RX PubMed=11515971;
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Male
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-CLG1
AC CVCL_Z639
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-CLG4
AC CVCL_Z640
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-CLG5
AC CVCL_Z641
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-CLG6
AC CVCL_Z642
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-CLG7
AC CVCL_Z643
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-HN11
AC CVCL_Z644
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-HN12
AC CVCL_Z645
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-HN14
AC CVCL_Z646
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-HN16
AC CVCL_Z647
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-HN2
AC CVCL_Z648
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvE-HN3
AC CVCL_Z649
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvVNC-WG1
AC CVCL_Z650
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvVNC-WG2
AC CVCL_Z651
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCIRL/RP-HvVNC-WG3
AC CVCL_Z652
RX PubMed=15311972;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BCK
AC CVCL_E472
SY TER99; TER166; TER243
DR dbMHC; 48488
DR ECACC; 94050326
DR IHW; IHW9262
DR IMGT/HLA; 10300
WW http://bioinformatics.hsanmartino.it/ecbr/cl262.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BCKN-1
AC CVCL_9637
SY BCKN1
DR EFO; EFO_0002049
DR BioSamples; SAMEA365939
DR BioSamples; SAMEA365949
DR GEO; GSM38802
DR GEO; GSM38803
RX PubMed=15613351;
RX PubMed=18230756;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C8285; AIDS related immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Bcl-2 KO SV40 MEF
AC CVCL_U628
DR ATCC; CRL-2908
CC Knockout cell: Method=KO mouse; MGI; MGI:88138; Bcl2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Bcl-x-KO MEF
AC CVCL_HC60
SY MEF Bcl-xL-KO
RX PubMed=22573883;
WW https://www.kerafast.com/product/2932/mouse-embryonic-fibroblast-bcl-xl-knock-out-cell-line-mef-bcl-xl-ko
CC Doubling time: 24 hours (Kerafast).
CC Knockout cell: Method=KO mouse; MGI; MGI:88139; Bcl2l1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Bcl-x-KO MEF Bcl-XL expressing
AC CVCL_HC61
RX PubMed=22573883;
WW https://www.kerafast.com/product/2931/mouse-embryonic-fibroblast-bcl-xl-expressing-cell-line-mef-wild-type
CC Doubling time: 24 hours (Kerafast).
CC Knockout cell: Method=KO mouse; MGI; MGI:88139; Bcl2l1.
CC Transfected with: HGNC; 992; BCL2L1 (isoform Bcl-xL).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HC60 ! Bcl-x-KO MEF
CA Transformed cell line
//
ID BCL1
AC CVCL_0166
SY BCL-1; BCL 1
DR MCCL; MCC:0000058
DR ChEMBL-Cells; CHEMBL3307956
DR ChEMBL-Targets; CHEMBL612420
WW http://www.cells-talk.com/index.php/page/copelibrary?key=BCL1
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-450.html
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID BCL1 clone 5B1b
AC CVCL_4119
DR CLO; CLO_0001903
DR ATCC; TIB-197
DR Lonza; 1255
DR NCBI_Iran; C551
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0166 ! BCL1
SX Female
CA Cancer cell line
//
ID BCL1 clone CW13.20-3B3
AC CVCL_4120
AS CVCL_6484
SY BCL1 clone CW13.20.3B3; BCL1 clone CW13.20; BCL1.3B3; CW13.20-3B3; CW13 clone 20-3B3
DR CLO; CLO_0001904
DR CLO; CLO_0002649
DR CLDB; cl404
DR ATCC; CRL-1669
DR ECACC; 90061904
DR JCRB; JCRB9117
DR Lonza; 237
RX PubMed=6601774;
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0166 ! BCL1
SX Female
CA Cancer cell line
//
ID BCL1-B20
AC CVCL_B994
DR CLO; CLO_0051571
DR RCB; RCB2618
DR TKG; TKG 0435
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0166 ! BCL1
SX Female
CA Cancer cell line
//
ID BCL2 (AAA) Jurkat
AC CVCL_U618
DR ATCC; CRL-2902
CC Transfected with: HGNC; 990; BCL2.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 7,10,11
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID BCL2 (S70A) Jurkat
AC CVCL_U619
DR ATCC; CRL-2900
CC Transfected with: HGNC; 990; BCL2 (with A-70).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID BCL2 (S87A) Jurkat
AC CVCL_U620
DR ATCC; CRL-2901
CC Transfected with: HGNC; 990; BCL2 (with A-87).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID BCL2 Jurkat
AC CVCL_U617
DR ATCC; CRL-2899
RX PubMed=10567572;
CC Transfected with: HGNC; 990; BCL2.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID BCLC-9
AC CVCL_9483
RX PubMed=15041736;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BCM-1
AC CVCL_M003
SY BrdU-treated CM-1
RX PubMed=7068778;
RX PubMed=8360273;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_H244 ! RPMI-3460/CM1
SX Male
CA Cancer cell line
//
ID BCmt-1
AC CVCL_C324
DR RCB; AES0020
DR RCB; RCB2169
RX PubMed=15601921;
CC Discontinued: RCB; RCB2169; true.
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BCmt-2
AC CVCL_C325
DR RCB; AES0021
DR RCB; RCB2170
RX PubMed=15601921;
CC Discontinued: RCB; RCB2170; true.
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BCN
AC CVCL_HX06
RX PubMed=10583232;
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BCNS1KO
AC CVCL_2866
DR BioSample; SAMN03470934
DR JCRB; JCRB0324
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 9,11
ST D18S51: 16,19
ST D19S433: 13,14.2
ST D21S11: 29,32
ST D2S1338: 17,23
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 14,15
ST FGA: 22,24
ST Penta D: 9
ST Penta E: 12,14
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID BCNS1KO hTERT
AC CVCL_F008
DR JCRB; JCRB3009
DR JCRB; KURB2738
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C2892; Nevoid basal cell carcinoma syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2866 ! BCNS1KO
SX Male
CA Telomerase immortalized cell line
//
ID BCP-1
AC CVCL_0107
SY BCP1
DR BTO; BTO:0002728
DR CLO; CLO_0001905
DR ATCC; CRL-2294
DR BioSample; SAMN03471861
DR CCLE; BCP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 683661
DR Cosmic; 1238079
DR Cosmic; 1588555
DR GEO; GSM634737
DR GEO; GSM710423
DR GEO; GSM710439
DR GEO; GSM886874
DR GEO; GSM887939
DR Wikidata; Q4835216
RX PubMed=8705864;
RX PubMed=15613351;
RX PubMed=21685375;
RX PubMed=22460905;
RX PubMed=25355872;
WW https://en.wikipedia.org/wiki/BCP-1_cells
WW http://www.cells-talk.com/index.php/page/copelibrary?key=BCP-1
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 10,11
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BCPb8
AC CVCL_6F37
RX PubMed=15619669;
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID BCRTi001-A
AC CVCL_9S03
SY P01-1
DR hPSCreg; BCRTi001-A
RX PubMed=27345784;
CC From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID BCRTi002-A
AC CVCL_9S04
SY P02-1
DR hPSCreg; BCRTi002-A
RX PubMed=27345784;
CC From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BCRTi004-A
AC CVCL_9S05
DR BioSamples; SAMEA4084802
DR hPSCreg; BCRTi004-A
RX PubMed=27345798;
CC From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BCRTi005-A
AC CVCL_9S06
DR hPSCreg; BCRTi005-A
RX PubMed=27345993;
CC From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
ST Source(s): PubMed=27345993
ST CSF1PO: 10,13
ST D13S317: 12,13
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 9,10
ST DXS101: 25
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BCS-1
AC CVCL_M004
SY BrdU-treated CS-1
RX PubMed=7068778;
RX PubMed=8360273;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_H244 ! RPMI-3460/CM1
SX Male
CA Cancer cell line
//
ID BCS-6
AC CVCL_M578
RX PubMed=15613351;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BCS-TC2
AC CVCL_B041
DR BTO; BTO:0002141
RX PubMed=1366654;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BCWM.1
AC CVCL_A035
SY BCWM-1; BCWM1
DR BTO; BTO:0005177
DR Cosmic; 1762456
DR LINCS; 51097
RX PubMed=17761288;
RX PubMed=18650470;
RX PubMed=22950966;
RX PubMed=25853860;
DI NCIt; C80307; Waldenstrom macroglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BD
AC CVCL_F568
SY TER338
DR IMGT/HLA; 10301
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BD-215
AC CVCL_1857
SY BD215
DR CLO; CLO_0001907
DR BioSample; SAMN03473577
DR DSMZ; ACC-398
RX PubMed=7689011;
CC Doubling time: ~40-50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,13
ST D5S818: 12,13
ST D7S820: 7,12
ST TH01: 8,9
ST TPOX: 10,11
ST vWA: 18
DI NCIt; C125704; Fanconi anemia, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BD.SP.
AC CVCL_Y451
DR ATCC; CRL-6296
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6296; true.
OX NCBI_TaxID=326577; ! Bdeogale nigripes
SX Sex undetermined
CA Finite cell line
//
ID BD0245
AC CVCL_8B90
DR ECACC; 92042906
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID BD0419
AC CVCL_8B91
DR ECACC; 92102013
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BD0437
AC CVCL_8B92
DR ECACC; 92111009
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BD0952
AC CVCL_GR83
SY BD952
DR ECACC; 94031517
DR TOKU-E; 4016
RX PubMed=14630800;
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94031517; true.
DI NCIt; C129026; Fanconi anemia, complementation group I
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID BD129fc-1
AC CVCL_C326
DR RCB; AES0027
DR RCB; RCB2176
CC Discontinued: RCB; RCB2176; true.
CC Breed/subspecies: (C57BL/6 x DBA/2) x 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID BD129fc-2
AC CVCL_C327
DR RCB; AES0028
DR RCB; RCB2177
CC Discontinued: RCB; RCB2177; true.
CC Breed/subspecies: (C57BL/6 x DBA/2) x 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID BD129mt-1
AC CVCL_C328
DR RCB; AES0025
DR RCB; RCB2174
CC Discontinued: RCB; RCB2174; true.
CC Breed/subspecies: (C57BL/6 x DBA/2) x 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BD129mt-2
AC CVCL_C329
DR RCB; AES0026
DR RCB; RCB2175
CC Discontinued: RCB; RCB2175; true.
CC Breed/subspecies: (C57BL/6 x DBA/2) x 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BD5-2d
AC CVCL_K125
DR CLO; CLO_0001908
DR ATCC; HB-9689
RX Patent=US5604107;
CC Monoclonal antibody target: UniProtKB; P04626; Human ERBB2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID BDCM
AC CVCL_4613
SY B-cell with DC Morphology
DR CLO; CLO_0001910
DR EFO; EFO_0002113
DR ATCC; CRL-2740
DR BioSample; SAMN03471781
DR CCLE; BDCM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR GEO; GSM886876
DR GEO; GSM887941
DR IGRhCellID; BDCM
RX PubMed=12437665;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 9,10
ST vWA: 16,17
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BDE/CTVM12
AC CVCL_Z142
RX PubMed=20388200;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=60189; ! Rhipicephalus decoloratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BDE/CTVM14
AC CVCL_Z143
SY BDE/CTVM 14
DR ECACC; 94022808
DR TCB; 2976
RX PubMed=20388200;
RX PubMed=21955214;
RX PubMed=22743047;
CC Group: Tick cell line.
CC Discontinued: ECACC; 94022808; probable.
OX NCBI_TaxID=60189; ! Rhipicephalus decoloratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BDE/CTVM16
AC CVCL_Z144
DR TCB; 2981
RX PubMed=15053931;
RX PubMed=17662657;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=60189; ! Rhipicephalus decoloratus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BDE1
AC CVCL_AS28
SY BDE 1
RX PubMed=7680017;
RX PubMed=16344070;
RX PubMed=18081149;
CC Doubling time: ~25 hours (PubMed=18081149).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID BDEneu
AC CVCL_AS29
RX PubMed=16344070;
RX PubMed=18081149;
CC Doubling time: ~17-19 hours (PubMed=18081149).
CC Transfected with: RGD; 2561; Erbb2 (with E-661).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: Activated Erbb2/neu.
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_AS28 ! BDE1
SX Male
CA Transformed cell line
//
ID BDEsp
AC CVCL_AS30
RX PubMed=18081149;
CC Characteristics: Spontaneous neoplastically transformed cholangiocytes capable of forming tumors after cell transplantation into the liver of isogenic rats.
CC Doubling time: ~20 hours (PubMed=18081149).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_AS28 ! BDE1
SX Male
CA Spontaneously immortalized cell line
//
ID BDfc-1
AC CVCL_C330
DR RCB; AES0018
DR RCB; RCB2167
RX PubMed=15601921;
CC Discontinued: RCB; RCB2167; true.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID BDft-1
AC CVCL_C331
DR RCB; AES0017
DR RCB; RCB2166
RX PubMed=15601921;
CC Discontinued: RCB; RCB2166; true.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID BDM-1
AC CVCL_0J24
RX PubMed=3142956;
CC Characteristics: CSF1 and CSF2 dependent.
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID BDM-2
AC CVCL_0J25
RX PubMed=3142956;
CC Characteristics: CSF1 and CSF2 dependent.
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID BDM-3 [Mouse ESC]
AC CVCL_0J20
RX PubMed=8987502;
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BDM-3 [Mouse macrophage]
AC CVCL_0J26
RX PubMed=3142956;
CC Characteristics: CSF2 and IL3 dependent.
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID BDmt-1
AC CVCL_C332
DR RCB; AES0015
DR RCB; RCB2164
RX PubMed=15601921;
CC Discontinued: RCB; RCB2164; true.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BDmt-2
AC CVCL_C333
DR RCB; AES0016
DR RCB; RCB2165
RX PubMed=15601921;
CC Discontinued: RCB; RCB2165; true.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BDmto-1
AC CVCL_F048
DR RCB; AES0051
DR RCB; RCB2200
RX PubMed=15601921;
CC Discontinued: RCB; RCB2200; true.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BDmto-2
AC CVCL_F049
DR RCB; AES0052
DR RCB; RCB2201
RX PubMed=15601921;
CC Discontinued: RCB; RCB2201; true.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID BE [Human colon carcinoma]
AC CVCL_H580
DR ChEMBL-Cells; CHEMBL3307709
DR ChEMBL-Targets; CHEMBL614798
DR Cosmic; 724835
DR GEO; GSM1374398
DR GEO; GSM1374399
RX PubMed=1737339;
CC Part of: KuDOS 95 cell line panel.
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BE [Human melanoma]
AC CVCL_9U99
SY BEmel
RX PubMed=9331097;
RX PubMed=10395702;
RX PubMed=11016658;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Be Ar
AC CVCL_3329
DR CLO; CLO_0001912
DR ATCC; CRL-1167
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Be Cal
AC CVCL_U685
DR ATCC; CRL-1171
CC Discontinued: ATCC; CRL-1171; true.
DI NCIt; C34568; Ehlers-Danlos syndrome
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Be Jar
AC CVCL_U769
DR ATCC; CRL-1143
CC Discontinued: ATCC; CRL-1143; true.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Be Sal
AC CVCL_3330
DR CLO; CLO_0001913
DR ATCC; CRL-1140
CC Discontinued: ATCC; CRL-1140; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Be Tim
AC CVCL_3331
SY XPH11F
DR CLO; CLO_0001914
DR ATCC; CRL-1254
CC Discontinued: ATCC; CRL-1254; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID BE-13
AC CVCL_1081
SY BE13; Be13
DR CLO; CLO_0001921
DR BioSample; SAMN03151896
DR ChEMBL-Cells; CHEMBL3308184
DR ChEMBL-Targets; CHEMBL2366303
DR Cosmic; 906763
DR Cosmic; 1115589
DR Cosmic; 1151773
DR Cosmic; 1330495
DR Cosmic; 1760518
DR Cosmic; 2165705
DR Cosmic-CLP; 906763
DR DSMZ; ACC-396
DR GDSC; 906763
DR GEO; GSM1669613
RX PubMed=6331881;
RX PubMed=12592342;
RX PubMed=20143388;
RX PubMed=22675565;
RX PubMed=27397505;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Peer derivative (PubMed=12592342, PubMed=20143388).
CC Doubling time: ~40-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,14
ST D16S539: 8,13
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 7,8
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1913 ! Peer
SX Female
CA Cancer cell line
//
ID BE-NQ2
AC CVCL_H581
RX PubMed=11377380;
CC Transfected with: HGNC; 2874; NQO1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H580 ! BE [Human colon carcinoma]
CA Cancer cell line
//
ID BE-NQ3
AC CVCL_H582
RX PubMed=11377380;
CC Transfected with: HGNC; 2874; NQO1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H580 ! BE [Human colon carcinoma]
CA Cancer cell line
//
ID BE-NQ4
AC CVCL_H583
RX PubMed=11377380;
CC Transfected with: HGNC; 2874; NQO1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H580 ! BE [Human colon carcinoma]
CA Cancer cell line
//
ID BE-NQ5
AC CVCL_H584
RX PubMed=11377380;
CC Transfected with: HGNC; 2874; NQO1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H580 ! BE [Human colon carcinoma]
CA Cancer cell line
//
ID BE-NQ7
AC CVCL_H585
SY BE-NQ
DR ChEMBL-Cells; CHEMBL3307688
DR ChEMBL-Targets; CHEMBL614702
RX PubMed=11377380;
CC Transfected with: HGNC; 2874; NQO1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H580 ! BE [Human colon carcinoma]
CA Cancer cell line
//
ID BE(2)-C/ADR(5)
AC CVCL_V006
SY Be2-C/ADR5; Be2C/ADR5
DR Cosmic; 922660
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0529 ! SK-N-BE(2)-C
SX Male
CA Cancer cell line
//
ID BE(2)-C/ACT(0.2)
AC CVCL_V007
RX PubMed=8660514;
CC Selected for resistance to: ChEBI; CHEBI:27666; Actinomycin D (ActD).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0529 ! SK-N-BE(2)-C
SX Male
CA Cancer cell line
//
ID BE(2)-C/CHC(1)
AC CVCL_V008
RX PubMed=8660514;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0529 ! SK-N-BE(2)-C
SX Male
CA Cancer cell line
//
ID BE(2)-C/CHCb
AC CVCL_V009
RX PubMed=8660514;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0529 ! SK-N-BE(2)-C
SX Male
CA Cancer cell line
//
ID BE(2)-C/CHCg
AC CVCL_V010
RX PubMed=8660514;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0529 ! SK-N-BE(2)-C
SX Male
CA Cancer cell line
//
ID BE0002
AC CVCL_8B93
DR ECACC; 91082308
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BE10
AC CVCL_8804
RX PubMed=3081277;
RX PubMed=7193044;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID BE10-7
AC CVCL_4121
SY BE 10-7
DR CLO; CLO_0001917
DR CLDB; cl408
DR ECACC; 93040125
RX PubMed=7193044;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8804 ! BE10
CA Transformed cell line
//
ID BE10-Early
AC CVCL_8808
SY BE10 early
DR ECACC; 93040118
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Discontinued: ECACC; 93040118; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8804 ! BE10
CA Transformed cell line
//
ID BE10-Intermediate
AC CVCL_8809
SY BE10 intermediate
DR CLO; CLO_0001918
DR CLDB; cl409
DR ECACC; 93040119
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8808 ! BE10-Early
CA Transformed cell line
//
ID BE10-Late
AC CVCL_8810
SY BE10 late
DR CLO; CLO_0001919
DR CLDB; cl410
DR ECACC; 93040120
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8809 ! BE10-Intermediate
CA Transformed cell line
//
ID BE11
AC CVCL_8805
DR TOKU-E; 4111
RX PubMed=3081277;
RX PubMed=7193044;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID BE11-Early
AC CVCL_4122
SY BE11 (Early); BE11-1
DR CLO; CLO_0001920
DR CLDB; cl411
DR ECACC; 93040121
RX PubMed=7193044;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8805 ! BE11
CA Transformed cell line
//
ID BE2
AC CVCL_J749
DR CLO; CLO_0001922
DR ATCC; TIB-182
RX PubMed=7287743;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BE26
AC CVCL_8806
RX PubMed=7193044;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID BE27
AC CVCL_8807
RX PubMed=7193044;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID BE29G1
AC CVCL_9165
DR CLO; CLO_0001923
DR ATCC; HB-233
RX PubMed=1672331;
CC Monoclonal antibody target: UniProtKB; P13597; Mouse Icam1/Cd54.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID BE3F9
AC CVCL_G640
DR CLO; CLO_0001924
DR ATCC; HB-133
RX PubMed=6193965;
CC Monoclonal antibody target: UniProtKB; P01317; Bovine INS (also reacts with other species including human).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID BEA,PL
AC CVCL_E473
SY BEA, PL
DR dbMHC; 48489
DR ECACC; 94082237
DR IHW; IHW9138
DR IMGT/HLA; 11681
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl138.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Bear
AC CVCL_0D14
SY BEAR
RX PubMed=12944992;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID BEAS-2B
AC CVCL_0168
SY Beas-2B; BEAS 2B; BEAS2B; Beas2B; Bronchial Epithelium transformed with Ad12-SV40 2B
DR BTO; BTO:0002923
DR CLO; CLO_0001925
DR EFO; EFO_0001089
DR MCCL; MCC:0000060
DR ATCC; CRL-9609
DR BioSample; SAMN03471073
DR BioSample; SAMN03472862
DR CCRID; 3131C0001000200027
DR CCRID; 3153C0001000000175
DR ECACC; 95102433
DR GEO; GSM253389
DR GEO; GSM827258
DR KCB; KCB 200922YJ
DR Lonza; 343
DR NCBI_Iran; C561
RX DOI=10.1007/978-1-4612-0411-4_25;
RX Patent=US4885238;
RX PubMed=2450641;
RX PubMed=2539488;
RX PubMed=15463957;
WW http://www.addexbio.com/productdetail?pid=26
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-39.html
CC Transformant: Ad12-SV40.
ST Source(s): ATCC; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 13
ST D16S539: 12 (ATCC; ECACC)
ST D16S539: 11,12 (PubMed=25877200)
ST D18S51: 18,19
ST D19S433: 13.2
ST D21S11: 28,30
ST D2S1338: 22,23
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 10,13
ST D8S1179: 13,15
ST FGA: 20,24
ST Penta D: 2.2,13
ST Penta E: 5,8
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0171 ! BET-1A
SX Male
CA Transformed cell line
//
ID Becker
AC CVCL_1093
SY BECKER; AK
DR BioSample; SAMN03472775
DR CCLE; BECKER_CENTRAL_NERVOUS_SYSTEM
DR CGH-DB; 140-1
DR ChEMBL-Cells; CHEMBL3308229
DR ChEMBL-Targets; CHEMBL2366230
DR Cosmic; 906746
DR Cosmic; 2367509
DR Cosmic-CLP; 906746
DR GDSC; 906746
DR GEO; GSM886877
DR GEO; GSM887942
DR GEO; GSM1669615
DR IFO; IFO50289
RX PubMed=283420;
RX PubMed=16232199;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 9
ST D16S539: 10,14
ST D5S818: 12
ST D7S820: 11
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BEI
AC CVCL_E474
DR dbMHC; 48490
DR ECACC; 86072902
DR IHW; IHW9294
DR IMGT/HLA; 10304
WW http://bioinformatics.hsanmartino.it/ecbr/cl294.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID BEL-1
AC CVCL_0081
SY BEL1
DR Cosmic; 2542842
RX PubMed=15327532;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BEL-7402
AC CVCL_5492
SY Bel-7402; BEL7402; Bel7402
DR BTO; BTO:0004050
DR CCRID; 3131C0001000700010
DR CCRID; 3142C0001000000035
DR ChEMBL-Cells; CHEMBL3307770
DR ChEMBL-Targets; CHEMBL614279
DR Cosmic; 1499247
DR GEO; GSM936754
DR GEO; GSM1374400
DR TOKU-E; 3571
RX PubMed=1849045;
RX PubMed=6154311;
RX PubMed=14571772;
RX PubMed=23167424;
RX PubMed=23505090;
WW http://www.tiandz.com/product/14186.html
CC Doubling time: 31.2 +- 1.1 hours (PubMed=23167424).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Tiandz
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 13.3
ST D16S539: 9,10
ST D18S51: 16
ST D19S433: 13
ST D21S11: 27,28
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 12
ST FGA: 18,21
ST TH01: 7
ST TPOX: 12
ST vWA: 16,18
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BEL-7402/5-FU
AC CVCL_5493
SY Bel7402/5-FU; BEL-7402/FU
RX PubMed=16696913;
RX PubMed=23167424;
WW http://www.tiandz.com/product/14185.html
CC Doubling time: 42.3 +- 3.3 hours (PubMed=23167424).
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5492 ! BEL-7402
SX Male
CA Cancer cell line
//
ID BEL-7402/5'-DFUR
AC CVCL_M184
RX PubMed=19033114;
CC Selected for resistance to: ChEBI; CHEBI:31521; Doxifluridine (5'-deoxy-5-fluorouridine; 5'DFUR).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5492 ! BEL-7402
SX Male
CA Cancer cell line
//
ID BEL-7404
AC CVCL_6568
SY Bel-7404; BEL7404; Bel7404; 7404
DR BTO; BTO:0005814
DR CCRID; 3131C0001000700064
DR ChEMBL-Cells; CHEMBL3307908
DR ChEMBL-Targets; CHEMBL614280
DR GEO; GSM936755
DR GEO; GSM1374401
RX PubMed=6154311;
RX PubMed=11774261;
RX PubMed=23505090;
WW http://www.tiandz.com/product/14187.html
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Tiandz
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 27,28
ST D2S1338: 17
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12
ST FGA: 21
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BEL-7404-CP.3
AC CVCL_IP16
SY BEL7404-CP.3; 7404-CP.3
RX PubMed=7710928;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6568 ! BEL-7404
SX Male
CA Cancer cell line
//
ID BEL-7404-CP1
AC CVCL_IP07
SY BEL7404-CP1; 7404-CP1
RX PubMed=7710928;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IP16 ! BEL-7404-CP.3
SX Male
CA Cancer cell line
//
ID BEL-7404-CP20
AC CVCL_IP09
SY BEL7404-CP20; 7404-CP20
RX PubMed=7710928;
RX PubMed=9443404;
RX PubMed=22571463;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IP08 ! BEL-7404-CP7.5
SX Male
CA Cancer cell line
//
ID BEL-7404-CP7.5
AC CVCL_IP08
SY BEL7404-CP7.5; 7404-CP7.5
RX PubMed=7710928;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IP07 ! BEL-7404-CP1
SX Male
CA Cancer cell line
//
ID BEL-7405
AC CVCL_6569
SY Bel-7405; BEL7405
DR CCRID; 3131C0001000700065
DR GEO; GSM1374402
RX PubMed=6154311;
WW http://www.gkzhan.com/st51173/product_1330826.html
CC Omics: Transcriptome analysis.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BEL5GB
AC CVCL_E475
SY TER260; TER304; TER424; Terasaki B-cell 260
DR dbMHC; 48491
DR ECACC; 96070216
DR IHW; IHW9320
DR IMGT/HLA; 10306
WW http://bioinformatics.hsanmartino.it/ecbr/cl320.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BEL6KG
AC CVCL_E476
DR dbMHC; 48492
DR ECACC; 94122028
DR IHW; IHW9321
DR IMGT/HLA; 10307
WW http://bioinformatics.hsanmartino.it/ecbr/cl321.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BEL7MON
AC CVCL_E477
SY TER328; TER407
DR dbMHC; 48493
DR ECACC; 94122029
DR IHW; IHW9322
DR IMGT/HLA; 10308
WW http://bioinformatics.hsanmartino.it/ecbr/cl322.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BEL8-CC
AC CVCL_E478
DR dbMHC; 48494
DR ECACC; 94122030
DR IHW; IHW9323
DR IMGT/HLA; 10309
WW http://bioinformatics.hsanmartino.it/ecbr/cl323.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BEN
AC CVCL_1082
DR BTO; BTO:0000253
DR CLO; CLO_0001926
DR EFO; EFO_0006537
DR CLDB; cl414
DR BioSample; SAMN03473096
DR BioSample; SAMN03473332
DR CCLE; BEN_LUNG
DR ChEMBL-Cells; CHEMBL3308709
DR ChEMBL-Targets; CHEMBL1075395
DR Cosmic; 753534
DR Cosmic; 1188583
DR Cosmic; 1995344
DR Cosmic-CLP; 753534
DR DSMZ; ACC-254
DR GDSC; 753534
DR GEO; GSM784239
DR GEO; GSM827594
DR GEO; GSM886878
DR GEO; GSM887943
DR GEO; GSM1669616
RX PubMed=1233082;
RX PubMed=10908148;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: '1BEN' in Cosmic 1188583.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X (DSMZ)
ST Amelogenin: X,Y (Cosmic-CLP; PubMed=25877200)
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11
ST D18S51: 15,16,18
ST D21S11: 30
ST D3S1358: 14
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 8
ST FGA: 21,25
ST Penta D: 12
ST Penta E: 20
ST TH01: 6
ST TPOX: 8,9 (Cosmic-CLP; DSMZ)
ST TPOX: 9 (PubMed=25877200)
ST vWA: 15
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ben-Men-1
AC CVCL_1959
SY BEN-MEN-1; BenMen 1
DR BTO; BTO:0004399
DR BioSample; SAMN03473495
DR DSMZ; ACC-599
RX PubMed=15965488;
CC Doubling time: ~40-50 hours (DSMZ).
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 13
ST D5S818: 12,13
ST D7S820: 9
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID BEND
AC CVCL_0169
SY Bovine ENDometrial cells
DR CLO; CLO_0001927
DR MCCL; MCC:0000061
DR ATCC; CRL-2398
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Spontaneously immortalized cell line
//
ID bEnd.1
AC CVCL_U212
RX PubMed=2379237;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID bEnd.3
AC CVCL_0170
SY bEND.3; Bend.3; bEnd3; b.End3
DR BTO; BTO:0003353
DR CLO; CLO_0001777
DR CLO; CLO_0001928
DR MCCL; MCC:0000496
DR CLDB; cl5049
DR ATCC; CRL-2299
DR BCRC; 60515
DR ECACC; 96091929
DR JCRB; NIHS0319
RX PubMed=2379237;
CC Discontinued: JCRB; NIHS0319; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID bEnd.4
AC CVCL_6275
RX PubMed=2379237;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID bEnd.5
AC CVCL_2252
SY b.End5; bEND5
DR CLO; CLO_0001778
DR CLDB; cl5050
DR ECACC; 96091930
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BEP2D
AC CVCL_6E77
RX DOI=10.1007/978-1-4612-0411-4_11;
RX PubMed=1717149;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E78 ! BEP3D
CA Transformed cell line
//
ID BEP2D R15H
AC CVCL_6E79
SY R15H
RX PubMed=12548635;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation.
CC Omics: Proteome analysis by 2D-DE/MS.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6E77 ! BEP2D
CA Transformed cell line
//
ID BEP2D R15H20
AC CVCL_6E80
SY R15H20
RX DOI=10.3760/cma.j.issn.0254-5098.2003.04.001;
RX PubMed=12548635;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6E79 ! BEP2D R15H
CA Transformed cell line
//
ID BEP2D R15H35
AC CVCL_6E81
SY R15H35
RX DOI=10.3760/cma.j.issn.0254-5098.2003.04.001;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: NCIt; C16279; Alpha radiation.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6E79 ! BEP2D R15H
CA Transformed cell line
//
ID BEP3D
AC CVCL_6E78
RX DOI=10.1007/978-1-4612-0411-4_11;
RX PubMed=1717149;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6E77 ! BEP2D
CA Transformed cell line
//
ID BER
AC CVCL_E479
DR dbMHC; 48495
DR ECACC; 8805209
DR IHW; IHW9093
DR IMGT/HLA; 11616
WW http://bioinformatics.hsanmartino.it/ecbr/cl93.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Ber Lin
AC CVCL_3650
DR CLO; CLO_0001929
DR ATCC; CRL-1132
CC Discontinued: ATCC; CRL-1132; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID BER-40
AC CVCL_HA73
SY BER40
RX PubMed=1459197;
RX PubMed=12204114;
RX PubMed=19023417;
CC Group: Non-human primate cell line.
CC Characteristics: A mutation in GBF1 is responsible for BFA resistance.
CC Selected for resistance to: ChEBI; CHEBI:48080; Brefeldin A (BFA).
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID BES-1A1.6
AC CVCL_H532
DR ATCC; CRL-9608
RX Patent=US4885238;
RX PubMed=2450641;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID bES[13]
AC CVCL_V175
SY BES[13]; bES(13); bES13; ESe028-A
DR hPSCreg; ESe028-A
DR ISCR; 2266
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_Lineas_bES13.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Bet-1
AC CVCL_8835
DR CLO; CLO_0001930
DR ATCC; HB-100
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BET-1A
AC CVCL_0171
SY BET1A; Bronchial Epithelium transformed with pRSV-T 1A
DR MCCL; MCC:0000062
DR ATCC; CRL-9442
RX Patent=US4885238;
RX PubMed=2450641;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
CC Discontinued: ATCC; CRL-9442; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0168 ! BEAS-2B
SX Male
CA Transformed cell line
//
ID Bet-2
AC CVCL_8836
DR CLO; CLO_0001931
DR ATCC; HB-88
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID BET-2A
AC CVCL_H533
SY BET2A; Bronchial Epithelium transformed with pRSV-T 2A
DR ATCC; CRL-9443
RX Patent=US4885238;
RX PubMed=2450641;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID BET-3A
AC CVCL_6F09
SY Bet-3A; Bronchial Epithelium transformed with pRSV-T 3A
RX PubMed=8050498;
RX PubMed=9175740;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6F10 ! BET-3B
OI CVCL_6F11 ! BET-3M
CA Transformed cell line
//
ID BET-3B
AC CVCL_6F10
SY Bet-3B; Bronchial Epithelium transformed with pRSV-T 3B
RX PubMed=8050498;
RX PubMed=9175740;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6F09 ! BET-3A
OI CVCL_6F11 ! BET-3M
CA Transformed cell line
//
ID BET-3M
AC CVCL_6F11
SY Bronchial Epithelium transformed with pRSV-T 3M
RX PubMed=8220580;
RX PubMed=9175740;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6F09 ! BET-3A
OI CVCL_6F10 ! BET-3B
CA Transformed cell line
//
ID Beta
AC CVCL_R799
RX PubMed=8891732;
CC Group: Non-human primate cell line.
CC From: Watkins D.; University of Wisconsin; Madison; USA.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
CA Transformed cell line
//
ID Beta-HC13
AC CVCL_GZ36
SY beta-HC13; betaHC13; beta HC13; HC13
DR TOKU-E; 4057
RX PubMed=8391634;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIP1Tag2.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Beta-HC8
AC CVCL_GZ37
SY beta-HC8; betaHC8
RX PubMed=8391634;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIP1Tag2.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Beta-TC-1
AC CVCL_W951
SY beta TC1; BetaTC1
RX PubMed=2848253;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIPTag4.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Beta-TC-2
AC CVCL_HF33
SY beta TC2; BetaTC2
RX PubMed=2848253;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIRTag2.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Beta-TC-3
AC CVCL_0172
SY beta-TC3; beta TC3; BETA-TC-3; BETATC3; BetaTC3; betaTC3; bTC3
DR BTO; BTO:0002993
DR CLO; CLO_0001932
DR MCCL; MCC:0000063
DR ChEMBL-Cells; CHEMBL3308357
DR ChEMBL-Targets; CHEMBL614063
DR DSMZ; ACC-324
DR TOKU-E; 4054
RX PubMed=1710218;
RX PubMed=2848253;
RX PubMed=22538498;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-210.html
CC Doubling time: ~34 hours (DSMZ).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIPTag2.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Beta-TC-6
AC CVCL_0605
SY beta-TC6; beta-TC-6; BetaTC6
DR BTO; BTO:0003428
DR CLO; CLO_0001933
DR ATCC; CRL-11506
DR ChEMBL-Cells; CHEMBL3308358
DR ChEMBL-Targets; CHEMBL614357
DR IZSLER; BS TCL 222
DR KCB; KCB 2010190YJ
RX PubMed=7533732;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIP1Tag2.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Beta-TC-7
AC CVCL_0J72
SY beta-TC7; BetaTC7
RX PubMed=8495813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C3HeB/FeJ transgenic RIPTag.
DI NCIt; C34053; Mouse insulinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Beta-TC-tet
AC CVCL_0185
SY BetaTCtet; betaTC-tet
DR MCCL; MCC:0000076
DR ATCC; CRL-3237
RX PubMed=7724601;
RX PubMed=11900281;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=betaTC-tet
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID BEVA
AC CVCL_M705
DR Cosmic; 2297013
DR GEO; GSM119482
RX PubMed=9293903;
RX PubMed=16960149;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BEVA-FBS
AC CVCL_6G76
RX PubMed=9293903;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M705 ! BEVA
SX Male
CA Cancer cell line
//
ID BeWo
AC CVCL_0044
SY BEWO; Be Wo; Be-Wo
DR BTO; BTO:0000798
DR CLO; CLO_0001934
DR CLO; CLO_0001935
DR CLO; CLO_0050014
DR EFO; EFO_0002050
DR CLDB; cl415
DR CLDB; cl416
DR ATCC; CCL-98
DR BCRC; 60073
DR BCRJ; 0048
DR BioSample; SAMN01821537
DR BioSample; SAMN01821617
DR BioSample; SAMN03471293
DR CCRID; 3111C0001CCC000156
DR CCRID; 3142C0001000000071
DR ChEMBL-Cells; CHEMBL3308359
DR ChEMBL-Targets; CHEMBL614525
DR CLS; 300123/p643_BEWO
DR DSMZ; ACC-458
DR ECACC; 86082803
DR GEO; GSM48269
DR GEO; GSM48270
DR GEO; GSM48271
DR GEO; GSM48272
DR GEO; GSM48273
DR IGRhCellID; BeWo
DR IMGT/HLA; 10312
DR IZSLER; BS TCL 3
DR JCRB; JCRB9111
DR KCLB; 10098
DR Lonza; 1449
DR RCB; RCB1644
DR RCB; RCB3678
DR TKG; TKG 0567
DR TOKU-E; 661
RX PubMed=2720636;
RX PubMed=4038916;
RX PubMed=4299001;
RX PubMed=5753554;
RX PubMed=6174649;
RX PubMed=7153601;
RX PubMed=7937597;
RX PubMed=11897413;
RX PubMed=14207855;
RX PubMed=16797695;
WW http://www.proteinatlas.org/learn/cellines
WW http://www2.kumc.edu/soalab/LabLinks/recipes/bewo.htm
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-163.html
CC Doubling time: ~30 hours (DSMZ).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Brain.
ST Source(s): ATCC; CLS; DSMZ; ECACC; KCLB; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 13,14
ST D18S51: 14,16
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 10,12
ST D8S1179: 12
ST FGA: 22,23,24 (CLS)
ST FGA: 22,23 (KCLB)
ST Penta D: 9,12
ST Penta E: 8,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0363 ! JEG-3
SX Male
CA Cancer cell line
//
ID BF-11
AC CVCL_7250
DR CLO; CLO_0001936
DR ATCC; CRL-8164
DR CCRID; 3131C0001000600015
DR ECACC; 95050413
RX Patent=US4558005;
CC Monoclonal antibody target: UniProtKB; P01588; Human EPO.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID BF-2
AC CVCL_4123
SY BF2; Bluegill Fry-2
DR CLO; CLO_0001937
DR CLDB; cl418
DR CLDB; cl5163
DR ATCC; CCL-91
DR BCRC; 60105
DR CCLV; CCLV-RIE 0193
DR ECACC; 00021712
DR ECACC; 00021713
DR ECACC; 87032603
DR IZSLER; BS CL 102
RX DOI=10.3147/jsfp.28.27;
CC Group: Fish cell line.
OX NCBI_TaxID=13106; ! Lepomis macrochirus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BF-32
AC CVCL_1960
DR CLO; CLO_0001938
DR DSMZ; ACC-272
CC Doubling time: ~34 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID BF-34
AC CVCL_1961
DR CLO; CLO_0001939
DR CLDB; cl419
DR DSMZ; ACC-156
CC Doubling time: ~30-40 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID BF-45
AC CVCL_1962
DR CLO; CLO_0001940
DR CLDB; cl421
DR ATCC; HB-278
DR DSMZ; ACC-221
CC Doubling time: ~45 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID BF-F3
AC CVCL_1963
DR CLO; CLO_0001946
DR CLDB; cl422
DR ATCC; HB-283
DR DSMZ; ACC-212
CC Doubling time: 20-30 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID BF-G6
AC CVCL_1964
DR CLO; CLO_0001947
DR DSMZ; ACC-274
CC Doubling time: ~30-40 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Bf1-Venus K/I EB3
AC CVCL_0I99
DR RCB; AES0173
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J647 ! EB3 [Mouse ESC]
SX Male
CA Embryonic stem cell
//
ID BF24
AC CVCL_X687
SY BF-24
DR NIH-ARP; 1296-124
RX PubMed=2789383;
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0006 ! THP-1
SX Male
CA Cancer cell line
//
ID BFA
AC CVCL_4124
SY Bovine Fetal Aorta
DR CLO; CLO_0001945
DR CLDB; cl426
DR CLS; 600124/NA
DR ECACC; 87022601
DR NCBI_Iran; C608
CC Discontinued: CLS; 600124; true.
OX NCBI_TaxID=9913; ! Bos taurus
CA Finite cell line
//
ID BFC-1
AC CVCL_0173
SY BFC1
DR MCCL; MCC:0000064
RX PubMed=2877896;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID BFC012
AC CVCL_U461
DR TOKU-E; 4109
RX PubMed=9108096;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-437.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BFC023
AC CVCL_9U85
RX PubMed=8639765;
RX PubMed=9108096;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BFL-5
AC CVCL_5T90
SY Bovine Fetal Liver-5
RX PubMed=26659396;
CC Characteristics: Requires feeder cells.
CC Miscellaneous: Breed from personal communication of Talbot N.C.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5N24 ! BFL-6
OI CVCL_5T91 ! BFL-7
OI CVCL_5N25 ! BFL-9
SX Sex undetermined
CA Finite cell line
//
ID BFL-6
AC CVCL_5N24
SY Bovine Fetal Liver-6
RX PubMed=26659396;
CC Characteristics: Requires feeder cells.
CC Miscellaneous: Breed from personal communication of Talbot N.C.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5T90 ! BFL-5
OI CVCL_5T91 ! BFL-7
OI CVCL_5N25 ! BFL-9
SX Sex undetermined
CA Finite cell line
//
ID BFL-7
AC CVCL_5T91
SY Bovine Fetal Liver-7
RX PubMed=26659396;
CC Characteristics: Requires feeder cells.
CC Miscellaneous: Breed from personal communication of Talbot N.C.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5T90 ! BFL-5
OI CVCL_5N24 ! BFL-6
OI CVCL_5N25 ! BFL-9
SX Sex undetermined
CA Finite cell line
//
ID BFL-9
AC CVCL_5N25
SY Bovine Fetal Liver-9
RX PubMed=26659396;
CC Characteristics: Requires feeder cells.
CC Miscellaneous: Breed from personal communication of Talbot N.C.
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
OI CVCL_5T90 ! BFL-5
OI CVCL_5N24 ! BFL-6
OI CVCL_5T91 ! BFL-7
SX Sex undetermined
CA Finite cell line
//
ID BFO
AC CVCL_IN45
SY Barfin Flounder Ovary
RX DOI=10.1007/s11802-015-2920-6;
CC Group: Fish cell line.
CC Doubling time: 32.7 hours, at 60th passage (DOI=10.1007/s11802-015-2920-6).
OX NCBI_TaxID=98923; ! Verasper moseri
SX Female
CA Spontaneously immortalized cell line
//
ID BFTC-905
AC CVCL_1083
SY BFTC 905; BFTC905
DR CLO; CLO_0001948
DR EFO; EFO_0002115
DR BCRC; 60068
DR BioSample; SAMN03471907
DR CCLE; BFTC905_URINARY_TRACT
DR ChEMBL-Cells; CHEMBL3308470
DR ChEMBL-Targets; CHEMBL1075396
DR Cosmic; 910926
DR Cosmic; 1046686
DR Cosmic; 1285113
DR Cosmic; 1286006
DR Cosmic; 2050438
DR Cosmic; 2057443
DR Cosmic; 2444237
DR Cosmic-CLP; 910926
DR DSMZ; ACC-361
DR GDSC; 910926
DR GEO; GSM827159
DR GEO; GSM886879
DR GEO; GSM887944
DR GEO; GSM1374403
DR GEO; GSM1669617
DR IGRhCellID; BFTC905
RX PubMed=8712703;
RX PubMed=22460905;
RX PubMed=24367658;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~60-90 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12
ST D18S51: 16
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 9,12
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 9
ST Penta E: 11
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BFTC-905-compact
AC CVCL_M888
RX PubMed=18398596;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1083 ! BFTC-905
SX Female
CA Cancer cell line
//
ID BFTC-905-diffuse
AC CVCL_M889
RX PubMed=18398596;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1083 ! BFTC-905
SX Female
CA Cancer cell line
//
ID BFTC-905-diffuse M
AC CVCL_M890
RX PubMed=18398596;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1083 ! BFTC-905
SX Female
CA Cancer cell line
//
ID BFTC-905-DOXO-II
AC CVCL_4V69
RX PubMed=25566959;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1083 ! BFTC-905
SX Female
CA Cancer cell line
//
ID BFTC-909
AC CVCL_1084
SY BFTC 909; BFTC909
DR CLO; CLO_0001949
DR EFO; EFO_0006538
DR BioSample; SAMN03473206
DR BCRC; 60069
DR CCLE; BFTC909_KIDNEY
DR ChEMBL-Cells; CHEMBL3308710
DR ChEMBL-Targets; CHEMBL1075397
DR Cosmic; 910698
DR Cosmic; 1046687
DR Cosmic; 1285114
DR Cosmic; 1286007
DR Cosmic; 2050439
DR Cosmic-CLP; 910698
DR DSMZ; ACC-367
DR GDSC; 910698
DR GEO; GSM886880
DR GEO; GSM887945
DR GEO; GSM1669618
RX PubMed=8712703;
RX PubMed=22460905;
RX PubMed=24367658;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,13
ST D16S539: 9,10
ST D18S51: 13
ST D21S11: 28,29
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 12
ST D8S1179: 13,15
ST FGA: 25.2
ST Penta D: 9,11
ST Penta E: 12,23
ST TH01: 7
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BG/F
AC CVCL_K223
SY BlueGill/Fin
RX PubMed=2919396;
CC Group: Fish cell line.
OX NCBI_TaxID=13106; ! Lepomis macrochirus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BG/G
AC CVCL_K224
SY BlueGill/Gill
RX PubMed=2919396;
CC Group: Fish cell line.
OX NCBI_TaxID=13106; ! Lepomis macrochirus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BG01
AC CVCL_9726
SY hESBGN-01; HESBGN-01; BGN-01; VIACe001-A
DR EFO; EFO_0007071
DR ENCODE; ENCBS742FEC
DR GEO; GSM856719
DR hPSCreg; VIACe001-A
DR ISCR; 62
DR TOKU-E; 4082
RX PubMed=12968106;
RX PubMed=15153607;
RX PubMed=16919167;
RX PubMed=17572666;
RX PubMed=23117585;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/bg01.cmsx
WW http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=6
CC From: ViaCyte, Inc. (originally from BresaGen).
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=16919167; WiCell
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID BG01V
AC CVCL_9727
SY hESC BG01V; hES BG01V; VIACe001-A-2
DR CLO; CLO_0003716
DR ATCC; SCRC-2002
DR BioSample; SAMN03471936
DR hPSCreg; VIACe001-A-2
DR ISCR; 63
DR TOKU-E; 1448
RX PubMed=15798361;
RX PubMed=16293579;
RX PubMed=16919167;
WW http://www.globalstem.com/image/data/pdf/flyers/BG01V_Rev2.pdf
CC From: National Institute on Drug Abuse; Bethesda; USA.
ST Source(s): ATCC; PubMed=15798361; PubMed=16919167
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9726 ! BG01
SX Male
CA Embryonic stem cell
//
ID BG01V/hOG
AC CVCL_9728
SY VIACe001-A-1
DR hPSCreg; VIACe001-A-1
RX PubMed=23089476;
WW http://www.thermofisher.com/order/catalog/product/R7799105
CC Characteristics: Transfected with the gene for emerald GFP (EmGFP) under the control of a Oct-4 promoter.
CC Transfected with: UniProtKB; P42212; GFP (with T-65, A-72, K-149, T-153, T-167 and L-231 = EmGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9727 ! BG01V
SX Male
CA Embryonic stem cell
//
ID BG02
AC CVCL_9729
SY BG02ES; hESBGN-02; HESBGN-02; BGN-02; VIACe002-A
DR EFO; EFO_0002778
DR BioSample; SAMN03471900
DR ENCODE; ENCBS274AAA
DR ENCODE; ENCBS275AAA
DR ENCODE; ENCBS276AAA
DR ENCODE; ENCBS277AAA
DR ENCODE; ENCBS278AAA
DR ENCODE; ENCBS279AAA
DR ENCODE; ENCBS280AAA
DR ENCODE; ENCBS281AAA
DR GEO; GSM472944
DR GEO; GSM856720
DR hPSCreg; VIACe002-A
DR ISCR; 64
RX PubMed=12968106;
RX PubMed=15153607;
RX PubMed=16919167;
RX PubMed=17572666;
RX PubMed=23117585;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/BG02ES_and_H9ES_Myers_protocols.pdf
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/bg02.cmsx
WW http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=11
CC Part of: ENCODE project common cell types; tier 3.
CC From: ViaCyte, Inc. (originally from BresaGen).
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=16919167; WiCell
ST Amelogenin: X,Y
ST CSF1PO: 8,10
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 12,14
ST TH01: 8,9
ST TPOX: 11
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID BG03
AC CVCL_9730
SY hESBGN-03; HESBGN-03; BGN-03; VIACe003-A
DR EFO; EFO_0002960
DR BioSample; SAMN03471901
DR GEO; GSM856721
DR hPSCreg; VIACe003-A
DR ISCR; 65
RX PubMed=12968106;
RX PubMed=16919167;
RX PubMed=17572666;
RX PubMed=23117585;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/bg03.cmsx
WW http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
WW https://stemcelldb.nih.gov/cellLineDetails.do?id=1
CC From: ViaCyte, Inc. (originally from BresaGen).
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=16919167; WiCell
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 11,13
ST D5S818: 13
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID BG04
AC CVCL_9731
SY hESBGN-04; HESBGN-04; BGN-04; VIACe004-A
DR hPSCreg; VIACe004-A
RX PubMed=12968106;
WW http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
CC From: ViaCyte, Inc. (originally from BresaGen).
CC Miscellaneous: Cell line has been lost.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID BG1
AC CVCL_6570
SY BG-1; BG-I; Bowman Gray-1; BG-1 FR
DR BTO; BTO:0000177
DR BioSample; SAMN03151838
DR ChEMBL-Cells; CHEMBL3307815
DR ChEMBL-Targets; CHEMBL613537
DR Cosmic; 844351
DR Cosmic; 1709248
DR GEO; GSM851910
RX PubMed=2910432;
RX PubMed=9769151;
RX PubMed=22328975;
RX PubMed=22710073;
RX PubMed=25321415;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Partially contaminated. Some stocks are contaminated by MCF-7 (PubMed=22710073, PubMed=25321415).
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25321415
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10
ST D16S539: 9,11
ST D18S51: 12,15
ST D19S433: 13,15
ST D21S11: 29,33.2
ST D2S1338: 22,23
ST D3S1358: 16,17
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 12,13
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BG1Luc4E2
AC CVCL_6571
SY BG-1Luc4E2; BG1Luc4E(2); BG1-ER
RX DOI=10.1787/9789264185395-en;
RX PubMed=10900408;
RX PubMed=26139245;
WW http://www.dioxins.com/lumi2.html
WW http://web.archive.org/web/20120303122316/http://www.alionscience.com/Services/Energy-and-Environmental-Sciences/Environmental-Science/Bioassay-Solutions/Endocrine-Disruptor-Testing
WW http://www.oecd-ilibrary.org/environment/test-no-457-bg1luc-estrogen-receptor-transactivation-test-method-for-identifying-estrogen-receptor-agonists-and-antagonists_9789264185395-en
CC Biotechnology: Cell line developed for BG1Luc ER TA (BG1Luc Estrogen Receptor TransActivation) bioassay.
CC Biotechnology: Used in Organisation for Economic Co-operation and Development (OECD) detection of estrogenic/antiestrogenic chemicals test method 457 (TG455).
CC Characteristics: BG1Luc ER TA is used for identifying estrogen receptor agonists and antagonists.
CC Characteristics: Acts through the activation of a luciferase gene under the control of estrogen response elements (EREs) upstream of the mouse mammary tumor viral (MMTV) promoter.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6570 ! BG1
SX Female
CA Cancer cell line
//
ID BG1LucERbc9
AC CVCL_DD13
SY BG1LucERbetac9
RX CelloPub=CLPUB00334;
RX PubMed=26139245;
CC Characteristics: Developed to be used for identifying estrogen receptor agonists and antagonists.
CC Characteristics: Acts through the activation of a luciferase gene under the control of estrogen response elements (EREs) upstream of the mouse mammary tumor viral (MMTV) promoter.
CC Transfected with: HGNC; 3468; ESR2.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6571 ! BG1Luc4E2
SX Female
CA Cancer cell line
//
ID BGC-1
AC CVCL_6572
SY Bovine Granulosa Cell line-1
RX PubMed=2170405;
RX PubMed=15541573;
CC Doubling time: 23.5 hours (PubMed=2170405).
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Spontaneously immortalized cell line
//
ID BGC-823
AC CVCL_3360
SY BGC823
DR BTO; BTO:0003878
DR CLO; CLO_0001952
DR CCRID; 3111C0001CCC000062
DR CCRID; 3131C0001000700011
DR ChEMBL-Cells; CHEMBL3307635
DR ChEMBL-Targets; CHEMBL614526
DR Cosmic; 2267322
DR GEO; GSM828793
DR GEO; GSM843444
DR GEO; GSM1374404
DR ICLC; HTL98007
RX PubMed=16344271;
CC Omics: Proteome analysis by 2D-DE.
CC Omics: Transcriptome analysis.
CC Discontinued: ICLC; HTL98007; true.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Bge
AC CVCL_T034
SY Biomphalaria glabrata embryonic
DR CLO; CLO_0001953
DR ATCC; CRL-1494
RX DOI=10.1016/B978-0-12-470270-7.50011-2;
RX PubMed=19133265;
RX PubMed=24198436;
WW http://www.beiresources.org/Catalog/cellBanks/NR-21959.aspx
CC Group: Mollusk cell line.
CC Discontinued: ATCC; CRL-1494; true.
OX NCBI_TaxID=6526; ! Biomphalaria glabrata
CA Spontaneously immortalized cell line
//
ID BGE
AC CVCL_E480
DR dbMHC; 48496
DR ECACC; 85121708
DR IHW; IHW9295
DR IMGT/HLA; 10314
WW http://bioinformatics.hsanmartino.it/ecbr/cl295.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID BGF
AC CVCL_R833
SY Banded Grouper Fin
RX CelloPub=CLPUB00022;
CC Group: Fish cell line.
OX NCBI_TaxID=152218; ! Epinephelus awoara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID bGB1
AC CVCL_IR46
RX PubMed=20978004;
CC Caution: Was originally classified as originating from a glioblastoma but seems to be from a malignant glioneuronal tumor (MGNT) which is a cancer type not recognized by WHO and NCIt.
DI NCIt; C92550; Glioneuronal tumor with neuropil-like islands
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BGK
AC CVCL_R834
SY Banded Grouper Kidney
RX CelloPub=CLPUB00022;
CC Group: Fish cell line.
OX NCBI_TaxID=152218; ! Epinephelus awoara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID BGM
AC CVCL_4125
AS CVCL_4789
SY Buffalo Green Monkey cells; BGMK; Buffalo Green Monkey Kidney cells
DR CLO; CLO_0001955
DR CLDB; cl432
DR CLDB; cl433
DR CLDB; cl435
DR CLDB; cl436
DR CLDB; cl437
DR BCRJ; 0049
DR BCRJ; 0313
DR CCLV; CCLV-RIE 0136
DR ECACC; 90092601
DR IZSLER; BS CL 7
RX PubMed=3010860;
RX PubMed=4993582;
WW http://www.atcc.org/support/faqs/3b13f/Buffalo%20Green%20Monkey%20Kidney%20BGMK%20cells-821.aspx
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/abgm.htm
WW http://en.vircell.com/products/bgm-cell-line/
CC Group: Non-human primate cell line.
CC Discontinued: BCRJ; 0049; probable.
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
SX Male
CA Spontaneously immortalized cell line
//
ID BgV
AC CVCL_5T71
RX PubMed=2303715;
CC Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC Breed/subspecies: BALB.B.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BH
AC CVCL_E481
SY BH13
DR dbMHC; 48497
DR IHW; IHW9046
DR IMGT/HLA; 11617
WW http://bioinformatics.hsanmartino.it/ecbr/cl46.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH-E
AC CVCL_0C06
DR NCBI_Iran; C567
RX PubMed=7736387;
RX PubMed=10100721;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BH0005
AC CVCL_8B94
DR ECACC; 91052404
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0008
AC CVCL_8B95
DR ECACC; 91062507
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0009
AC CVCL_8B96
DR ECACC; 91062508
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0012
AC CVCL_8B97
DR ECACC; 91091702
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0013
AC CVCL_8B98
DR ECACC; 91091703
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0015
AC CVCL_8B99
DR ECACC; 91112205
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0016
AC CVCL_8S66
DR ECACC; 91112206
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0017
AC CVCL_8S67
DR ECACC; 91112207
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0022
AC CVCL_8S68
DR ECACC; 92060308
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0046
AC CVCL_8S69
DR ECACC; 94113018
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84609; Campomelic dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0050
AC CVCL_8S70
DR ECACC; 95052411
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3267; Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0068
AC CVCL_8S71
DR ECACC; 96091306
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C118434; Albright's hereditary osteodystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0078
AC CVCL_8S72
DR ECACC; 97030411
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0079
AC CVCL_8S73
DR ECACC; 97032707
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C80076; Azoospermia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0082
AC CVCL_8S74
DR ECACC; 97111303
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34415; Beckwith-Wiedemann syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0083
AC CVCL_8S75
DR ECACC; 97111304
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0084
AC CVCL_8S76
DR ECACC; 97111305
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0091
AC CVCL_8S77
DR ECACC; 98012319
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0096
AC CVCL_8S78
DR ECACC; 98063003
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0101
AC CVCL_8S79
DR ECACC; 98082703
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0106
AC CVCL_8S80
DR ECACC; 98101809
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0109
AC CVCL_8S81
DR ECACC; 98112616
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex ambiguous
CA Transformed cell line
//
ID BH0110
AC CVCL_8S82
DR ECACC; 99021704
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0111
AC CVCL_8S83
DR ECACC; 99021705
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0122
AC CVCL_8S84
DR ECACC; 00070651
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID BH0123
AC CVCL_8S85
DR ECACC; 00070652
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH0124
AC CVCL_8S86
DR ECACC; 00070653
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BH24
AC CVCL_1H22
SY BH 24
DR NIH-ARP; 11087-113
RX PubMed=15910683;
CC Characteristics: HTLV-1 producing cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Female
CA Transformed cell line
//
ID Bhas42
AC CVCL_5494
SY Bhas 42
DR JCRB; JCRB0149
RX PubMed=3141328;
RX PubMed=27844419;
CC Problematic cell line: Contaminated/misidentified. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419).
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J646 ! BALB/3T3 A31-1-1
CA Spontaneously immortalized cell line
//
ID BHCP
AC CVCL_6G64
DR IMGT/HLA; 12645
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID BHD-F59RSVT
AC CVCL_IR12
RX PubMed=27991910;
DI NCIt; C28244; Birt-Hogg-Dube syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BHFTE
AC CVCL_0E76
SY BigHorn sheep Fetal Tongue Explant
DR ATCC; CRL-1941
RX PubMed=2562198;
CC Characteristics: Can be propagated through at least 23 PDL.
CC Discontinued: ATCC; CRL-1941; true.
OX NCBI_TaxID=112261; ! Ovis canadensis nelsoni
SX Female
CA Finite cell line
//
ID BHH2C
AC CVCL_DD22
RX PubMed=12021321;
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
HI CVCL_0421 ! MDBK
CA Hybrid cell line
//
ID BHH3
AC CVCL_DD23
RX PubMed=12021321;
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
HI CVCL_0421 ! MDBK
CA Hybrid cell line
//
ID BHH8
AC CVCL_DD24
RX PubMed=12021321;
OX NCBI_TaxID=9913; ! Bos taurus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
HI CVCL_0421 ! MDBK
CA Hybrid cell line
//
ID BHK 165-23
AC CVCL_R995
SY BHK165-23; 165-23
DR BTO; BTO:0000674
RX PubMed=12870;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_R994 ! C13/SV28
SX Male
CA Transformed cell line
//
ID BHK 21/13 subline B1
AC CVCL_L927
SY Subline B1; Line B-1; GM00348
DR CLO; CLO_0025564
DR Coriell; GM00348
RX PubMed=4290606;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK TK-
AC CVCL_4126
DR CLO; CLO_0001963
DR CLDB; cl443
DR ECACC; 85011423
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-21
AC CVCL_1914
SY BHK 21; BHK21; Baby Hamster Kidney-21; Baby Hamster Kidney 21; BHK
DR ATCC; CRL-6282
DR Wikidata; Q4838438
RX PubMed=25903999;
WW https://en.wikipedia.org/wiki/Baby_hamster_kidney_cell
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Miscellaneous: Not distributed parent cell line.
CC Discontinued: ATCC; CRL-6282; true.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-21 clone 13
AC CVCL_1915
SY BHK 21 clone 13; BHK21 clone 13; BHK-21 (clone 13); BHK 21 (clone 13); BHK21 (clone-13); BHK-21 (C-13); BHK-21(C-13); BHK-21(C13); BHK-21 C-13; BHK-21-C13; BHK-21/C13; BHK 21 CL13; BHK 21 C13; BHK21-C13; BHK-21 C 13; BHK 21/13; BHK21/C13; BHK21/13; BHK21 C13; BHK21C13; C13
DR CLO; CLO_0001957
DR CLO; CLO_0001958
DR CLO; CLO_0001959
DR CLO; CLO_0001965
DR CLO; CLO_0001966
DR CLO; CLO_0001967
DR CLO; CLO_0051403
DR CLDB; cl439
DR CLDB; cl444
DR CLDB; cl445
DR CLDB; cl446
DR CLDB; cl447
DR CLDB; cl448
DR ATCC; CCL-10
DR BCRC; 60041
DR BCRJ; 0050
DR CCLV; CCLV-RIE 0179
DR CCLV; CCLV-RIE 0194
DR CCRID; 3111C0001CCC000097
DR CCRID; 3111C0002000000033
DR CCRID; 3131C0001000100001
DR CCRID; 3142C0001000000010
DR CCRID; 3153C0001000000036
DR ChEMBL-Cells; CHEMBL3308360
DR ChEMBL-Targets; CHEMBL614527
DR CLS; 603126/p632_BHK-21
DR DSMZ; ACC-61
DR ECACC; 85011433
DR ECACC; 93120815
DR IZSLER; BS CL 8
DR JCRB; JCRB9020
DR KCB; KCB 90020YJ
DR KCB; KCB 92005YJ
DR KCLB; 10010
DR Lonza; 762
DR NCBI_Iran; C107
DR RCB; RCB1423
DR TKG; TKG 0308
DR TOKU-E; 667
RX PubMed=14468055;
RX PubMed=19941903;
WW https://en.wikipedia.org/wiki/Baby_hamster_kidney_cell
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/bhk/bhkcells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-18.html
CC Doubling time: ~32-50 hours (DSMZ).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1914 ! BHK-21
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-21 strain 31
AC CVCL_2303
SY BHK 21 strain 31; BHK 21 STRAIN 31
DR CLO; CLO_0001960
DR CLDB; cl440
DR ECACC; 93120840
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-21 strain 35
AC CVCL_2304
SY BHK 21 strain 35; BHK 21 STRAIN 35
DR CLO; CLO_0001961
DR CLDB; cl441
DR ECACC; 93120841
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-21 strain 38
AC CVCL_2305
SY BHK 21 strain 38; BHK 21 STRAIN 38
DR CLO; CLO_0001962
DR CLDB; cl442
DR ECACC; 93120842
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-21/WI-2
AC CVCL_HB78
SY BHK 21/WI-2; BHK21/WI-2; BHK-21 clone WI-2; WI-2
RX PubMed=5320494;
RX PubMed=20709108;
WW https://www.kerafast.com/product/698/bhk-21-cells-for-generating-vsv
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1914 ! BHK-21
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-HVJ
AC CVCL_W329
DR CLO; CLO_0001973
DR CLDB; cl450
RX PubMed=163346;
RX PubMed=4559687;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1914 ! BHK-21
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-IR
AC CVCL_R858
SY BHKIR
RX PubMed=1320025;
CC Transfected with: HGNC; 6091; INSR.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-JC-19
AC CVCL_HA33
DR BCRJ; 0053
CC Discontinued: BCRJ; 0053; probable.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-M
AC CVCL_4U20
DR ATCC; PTA-4506
RX Patent=US6458563;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-MMP1
AC CVCL_AB52
WW http://dartmouth.eagle-i.net/i/0000013e-d7bc-6cda-6a92-b95280000000
CC Transfected with: HGNC; 7155; MMP1.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-MMP3
AC CVCL_AB53
WW http://dartmouth.eagle-i.net/i/0000013e-d7bd-8c64-6a92-b95280000000
CC Transfected with: HGNC; 7173; MMP3.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-MP1
AC CVCL_HB79
RX PubMed=562143;
CC Characteristics: In vitro persistently infected by Rubella virus strain M33.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_HB78 ! BHK-21/WI-2
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-MP2
AC CVCL_HB80
RX PubMed=562143;
CC Characteristics: In vitro persistently infected by Rubella virus strain M33.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_HB78 ! BHK-21/WI-2
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-MS-HA16
AC CVCL_4U21
DR ATCC; PTA-12461
RX Patent=US8986991;
CC Discontinued: ATCC; PTA-12461; probable.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_4U20 ! BHK-M
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-PPI-C16
AC CVCL_HA57
SY BHK-21-PPI-C16
RX PubMed=19002958;
CC Characteristics: Releases unprocessed proinsulin.
CC Transfected with: HGNC; 6081; INS.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-PPI-C16-GCK
AC CVCL_HA58
RX PubMed=19002958;
CC Transfected with: HGNC; 4195; GCK.
CC Transfected with: HGNC; 6081; INS.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_HA57 ! BHK-PPI-C16
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-PPI-C16-GCK-GLUT
AC CVCL_HA59
RX PubMed=19002958;
CC Transfected with: HGNC; 4195; GCK.
CC Transfected with: HGNC; 6081; INS.
CC Transfected with: HGNC; 1006; SLC2A2.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_HA58 ! BHK-PPI-C16-GCK
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-RR-B51E
AC CVCL_1J91
DR ATCC; PTA-5257
RX Patent=US7585667;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1J90 ! BHK-SR19-T7
SX Male
CA Spontaneously immortalized cell line
//
ID BHK-SR19-T7
AC CVCL_1J90
SY BHK/SR19/T7; BHKSR19-T7
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK/AC9
AC CVCL_4127
DR CLO; CLO_0001964
DR CLDB; cl451
DR ECACC; 85040103
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK21-Hektor
AC CVCL_AR44
DR ECACC; 05062301
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8837 ! BHK21C13-2P
SX Male
CA Spontaneously immortalized cell line
//
ID BHK21-InVitrus
AC CVCL_6F52
DR ECACC; 05062302
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8837 ! BHK21C13-2P
SX Male
CA Spontaneously immortalized cell line
//
ID BHK21-pcDNA3.1-HC
AC CVCL_6369
DR CLO; CLO_0001970
DR ATCC; CRL-13001
DR ATCC; PTA-419
RX Patent=US6376218;
CC Transfected with: HGNC; 3415; EPO.
CC Discontinued: ATCC; PTA-419; true.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK21C13-2P
AC CVCL_8837
SY BHK-21C13-2P; BHK21-2P (clone-13)
DR CLO; CLO_0001968
DR CLO; CLO_0051413
DR CLDB; cl452
DR ECACC; 84111301
DR NCBI_Iran; C108
DR RCB; RCB0420
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK21C13-3P
AC CVCL_8838
SY BHK-21C13-3P
DR CLO; CLO_0001969
DR CLDB; cl453
DR ECACC; 84100501
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHK570
AC CVCL_6370
SY BHK-570; BHK 570
DR CLO; CLO_0001971
DR ATCC; CRL-10314
DR BCRJ; 0051
RX Patent=US5385831;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID BHL-89
AC CVCL_2306
DR ECACC; 98070109
RX PubMed=7672713;
CC Doubling time: 48 hours (ECACC).
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BHP 10-3
AC CVCL_6278
SY BHP10-3; BHP-10
DR BioSample; SAMN03151969
DR Cosmic; 1005449
DR Cosmic; 1094767
RX PubMed=9253346;
RX PubMed=18713817;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817, PubMed=20143388).
ST Source(s): PubMed=18713817
ST Amelogenin: X
ST D13S317: 11,12
ST D18S51: 13,16
ST D21S11: 30,31.2
ST D3S1358: 16,17
ST D5S818: 8,10
ST D7S820: 11
ST D8S1179: 11,17
ST FGA: 20,21
ST vWA: 14,18
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6298 ! TPC-1
SX Female
CA Cancer cell line
//
ID BHP 14-9
AC CVCL_6279
SY BHP14-9; BHP-14
DR BioSample; SAMN03151827
DR Cosmic; 1005450
DR Cosmic; 1094768
RX PubMed=8675585;
RX PubMed=18713817;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817, PubMed=20143388).
CC Derived from metastatic site: Subcutaneous; right buttock.
ST Source(s): PubMed=18713817
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 13,17
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21
ST vWA: 16,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1395 ! M14
SX Male
CA Cancer cell line
//
ID BHP 15-3
AC CVCL_6280
SY BHP15-3; BHP-15
RX PubMed=8675585;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BHP 17-10
AC CVCL_6281
SY BHP17-10; BHP-17
DR BioSample; SAMN03151828
DR Cosmic; 1005451
DR Cosmic; 1094769
RX PubMed=8675585;
RX PubMed=18713817;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817, PubMed=20143388).
CC Derived from metastatic site: Subcutaneous; right buttock.
ST Source(s): PubMed=18713817
ST Amelogenin: X
ST D13S317: 12
ST D18S51: 13,17
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21
ST vWA: 16,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1395 ! M14
SX Male
CA Cancer cell line
//
ID BHP 18-21
AC CVCL_6282
SY BHP18-21; BHP-18
DR Cosmic; 1005452
DR Cosmic; 1094770
RX PubMed=8675585;
RX PubMed=9253346;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BHP 19-24
AC CVCL_D017
SY BHP19-24; BHP-19
DR Cosmic; 1005453
DR Cosmic; 1094771
RX PubMed=8675585;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BHP 2-7
AC CVCL_6283
SY BHP2-7; BHP-2
DR BioSample; SAMN03151970
DR Cosmic; 1005446
DR Cosmic; 1094764
DR Lonza; 783
RX PubMed=9253346;
RX PubMed=18713817;
RX PubMed=20143388;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817, PubMed=20143388, PubMed=21868764).
ST Source(s): PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 13,16
ST D21S11: 30,31.2
ST D3S1358: 16,17
ST D5S818: 8,10
ST D7S820: 11
ST D8S1179: 11,17
ST FGA: 20,21
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6298 ! TPC-1
SX Female
CA Cancer cell line
//
ID BHP 5-16
AC CVCL_6284
SY BHP5-16; BHP-5
DR BioSample; SAMN03151829
DR Cosmic; 1005447
DR Cosmic; 1094765
RX PubMed=8675585;
RX PubMed=18713817;
RX PubMed=20143388;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817, PubMed=20143388, PubMed=21868764).
CC Derived from metastatic site: Subcutaneous; right buttock.
ST Source(s): PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 9,13
ST D18S51: 13,17
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1395 ! M14
SX Male
CA Cancer cell line
//
ID BHP 7-13
AC CVCL_6285
SY BHP7-13; BPH-7
DR BioSample; SAMN03151971
DR Cosmic; 1005448
DR Cosmic; 1094766
RX PubMed=9253346;
RX PubMed=18713817;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817, PubMed=20143388).
ST Source(s): PubMed=18713817
ST Amelogenin: X
ST D13S317: 11,12
ST D18S51: 13,16
ST D21S11: 30,31.2
ST D3S1358: 16,17
ST D5S818: 8,10
ST D7S820: 11
ST D8S1179: 11,17
ST FGA: 20,21
ST vWA: 14,18
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6298 ! TPC-1
SX Female
CA Cancer cell line
//
ID BHP2-7 Pazopanib selected
AC CVCL_4W01
RX PubMed=24628546;
CC Problematic cell line: Contaminated. Parent cell line (BHP 2-7) has been shown to be a TPC-1 derivative.
CC Selected for resistance to: ChEBI; CHEBI:71219; Pazopanib (Votrient).
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6283 ! BHP 2-7
SX Female
CA Cancer cell line
//
ID BHT-101
AC CVCL_1085
SY BHT101
DR BTO; BTO:0002274
DR CLO; CLO_0001974
DR EFO; EFO_0002116
DR BioSample; SAMN03473340
DR CCLE; BHT101_THYROID
DR ChEMBL-Cells; CHEMBL3308096
DR ChEMBL-Targets; CHEMBL1075398
DR Cosmic; 891255
DR Cosmic; 906696
DR Cosmic; 1162841
DR Cosmic; 1239963
DR Cosmic; 2054079
DR Cosmic-CLP; 906696
DR DSMZ; ACC-279
DR GDSC; 906696
DR GEO; GSM886881
DR GEO; GSM887946
DR GEO; GSM1669619
DR IGRhCellID; BHT101
RX PubMed=8099464;
RX PubMed=18713817;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~2-3 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=18713817
ST Amelogenin: X
ST CSF1PO: 12,13 (Cosmic-CLP)
ST CSF1PO: 12 (DSMZ)
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 12,15
ST D21S11: 29,32.2
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 10,11
ST D8S1179: 13,14,15
ST FGA: 18,24
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 19 (Cosmic-CLP; DSMZ)
ST vWA: 18,19 (PubMed=18713817)
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BHY
AC CVCL_1086
DR BTO; BTO:0004588
DR CLO; CLO_0001975
DR EFO; EFO_0006539
DR BioSample; SAMN03473142
DR CCLE; BHY_UPPER_AERODIGESTIVE_TRACT
DR ChEMBL-Cells; CHEMBL3308711
DR ChEMBL-Targets; CHEMBL1075399
DR Cosmic; 753535
DR Cosmic; 2296290
DR Cosmic-CLP; 753535
DR DSMZ; ACC-404
DR GDSC; 753535
DR GEO; GSM886882
DR GEO; GSM887947
DR GEO; GSM1669620
DR NCBI_Iran; C622
RX PubMed=8985100;
RX PubMed=22460905;
RX PubMed=25275298;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Doubling time: ~70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25275298; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 12
ST D18S51: 14
ST D21S11: 29,31.2
ST D3S1358: 17
ST D5S818: 10
ST D7S820: 11,12
ST D8S1179: 11,14
ST FGA: 24
ST Penta D: 13,14
ST Penta E: 14 (PubMed=25275298)
ST Penta E: 14,20 (PubMed=25877200)
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Bi Fin
AC CVCL_3651
DR CLO; CLO_0001976
DR ATCC; CRL-1219
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID BIC-1
AC CVCL_8092
SY Bic-1; BIC1; Bic1; BIC
DR BTO; BTO:0003429
DR BioSample; SAMN03151929
RX PubMed=9407969;
RX PubMed=16364037;
RX PubMed=20075370;
RX PubMed=23795680;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=20075370). Originally thought to originate from a esophageal adenocarcinoma.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID BICR 10
AC CVCL_2307
SY BICR-10; BICR10
DR EFO; EFO_0006540
DR BioSample; SAMN03473143
DR Cosmic-CLP; 1290724
DR ECACC; 04072103
DR GDSC; 1290724
DR GEO; GSM827321
DR GEO; GSM1669621
DR Ximbio; 152841
RX PubMed=7646764;
RX PubMed=10523844;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 8,14
ST D16S539: 9,13
ST D18S51: 14,19
ST D21S11: 30.2,32.2
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 21,22
ST Penta D: 9,12
ST Penta E: 7,18
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BICR 16
AC CVCL_2308
SY BICR-16; BICR16
DR CCLE; BICR16_UPPER_AERODIGESTIVE_TRACT
DR ECACC; 06031001
DR GEO; GSM886883
DR GEO; GSM887948
DR Ximbio; 152842
RX PubMed=7646764;
RX PubMed=10523844;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12
ST D5S818: 13
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BICR 18
AC CVCL_2309
SY BICR-18; BICR18
DR CLDB; cl7215
DR CCLE; BICR18_UPPER_AERODIGESTIVE_TRACT
DR ECACC; 06051601
DR GEO; GSM886884
DR GEO; GSM887949
DR ICLC; HTL10003
DR Ximbio; 152843
RX PubMed=7646764;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; ICLC
ST Amelogenin: X (ECACC)
ST Amelogenin: X,Y (ICLC)
ST CSF1PO: 11,12
ST D13S317: 8,13 (ECACC)
ST D13S317: 10,11 (ICLC)
ST D16S539: 12,14
ST D21S11: 29
ST D5S818: 12 (ECACC)
ST D5S818: 11 (ICLC)
ST D7S820: 9 (ECACC)
ST D7S820: 10,12 (ICLC)
ST TH01: 7 (ECACC)
ST TH01: 9.3 (ICLC)
ST TPOX: 9,12 (ECACC)
ST TPOX: 8 (ICLC)
ST vWA: 17,20 (ECACC)
ST vWA: 16,18 (ICLC)
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BICR 22
AC CVCL_2310
SY BICR-22; BICR22
DR EFO; EFO_0006541
DR BioSample; SAMN03473144
DR CCLE; BICR22_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 1995345
DR Cosmic; 2296291
DR Cosmic-CLP; 1240121
DR ECACC; 04072106
DR GDSC; 1240121
DR GEO; GSM827154
DR GEO; GSM886885
DR GEO; GSM887950
DR GEO; GSM1669622
DR Ximbio; 152844
RX PubMed=7646764;
RX PubMed=22460905;
RX PubMed=25275298;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25275298; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 14
ST D21S11: 28,31
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 10,15
ST FGA: 24 (PubMed=25275298)
ST FGA: 23,24 (PubMed=25877200)
ST Penta D: 9,13
ST Penta E: 12,14
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BICR 3
AC CVCL_2311
SY BICR-3; BICR3
DR Cosmic; 848752
DR ECACC; 06032203
DR Ximbio; 152845
RX PubMed=7646764;
RX PubMed=10523844;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BICR 31
AC CVCL_2312
SY BICR-31; BICR31
DR EFO; EFO_0006542
DR BioSample; SAMN03473145
DR CCLE; BICR31_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 848754
DR Cosmic-CLP; 1290725
DR ECACC; 04072107
DR GDSC; 1290725
DR GEO; GSM827311
DR GEO; GSM886886
DR GEO; GSM887951
DR GEO; GSM1669623
DR Ximbio; 152846
RX PubMed=7646764;
RX PubMed=10523844;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,14
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 16
ST D21S11: 28
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 8,12
ST D8S1179: 13
ST FGA: 24
ST Penta D: 12
ST Penta E: 11
ST TH01: 9
ST TPOX: 10
ST vWA: 18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BICR 56
AC CVCL_2313
SY BICR-56; BICR56
DR CCLE; BICR56_UPPER_AERODIGESTIVE_TRACT
DR ECACC; 06031002
DR GEO; GSM886887
DR GEO; GSM887952
DR Ximbio; 152847
RX PubMed=7646764;
RX PubMed=10523844;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BICR 6
AC CVCL_2314
SY BICR-6; BICR6
DR CCLE; BICR6_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 848753
DR ECACC; 05070501
DR GEO; GSM886888
DR GEO; GSM887953
DR Ximbio; 152848
RX PubMed=7646764;
RX PubMed=10523844;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 14
ST D16S539: 11
ST D5S818: 12
ST D7S820: 10
ST TH01: 6
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BICR 63
AC CVCL_S694
SY BICR-63; BICR63
RX PubMed=7646764;
RX PubMed=10523844;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BICR 68
AC CVCL_S695
SY BICR-68; BICR68
RX PubMed=7646764;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BICR 78
AC CVCL_2315
SY BICR-78; BICR78
DR EFO; EFO_0006543
DR BioSample; SAMN03473146
DR Cosmic; 848755
DR Cosmic; 1995346
DR Cosmic-CLP; 1240122
DR ECACC; 04072111
DR GDSC; 1240122
DR GEO; GSM827457
DR GEO; GSM1669624
DR Ximbio; 152849
RX PubMed=7646764;
RX PubMed=10523844;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 13,19
ST D21S11: 33.2
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 19
ST Penta D: 10
ST Penta E: 11,13
ST TH01: 6,9.3
ST TPOX: 9,10
ST vWA: 15,16
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BICR 82
AC CVCL_2316
SY BICR-82; BICR82
DR Cosmic; 848756
DR ECACC; 04072112
DR Ximbio; 152850
RX PubMed=7646764;
RX PubMed=10523844;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BICR/M1Rk
AC CVCL_4128
SY BICR/M1RK; BICR-M1Rk
DR CLO; CLO_0001978
DR ECACC; 96112021
CC Breed/subspecies: Marshall.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID Bid KO SV40 MEF
AC CVCL_U629
DR ATCC; CRL-2911
CC Knockout cell: Method=KO mouse; MGI; MGI:108093; Bid.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID BID007
AC CVCL_W890
DR Cosmic; 2093906
RX PubMed=24353160;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BID7
AC CVCL_1Q40
SY BID 7
RX PubMed=2722195;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybrid cell line
//
ID BIE
AC CVCL_HC67
SY Bovine Intestinal Epithelial cell line
RX PubMed=19830445;
RX PubMed=22047818;
RX PubMed=23497067;
CC Doubling time: 36.7 hours (PubMed=19830445).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Japanese black.
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Transformed cell line
//
ID BIHi001-A
AC CVCL_IT54
SY BCRT-3
DR BioSamples; SAMEA103885931
DR hPSCreg; BIHi001-A
CC From: Berlin Institute of Health; Berlin; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID BIHi004-A
AC CVCL_IT55
SY EpiCl5 iPSC
DR BioSamples; SAMEA103992834
DR hPSCreg; BIHi004-A
CC From: Berlin Institute of Health; Berlin; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BIHi005-A
AC CVCL_IT56
SY LMNA Pt5 mRNA cl 1 Stanford samples (SCVI 111 sample material
DR BioSamples; SAMEA104012190
DR hPSCreg; BIHi005-A
CC From: Berlin Institute of Health; Berlin; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID BIN-16
AC CVCL_S984
RX PubMed=2845729;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BIN-22
AC CVCL_S985
RX PubMed=2845729;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BIN-53
AC CVCL_S986
RX PubMed=2845729;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BIN-67
AC CVCL_S987
SY BIN67
DR BTO; BTO:0005818
DR Cosmic; 1948264
DR Cosmic; 2141841
DR Cosmic; 2161693
RX PubMed=1331173;
RX PubMed=2845729;
RX PubMed=23433318;
DI NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BIN40
AC CVCL_E482
DR dbMHC; 48498
DR ECACC; 86112010
DR IHW; IHW9296
DR IMGT/HLA; 10316
WW http://bioinformatics.hsanmartino.it/ecbr/cl296.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Bine4.8
AC CVCL_GR74
SY BINE4.8
DR TOKU-E; 4010
RX PubMed=7499835;
CC Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_GR73 ! 18-81
CA Transformed cell line
//
ID Bing
AC CVCL_3652
SY CAK 8; CAK8
DR CLO; CLO_0001979
DR ATCC; CRL-11554
DR BioSample; SAMN03471341
DR TOKU-E; 671
RX Patent=WO1994019478A1;
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12,15
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,17,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3645 ! Anjou 65
SX Female
CA Transformed cell line
//
ID BIONi010-A
AC CVCL_1E66
SY K1_shp53; K1P53
DR BioSamples; SAMEA3105765
DR EBiSC; BIONi010-A
DR ECACC; 66540022
DR hPSCreg; BIONi010-A
RX PubMed=25241739;
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1E67 ! BIONi010-B
OI CVCL_1E68 ! BIONi010-C
SX Male
CA Induced pluripotent stem cell
//
ID BIONi010-B
AC CVCL_1E67
SY K2_shp53; K2P53
DR BioSamples; SAMEA3158000
DR EBiSC; BIONi010-B
DR ECACC; 66540030
DR hPSCreg; BIONi010-B
RX PubMed=25241739;
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1E66 ! BIONi010-A
OI CVCL_1E68 ! BIONi010-C
SX Male
CA Induced pluripotent stem cell
//
ID BIONi010-C
AC CVCL_1E68
SY K3_shp53; K3P53
DR BioSamples; SAMEA3158050
DR EBiSC; BIONi010-C
DR ECACC; 66540023
DR hPSCreg; BIONi010-C
RX PubMed=25241739;
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1E66 ! BIONi010-A
OI CVCL_1E67 ! BIONi010-B
SX Male
CA Induced pluripotent stem cell
//
ID BIONi010-C-2
AC CVCL_II81
SY BIONi010-C ApoE E3/E3 #H8 P32
DR BioSamples; SAMEA4342705
DR EBiSC; BIONi010-C-2
DR ECACC; 66540268
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1E68 ! BIONi010-C
SX Male
CA Induced pluripotent stem cell
//
ID BIONi010-C-3
AC CVCL_II82
SY BIONi010-C ApoE KO #KO30 P30
DR BioSamples; SAMEA4342740
DR EBiSC; BIONi010-C-3
DR ECACC; 66540269
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1E68 ! BIONi010-C
SX Male
CA Induced pluripotent stem cell
//
ID BIONi010-C-4
AC CVCL_II83
SY BIONi010-C ApoE E4/E4 #B44 P27
DR BioSamples; SAMEA4452060
DR EBiSC; BIONi010-C-4
DR ECACC; 66540366
DR hPSCreg; BIONi010-C-4
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1E68 ! BIONi010-C
SX Male
CA Induced pluripotent stem cell
//
ID BIONi010-C-5
AC CVCL_II84
SY BIONi010-C CD33 E2del #N14 P26
DR ECACC; 66540367
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1E68 ! BIONi010-C
SX Male
CA Induced pluripotent stem cell
//
ID BIONi010-C-6
AC CVCL_II85
SY BIONi010-C ApoE E2/E2
DR BioSamples; SAMEA4454009
DR EBiSC; BIONi010-C-6
DR ECACC; 66540368
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1E68 ! BIONi010-C
SX Male
CA Induced pluripotent stem cell
//
ID BIONi010-C-7
AC CVCL_II86
SY BIONi010-C Trem2 R47H
DR BioSamples; SAMEA4454010
DR EBiSC; BIONi010-C-7
DR ECACC; 66540369
CC From: Bioneer A/S; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1E68 ! BIONi010-C
SX Male
CA Induced pluripotent stem cell
//
ID BIOT-0630-LOAD
AC CVCL_GP72
RX PubMed=27558606;
CC From: BioTalentum, Ltd.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID BIOT-0708-EHMT1
AC CVCL_IJ19
RX PubMed=27789404;
CC From: BioTalentum, Ltd.
CC Characteristics: Heterozygous for the EHMT1 p.Trp1138Ter mutation.
DI NCIt; C129976; Kleefstra syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BIOT-0726-LOAD
AC CVCL_GP73
RX PubMed=27558607;
CC From: BioTalentum, Ltd.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BIOT-0904-LOAD
AC CVCL_GP74
RX PubMed=27558608;
CC From: BioTalentum, Ltd.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BIOT-4828-LOAD
AC CVCL_GP75
RX PubMed=27558605;
CC From: BioTalentum, Ltd.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BIOT-7183-PSEN1
AC CVCL_GP76
RX PubMed=27558604;
CC From: BioTalentum, Ltd.
CC Characteristics: Heterozygous for the PSEN1 p.Val89Leu mutation.
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID BIU-87
AC CVCL_6881
SY BIU87
DR CCRID; 3142C0001000000093
DR KCB; KCB 2006103YJ
DR Wikidata; Q28658473
RX PubMed=26116706;
CC Problematic cell line: Contaminated/misidentified. Seems to contaminated by non-human cells (PubMed=26116706). Was originally thought to originate from a male patient urinary bladder carcinoma.
OX NCBI_TaxID=32644; ! Unidentified
SX Sex undetermined
CA Undefined cell line type
//
ID BIU-87/ADMR
AC CVCL_6882
RX PubMed=9594332;
CC Problematic cell line: Contaminated/misidentified. Parent cell line (BIU-87) seems to contaminated by non-human cells.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
OX NCBI_TaxID=32644; ! Unidentified
HI CVCL_6881 ! BIU-87
SX Sex undetermined
CA Undefined cell line type
//
ID BJ [Human B-cell]
AC CVCL_E483
DR dbMHC; 48499
DR ECACC; 94022524
DR IHW; IHW9254
DR IMGT/HLA; 10317
WW http://bioinformatics.hsanmartino.it/ecbr/cl254.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BJ [Human fibroblast]
AC CVCL_3653
SY FF-WT-BJ; BJ1
DR BTO; BTO:0003807
DR CLO; CLO_0001980
DR EFO; EFO_0002779
DR ATCC; CRL-2522
DR ChEMBL-Cells; CHEMBL3307781
DR ChEMBL-Targets; CHEMBL614358
DR Cosmic; 710853
DR ENCODE; ENCBS070WLP
DR ENCODE; ENCBS074ENC
DR ENCODE; ENCBS137RRI
DR ENCODE; ENCBS170GUW
DR ENCODE; ENCBS198NMJ
DR ENCODE; ENCBS335XLL
DR ENCODE; ENCBS339MSO
DR ENCODE; ENCBS610AAA
DR ENCODE; ENCBS611AAA
DR ENCODE; ENCBS612AAA
DR ENCODE; ENCBS613AAA
DR ENCODE; ENCBS614AAA
DR ENCODE; ENCBS615AAA
DR ENCODE; ENCBS616AAA
DR ENCODE; ENCBS683XYV
DR ENCODE; ENCBS753AAA
DR ENCODE; ENCBS754AAA
DR ENCODE; ENCBS772THG
DR ENCODE; ENCBS815JWZ
DR ENCODE; ENCBS911DVL
DR ENCODE; ENCBS935PZD
DR GEO; GSM248213
DR GEO; GSM248214
DR GEO; GSM472898
DR GEO; GSM472924
DR GEO; GSM472925
DR GEO; GSM579886
DR GEO; GSM579887
DR GEO; GSM945178
DR GEO; GSM945204
DR GEO; GSM945207
DR GEO; GSM945235
DR Lonza; 723
DR TOKU-E; 672
RX PubMed=23325432;
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=67
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/BJ_Stam_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,9
ST D16S539: 9,13
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 10,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID BJ epi iPS-C
AC CVCL_X732
WW http://harvard.eagle-i.net/i/00000147-c60c-15ae-6889-6c3880000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ hiPSC #11
AC CVCL_6D12
SY BJ hiPSC 5 factor #11
DR SKIP; SKIP000622
RX PubMed=18786420;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ hiPSC #12
AC CVCL_6D13
SY BJ hiPSC 5 factor #12
RX PubMed=18786420;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ hiPSC #5
AC CVCL_6D14
SY BJ hiPSC 4 factor #5
DR SKIP; SKIP000623
RX PubMed=18786420;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ hiPSC #8
AC CVCL_6D15
SY BJ hiPSC 4 factor #8
RX PubMed=18786420;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ RiPS-A
AC CVCL_X737
WW http://harvard.eagle-i.net/i/00000147-c60e-dd6e-6889-6c3880000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ RiPS-D
AC CVCL_X738
WW http://harvard.eagle-i.net/i/00000147-c610-0041-6889-6c3880000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ RiPS-E
AC CVCL_X739
WW http://harvard.eagle-i.net/i/00000147-c610-841f-6889-6c3880000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ SiPS-C
AC CVCL_X740
WW http://harvard.eagle-i.net/i/00000144-0889-602f-0803-96bd80000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X741 ! BJ SiPS-D
SX Male
CA Induced pluripotent stem cell
//
ID BJ SiPS-D
AC CVCL_X741
WW http://harvard.eagle-i.net/i/00000144-088d-7a75-0803-96bd80000000
CC From: Harvard University; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X740 ! BJ SiPS-C
SX Male
CA Induced pluripotent stem cell
//
ID BJ-610
AC CVCL_6F02
SY BJ/610
RX PubMed=1328042;
CC Transformant: NCBI_TaxID; 35252; Alcelaphine herpesvirus 1.
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Transformed cell line
//
ID BJ-RiPS-1.1
AC CVCL_C922
SY BJ_RiPS_1.1
DR GEO; GSM579907
DR ISCR; 1721
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ-RiPS-1.2
AC CVCL_C923
SY BJ_RiPS_1.2
DR GEO; GSM579908
DR ISCR; 1722
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ-RiPS-1.3
AC CVCL_C924
SY BJ_RiPS_1.3
DR GEO; GSM579909
DR ISCR; 1723
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ0003
AC CVCL_8S87
DR ECACC; 91090501
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BJ1-hTERT
AC CVCL_6573
AS CVCL_3654
SY hTERT-BJ1; HTERT-BJ1; hTERT-BJ; hTERT BJ; BJ hTERT; BJ1; BJ-1; BJ-5ta; BJ-tert; BJHTERT
DR ATCC; CRL-4001
DR CLO; CLO_0001981
DR BioSample; SAMN03472773
DR CCLE; BJHTERT_SKIN
DR Lonza; 155
RX PubMed=9454332;
RX PubMed=25984343;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/BJ-5ta_Struhl_protocol.pdf
WW http://www.immanis.com/TelomeraseImmortalizedCellLineCulturingGuide.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 36 hours (PubMed=25984343).
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,9
ST D16S539: 9,13
ST D18S51: 17,19
ST D21S11: 29
ST D3S1358: 14,16
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 9,11
ST FGA: 22,23
ST Penta D: 12,13
ST Penta E: 7,17
ST TH01: 7,8
ST TPOX: 10,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Telomerase immortalized cell line
//
ID BJ1-iPS1
AC CVCL_C921
SY BJ1-IPS1
DR GEO; GSM248215
DR ISCR; 13
RX PubMed=18157115;
CC From: Children's Hospital Boston; Boston; USA.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJ1-iPS3
AC CVCL_V235
RX PubMed=18157115;
CC From: Children's Hospital Boston; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJAB
AC CVCL_5711
SY BJAb; BJA-B; BJAB-1; BJA-B-1
DR BTO; BTO:0001931
DR EFO; EFO_0002815
DR BioSample; SAMN03470800
DR CGH-DB; 9192-4
DR ChEMBL-Cells; CHEMBL3308492
DR ChEMBL-Targets; CHEMBL613536
DR Cosmic; 998715
DR Cosmic; 1019312
DR Cosmic; 1037700
DR Cosmic; 1086323
DR Cosmic; 1127265
DR Cosmic; 1517659
DR Cosmic; 1588562
DR Cosmic; 1945179
DR DSMZ; ACC-757
DR GEO; GSM710427
DR GEO; GSM710443
DR GEO; GSM1059805
DR Lonza; 107
DR TOKU-E; 3575
RX PubMed=171663;
RX PubMed=179629;
RX PubMed=1915267;
RX PubMed=3495441;
RX PubMed=4369887;
RX PubMed=6286763;
RX PubMed=6600440;
RX PubMed=7316467;
RX PubMed=8344493;
RX PubMed=8515068;
RX PubMed=23292937;
RX PubMed=25485619;
WW http://www.addexbio.com/productdetail?pid=4884
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-73.html
CC Characteristics: EBV-negative.
CC Characteristics: Heterozygous for the TP53 p.His193Arg mutation.
CC Doubling time: ~40-60 hours (DSMZ).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8,10
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 16,22
ST D21S11: 27,28
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 15
ST FGA: 27,28
ST Penta D: 10,11
ST Penta E: 7
ST TH01: 7
ST TPOX: 6,9
ST vWA: 14,15 (DSMZ)
ST vWA: 14,16 (PubMed=25877200)
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BJAB-K3
AC CVCL_9876
SY BJAB/K3; BJABK3
DR EFO; EFO_0001090
RX PubMed=8627226;
RX PubMed=17166914;
CC Characteristics: EBV-negative.
CC Transfected with: UniProtKB; P12978; EBV EBNA2.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5711 ! BJAB
SX Female
CA Cancer cell line
//
ID BJAB-K5
AC CVCL_9666
SY BJAB/K5
RX PubMed=17166914;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5711 ! BJAB
SX Female
CA Cancer cell line
//
ID BJC
AC CVCL_0G92
DR SKIP; SKIP000561
RX PubMed=23283491;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJD
AC CVCL_0G93
DR SKIP; SKIP000562
RX PubMed=23283491;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3653 ! BJ [Human fibroblast]
SX Male
CA Induced pluripotent stem cell
//
ID BJMC338
AC CVCL_6574
RX PubMed=22295235;
CC Breed/subspecies: BALB/c.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6575 ! BJMC3879
SX Female
CA Cancer cell line
//
ID BJMC3879
AC CVCL_6575
DR Lonza; 108
RX PubMed=22295235;
CC Breed/subspecies: BALB/c.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6574 ! BJMC338
SX Female
CA Cancer cell line
//
ID BJNhem19
AC CVCL_B842
SY BJNhem 19; BJN hem19; JNCASRe001-A; JNCSRe001-A
DR hPSCreg; JNCSRe001-A
DR ISCR; 761
RX PubMed=18616385;
RX PubMed=20178003;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/bjnhem19.aspx
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=244
CC From: Jawaharlal Nehru Centre for Advanced Scientific Research; India.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0083.
CC Registration: UK Stem Cell Bank (UKSCB); R-08-022, Steering comm. appl. SCSC07-43(1).
CC Miscellaneous: Sibling to BJNhem20 (CVCL_B843).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID BJNhem20
AC CVCL_B843
SY BJNhem 20; BJN hem20; JNCASRe002-A; JNCSRe002-A
DR hPSCreg; JNCSRe002-A
DR ISCR; 762
RX PubMed=18616385;
RX PubMed=20178003;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/bjnhem20.aspx
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=245
CC From: Jawaharlal Nehru Centre for Advanced Scientific Research; India.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0084.
CC Registration: UK Stem Cell Bank (UKSCB); R-08-021, Steering comm. appl. SCSC07-43(2).
CC Miscellaneous: Sibling to BJNhem19 (CVCL_B842).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID BJNhem20-Asrij
AC CVCL_DQ71
RX PubMed=27345997;
CC Transfected with: MGI; MGI:1915345; Ociad1.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B843 ! BJNhem20
SX Female
CA Embryonic stem cell
//
ID BJNhem20-OCIAD1-CRISPR-20
AC CVCL_9S74
RX PubMed=27345969;
CC Knockout cell: Method=CRISPR/Cas9; HGNC; 16074; OCIAD1.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B843 ! BJNhem20
SX Female
CA Embryonic stem cell
//
ID BJNhem20-OCIAD1-CRISPR-39
AC CVCL_DQ69
RX PubMed=27345991;
CC Knockout cell: Method=CRISPR/Cas9 (1 of 2 alleles); HGNC; 16074; OCIAD1.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B843 ! BJNhem20
SX Female
CA Embryonic stem cell
//
ID BJNhem20-OCIAD1-OV
AC CVCL_AB54
RX PubMed=27345812;
CC Transfected with: HGNC; 16074; OCIAD1.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B843 ! BJNhem20
SX Female
CA Embryonic stem cell
//
ID BJNhem20-OCIAD1-Tet-On
AC CVCL_DQ66
RX PubMed=27345976;
CC Transfected with: HGNC; 16074; OCIAD1.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B843 ! BJNhem20
SX Female
CA Embryonic stem cell
//
ID BJNhem20-pCAG-EGFP
AC CVCL_DQ70
SY BJNhem20 pCAG-EGFP
RX PubMed=27345992;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B843 ! BJNhem20
SX Female
CA Embryonic stem cell
//
ID BJNhem20-pCAG-tdTomato
AC CVCL_DQ68
RX PubMed=27345986;
CC Transfected with: tdTomato; a bright red fluorescent protein derived from drFP583 (DsRed).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B843 ! BJNhem20
SX Female
CA Embryonic stem cell
//
ID BJNhem20-TetR
AC CVCL_DQ67
RX PubMed=27345981;
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B843 ! BJNhem20
SX Female
CA Embryonic stem cell
//
ID BJO,PA
AC CVCL_E484
SY BJO, PA
DR dbMHC; 48500
DR IHW; IHW9116
DR IMGT/HLA; 11661
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl116.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID BK-10
AC CVCL_S718
SY BK 10; BK10
DR SKY/M-FISH/CGH; 1465
RX PubMed=9719413;
RX PubMed=10221340;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BK-T
AC CVCL_0C07
DR Cosmic; 2239083
RX PubMed=1311980;
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BK0013
AC CVCL_GZ15
DR ECACC; 98100924
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 98100924; probable.
DI NCIt; C3407; Essential thrombocythemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BK0015
AC CVCL_8S88
DR ECACC; 99092421
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3407; Essential thrombocythemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID BKD
AC CVCL_M571
RX PubMed=2423498;
OX NCBI_TaxID=9685; ! Felis catus
SX Female
CA Cancer cell line
//
ID BKO84
AC CVCL_K035
RX PubMed=16794253;
CC Knockout cell: Method=KO mouse; MGI; MGI:96878; Blnk.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID BKP1
AC CVCL_1K06
RX PubMed=25314094;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BL
AC CVCL_U802
SY BLmel
DR Cosmic; 888987
DR Cosmic; 897737
DR Cosmic; 928724
DR GEO; GSM170823
RX PubMed=9331097;
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=15688405;
RX PubMed=17516929;
RX PubMed=19383913;
RX PubMed=23039341;
WW http://biogps.org/dataset/1409/63-melanoma-cell-lines/
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-10
AC CVCL_C131
SY BL10; BL 10; IARC/BL10; IARC-BL10; IARC BL10; IARC BL 10
DR Cosmic; 931116
RX PubMed=3934070;
RX PubMed=6825067;
RX PubMed=9473234;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BL-100
AC CVCL_1965
DR BioSample; SAMN03473437
DR DSMZ; ACC-684
CC Characteristics: EBV-negative.
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 9,13
ST D5S818: 10,11
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BL-104
AC CVCL_IU51
SY BL104; BL 104; IARC/BL104; IARC-BL104
RX PubMed=2052620;
RX PubMed=3035497;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IV18 ! IARC-629
CA Cancer cell line
//
ID BL-108
AC CVCL_IV12
SY BL108; BL 108; IARC/BL108; IARC-BL108
RX PubMed=1356511;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-113
AC CVCL_C132
SY BL113; BL 113; IARC/BL113; IARC-BL113
DR Cosmic; 1517662
RX PubMed=1356511;
RX PubMed=2052620;
RX PubMed=3934070;
RX PubMed=10997876;
CC Characteristics: Has a TP53 p.Arg273Cys mutation.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IV07 ! IARC-632
CA Cancer cell line
//
ID BL-116
AC CVCL_C133
SY BL116; BL 116; IARC/BL116; IARC-BL116
RX PubMed=1356511;
RX PubMed=3934070;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-12
AC CVCL_M640
SY BL12; BL 12; IARC/BL12; IARC-BL12; IARC BL12; IARC BL 12
RX PubMed=3027441;
RX PubMed=6825067;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Caution: Indicated as being from a male patient in PubMed=3027441 and from a female patient in PubMed=6825067.
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BL-121
AC CVCL_C160
SY BL121; BL 121; IARC/BL121; IARC-BL121
RX PubMed=3934070;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-125
AC CVCL_C161
SY BL125; BL 125; IARC/BL125; IARC-BL125
RX PubMed=3934070;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-126
AC CVCL_C134
SY BL126; BL 126; IARC/BL126; IARC-BL126
RX PubMed=3934070;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-13
AC CVCL_C135
SY BL13; BL 13; IARC/BL13; IARC-BL13; IARC BL13; IARC BL 13
RX PubMed=3934070;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-135
AC CVCL_IV13
SY BL135; BL 135; IARC/BL135; IARC-BL135
RX PubMed=1356511;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-136
AC CVCL_C136
SY BL136; BL 136; IARC/BL136; IARC-BL136
RX PubMed=3934070;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID BL-14
AC CVCL_M558
SY BL14; BL 14; IARC/BL14; IARC-BL14; IARC BL14; IARC BL 14
RX PubMed=3027441;
RX PubMed=6090749;
RX PubMed=6806672;
RX PubMed=6825067;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BL-16
AC CVCL_C137
SY BL16; BL 16; IARC/BL16; IARC-BL16; IARC BL16; IARC-BL-16; IARC BL 16; GM08686; GM17348
DR CLO; CLO_0010619
DR CLO; CLO_0013749
DR Coriell; GM08686
DR Coriell; GM17348
DR Cosmic; 931117
RX PubMed=2898508;
RX PubMed=2985508;
RX PubMed=3027441;
RX PubMed=3934070;
RX PubMed=6825067;
RX PubMed=9473234;
CC Part of: Human variation panel.
CC Population: Africans south of the Sahara.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BL-17
AC CVCL_C138
SY BL17; BL 17; IARC/BL17; IARC-BL17; IARC BL17; IARC BL 17
RX PubMed=3027441;
RX PubMed=3934070;
RX PubMed=6090749;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M555 ! BL-7
OI CVCL_M639 ! BL-21
SX Male
CA Cancer cell line
//
ID BL-18
AC CVCL_C139
SY BL18; BL 18; IARC/BL18; IARC-BL18; IARC BL18; IARC-BL-18; IARC BL 18; GM08687; GM17384
DR CLO; CLO_0010612
DR CLO; CLO_0012171
DR Coriell; GM08687
DR Coriell; GM17384
DR Cosmic; 931096
RX PubMed=2898508;
RX PubMed=2985508;
RX PubMed=3004968;
RX PubMed=3027441;
RX PubMed=3934070;
RX PubMed=6825067;
RX PubMed=9473234;
CC Part of: Human variation panel.
CC Population: Africans north of the Sahara.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BL-2
AC CVCL_1966
SY BL2; BL 2; BL 02; BL02; IARC/BL2; IARC-BL2; IARC BL2; IARC-BL-2; IARC BL 2
DR BTO; BTO:0002748
DR EFO; EFO_0005475
DR BioSample; SAMN03473506
DR Cosmic; 931095
DR DSMZ; ACC-625
DR Lonza; 110
RX PubMed=1356511;
RX PubMed=1915267;
RX PubMed=2052620;
RX PubMed=3027441;
RX PubMed=3035497;
RX PubMed=3004968;
RX PubMed=3934070;
RX PubMed=6806672;
RX PubMed=6825067;
RX PubMed=9473234;
CC Characteristics: EBV-negative.
CC Doubling time: ~24 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 8,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IV28 ! IARC-304
SX Male
CA Cancer cell line
//
ID BL-21
AC CVCL_M639
SY BL21; BL 21; IARC/BL21; IARC-BL21; IARC BL21; IARC BL 21
RX PubMed=3027441;
RX PubMed=6806672;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M555 ! BL-7
OI CVCL_C138 ! BL-17
SX Male
CA Cancer cell line
//
ID BL-22
AC CVCL_C140
SY BL22; BL 22; IARC/BL22; IARC-BL22; IARC BL22; IARC BL 22
RX PubMed=3027441;
RX PubMed=3934070;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BL-28
AC CVCL_M567
SY BL28; BL 28; IARC/BL28; IARC-BL28; IARC BL28; IARC BL 28
DR Cosmic; 931097
DR NCBI_Iran; C103
RX PubMed=3027441;
RX PubMed=6090749;
RX PubMed=6806672;
RX PubMed=6825067;
RX PubMed=9473234;
RX PubMed=17254797;
CC Characteristics: EBV-negative.
ST Source(s): PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 12,13
ST D21S11: 29,31
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 8,12
ST D8S1179: 10,13
ST FGA: 23,25
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C142 ! BL-30
OI CVCL_C144 ! BL-32
SX Male
CA Cancer cell line
//
ID BL-29
AC CVCL_C141
SY BL29; BL 29; IARC/BL29; IARC-BL29; IARC BL29; IARC-BL-29; IARC BL 29
DR Cosmic; 931118
RX PubMed=1356511;
RX PubMed=2898508;
RX PubMed=2985508;
RX PubMed=3027441;
RX PubMed=3934070;
RX PubMed=6806672;
RX PubMed=6825067;
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID BL-3 [Bovine leukemia]
AC CVCL_3454
SY BL3; BL-1
DR BTO; BTO:0004404
DR CLO; CLO_0001985
DR CLDB; cl458
DR ATCC; CRL-8037
DR ECACC; 86062401
DR Lonza; 111
RX PubMed=4171552;
CC Breed/subspecies: Hereford.
DI NCIt; C131469; Bovine leukemia
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Cancer cell line
//
ID BL-3 [Human Burkitt lymphoma]
AC CVCL_M562
SY BL3; BL 3; BL03; IARC/BL3; IARC-BL3; IARC BL3; IARC BL 3
RX PubMed=3027441;
RX PubMed=6806672;
RX PubMed=6825067;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BL-30
AC CVCL_C142
SY BL30; BL 30; IARC/BL30; IARC-BL30; IARC BL30; IARC BL 30
RX PubMed=1356511;
RX PubMed=1915267;
RX PubMed=3934070;
RX PubMed=6090749;
RX PubMed=8515068;
RX PubMed=9973220;
CC Characteristics: EBV-negative.
CC Characteristics: Has a TP53 p.Met246Tyr mutation.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M567 ! BL-28
OI CVCL_C144 ! BL-32
SX Male
CA Cancer cell line
//
ID BL-31
AC CVCL_C143
SY BL31; BL 31; IARC/BL31; IARC-BL31; IARC BL31; IARC-BL-31; IARC BL 31
RX PubMed=3027441;
RX PubMed=3934070;
RX PubMed=6090749;
RX PubMed=6806672;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID BL-32
AC CVCL_C144
SY BL32; BL 32; IARC/BL32; IARC-BL32; IARC BL32; IARC BL 32
RX PubMed=3934070;
RX PubMed=6090749;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M567 ! BL-28
OI CVCL_C142 ! BL-30
SX Male
CA Cancer cell line
** -----------------------------------------------------------------------
** CALIPHO group at the SIB - Swiss Institute of Bioinformatics
** Geneva, Switzerland
** -----------------------------------------------------------------------
**
** Description: References file for the Cellosaurus
** Version: 24.0
** Last update: 15-November-2017
**
** -----------------------------------------------------------------------
您正在向 biovector.net 发送关于产品 细胞株6-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
免费订购电话: 400-800-2947